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ABSTRACT 
 Pharmaceutical manufacturing has been undergoing a paradigm shift from ‘quality by 
testing’ to ‘quality by design’ in recent years. In the new scenario, along with a thorough 
understanding of product and process parameters, continuous monitoring of critical process 
parameters and critical quality attributes has paramount importance in order to ensure 
consistent product quality. Process analytical technology (PAT) tools e.g. Near-infrared 
spectroscopy (NIRS) are rapidly being developed for the purpose of monitoring product 
attributes during different stages of product manufacturing. With the advent of real-time 
release testing (RTRt) concept in the pharmaceutical industry, the need for monitoring all of 
the critical manufacturing steps is even more intensified. Consequently, there is a growing 
need to develop innovative and robust PAT tools for process understanding, monitoring, and 
control.  
 This Ph.D. work is directed to monitoring powder blend concentrations inside the feed 
frame during the tablet compression process. More specifically, near-infrared chemical 
imaging (NIR CI) has been introduced as a new PAT tool for feed frame monitoring 
comparing with NIRS as the reference method. NIR CI (‘area scan’-using discrete wavelength 
filter in front of NIR camera and ‘line scan’-using spectrograph in front of NIR camera) is 
capable of providing spectral and spatial information, both at the same time. This thesis also 
substantially contributes to increasing the available knowledge base on NIRS-based PAT 
methods for feed frame monitoring. 
 In the present work, the feasibility of NIR CI as a new PAT method for feed frame 
monitoring is verified in a 2 wheel feed frame of (Manesty Novapress) tablet compression 
machine both off-line and in-line. Following the optimization of sample presentation and data 
acquisition, the suitability of NIR CI (area scan) for feed frame concentration monitoring is 
evaluated in a simple composition comprising single active and 2 non-active ingredients. NIR 
CI is also evaluated for detecting segregation potential of the powder blends, in addition to 
concentration prediction (alone and in combination with NIRS). The initial off-line feasibility 
study led to the evaluation of in-line concentration monitoring in a pharmaceutically relevant 
tablet blend (single active and 5 non-active ingredients). Feed frame concentrations are 
compared with compressed tablets tested in-line and off-line with NIRS. Stratified tablet 
samples collected during the compression are also tested with ultraviolet (UV) spectroscopic 
analysis for assay comparison. Finally concentration monitoring for a complex pharmaceutical 
blend containing 2 actives and 5 non-active ingredients) is evaluated using NIR CI (line scan) 
and NIRS. 
 NIR CI (area scan) has been found to be suitable for concentration monitoring in 
comparison to NIRS. NIR CI has 5x larger tested sample volume than NIRS in imaging 
conditions (NIR light penetration, sample area covered by NIR CI, sample density) applied in 
the present work. NIR CI (area scan) has been found to be suitable to detect the presence of 
powder blend segregation inside the feed frame. In comparatively complex pharmaceutical 
blend compositions, NIR CI (area scan) captures gross concentration changes as low as 2% 
w/w but with slightly lower signal-to-noise ratio in comparison to NIRS. Feed frame 
concentrations as predicted by NIRS and NIR CI closely match with compressed tablet 
concentrations when tested by NIRS as well as UV assay. The geometry of feed frame and 
placement of PAT tools inside the feed frame govern the delay in onset of concurrent 
concentration change in the tablets. 
 NIR CI (line scan) has been found successful to monitor the concentration of 2 active 
ingredients in a complex powder blend with a higher signal-to-noise ratio as compared to NIR 
CI (area scan). NIRS and NIR CI (line scan) predicted concentrations of both the actives at a 
similar spatial location inside the feed frame matched closely indicating similar concentration 
monitoring performance of these PAT tools.  Capturing the entire area of the powder inside 
feed frame, NIR CI (line scan) gives data equivalent to multiple NIRS probes placed side by 
side inside the feed frame. This is certainly an advantage over NIRS since side by side 
placement of multiple NIR probes is not feasible considering the geometry of feed frame. Off-
line calibration models have been successfully transferred to in-line monitoring; such an 
approach can potentially offer high material and human resource savings when monitoring 
newer formulations. 
 Overall this Ph.D. thesis successfully demonstrates the feasibility and advantages of NIR 
CI for feed frame monitoring in comparison to NIRS. It has the potential to become a PAT 
workhorse alone or along with the NIRS methods for pharmaceutical process monitoring. 
Keywords: PAT; NIRS; NIR CI; RTRt; segregation; concentration monitoring; in-line; off-
line
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RÉSUMÉ 
Ces dernières années, la fabrication des produits pharmaceutiques a connu un changement 
de paradigme passant de la « qualité par le contrôle » à la « qualité par la conception ». Dans 
le nouveau modèle de pensée, le contrôle continu des paramètres critiques de procédé et des 
attributs critiques de la qualité, de même que la compréhension approfondie des paramètres de 
produit et de procédé, revêt une importance primordiale afin d’assurer une qualité cohérente 
du produit pharmaceutique. Les outils de technologie analytique des procédés (PAT), par 
exemple la spectroscopie proche infrarouge (NIRS), se développent rapidement dans le but de 
surveiller les attributs qualité du produit au cours des différentes étapes de fabrication. Avec 
l’arrivée de concept de test de libération en temps réel (RTRt) dans l’industrie 
pharmaceutique, le besoin de surveiller toutes les étapes critiques de la fabrication se renforce. 
C’est pourquoi il est de plus en plus nécessaire de développer des outils PAT innovants et 
robustes pour la compréhension, le contrôle et la maîtrise des procédés. 
 Ce travail de doctorat vise à contrôler les concentrations de mélanges de poudre à 
l’intérieur de la trémie d’alimentation pendant le procédé de compression des comprimés. Plus 
précisément, l’imagerie chimique en proche infrarouge (NIR CI) est introduite comme un 
nouvel outil PAT pour le contrôle du système d’alimentation, en comparaison avec la NIRS, 
méthode de référence. La NIR CI est capable de fournir des informations spectrales et 
spatiales, et celles-ci en même temps. Cette thèse contribue également à l’augmentation 
considérable de la connaissance sur les méthodes PAT basées sur la NIRS pour le contrôle du 
système d’alimentation. 
Dans ce travail, la faisabilité de la NIR CI en tant que nouvelle méthode PAT pour la 
surveillance du système d’alimentation est vérifiée hors-ligne et en ligne, dans une trémie 
d’alimentation à deux roues de la machine de compression (Manesty Novapress). Après 
l’optimisation de la préparation des échantillons et de l’acquisition des données, la pertinence 
de la NIR CI pour le contrôle de la concentration dans la trémie d’alimentation est évaluée à 
partir d’un mélange simple comprenant un principe actif et deux excipients inertes. La NIR CI 
est également évaluée pour son potentiel de détection de la ségrégation des mélanges de 
poudres, en plus de la prévision de la concentration (seul et en combinaison avec la NIRS). 
L’étude initiale de faisabilité, effectuée hors ligne, a conduit à l’évaluation du contrôle de la 
concentration en ligne dans un mélange approprié de comprimés pharmaceutiques (1 principe 
actif et 5 excipients inertes). Les concentrations dans la trémie d’alimentation sont comparées 
aux comprimés testés par NIRS en ligne et hors ligne. Des échantillons de comprimés 
stratifiés collectés pendant la compression sont également testés par spectroscopiques UV 
pour la comparaison des dosages. Enfin, la surveillance de la concentration d’un mélange 
pharmaceutique complexe contenant 2 principes actifs et 5 excipients inertes est faite par NIR 
CI (balayage linéaire) et NIRS. 
La NIR CI (d’image globale), en comparaison à la NIRS, est réputée adaptée au contrôle 
de la concentration. La NIR CI permet de tester un volume d’échantillon 5 fois supérieur à la 
NIRS, dans les conditions d’imagerie appliquées (entrée de lumière NIR, surface d’échantillon 
couverte par NIR CI, densité d’échantillon) des travaux actuels. La NIR CI est réputée 
appropriée pour détecter la ségrégation d’un mélange de poudres dans la trémie 
d’alimentation. Dans des mélanges pharmaceutiques relativement complexes, la NIR CI 
détecte des variations de concentrations brutes aussi faibles que 2 % w/w, mais avec un 
rapport signal/bruit légèrement plus faible que la NIRS. Les concentrations dans la trémie 
d’alimentation prédite par la NIRS et la NIR CI correspondent de près aux concentrations des 
comprimés lorsqu’elles sont testées par NIRS, ainsi que par dosage UV. La géométrie de la 
trémie d’alimentation et la mise en place d’outils PAT à l’intérieur du système d’alimentation 
déterminent le délai de début du changement simultané de la concentration dans les 
comprimés. 
Le balayage linéaire NIR CI est connu pour contrôler avec succès la concentration de 2 
ingrédients actifs dans un mélange de poudre complexe avec un rapport signal sur bruit plus 
élevé par rapport à la NIR CI à filtre unique. La NIRS et NIR CI (balayage linéaire) prévoient 
des concentrations des deux actifs aux emplacements spacieux similaires à l’intérieur de la 
trémie d’alimentation correspondent étroitement indiquant une performance de surveillance de 
la concentration similaire de ces outils PAT.   
Capturant la totalité de la surface de la poudre dans la trémie d’alimentation, la NIR CI 
(balayage linéaire) fournit des données équivalentes à plusieurs sondes NIRS placées côte à 
côte à l’intérieur du système d’alimentation. Ceci est certainement un avantage par rapport à la 
NIRS, car un tel placement de sondes NIR n’est pas réalisable compte tenu de la géométrie de 
la trémie d’alimentation. Les modèles d’étalonnage hors ligne ont été remplacés avec succès 
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par des modèles en ligne ; une telle approche peut potentiellement offrir des économies 
importantes en matériel et en ressources humaines lors du contrôle de nouvelles formulations. 
Dans l’ensemble, cette thèse de doctorat démontre avec succès la faisabilité et les 
avantages de la NIR CI par rapport à la NIRS pour le contrôle dans la trémie d’alimentation. 
Elle a le potentiel de devenir un outil PAT fiable, seul ou avec les méthodes NIRS, pour la 
surveillance des procédés pharmaceutiques. 
 
Mots-clés : PAT; spectroscopie proche infrarouge (NIRS); l’imagerie chimique en proche 
infrarouge (NIR CI); test de libération en temps réel (RTRt); contrôler des concentrations; en 
ligne; hors ligne 
  v 
ACKNOWLEDGMENTS 
Completing doctoral studies had been my long cherished dream. Indeed, this has been a 
memorable phase of my life and I solemnly express my gratitude to all the people who have 
directly and indirectly contributed to realizing my dream! 
 
First of all, I would like to thank my research director Prof. Ryan Gosselin for showing 
confidence in me and offering me this opportunity. I still remember your reply to my first 
email and your prompt replies ever since! I am also grateful to my research co-director Prof. 
Nicolas Abatzoglou, you both have been great personal and professional supporters. I will 
always cherish the learnings and time spent with you. 
 
I am grateful to Jean-Sébastien (Pfizer, Canada) along with Prof. Nicolas Abatzoglou and 
Prof. Ryan Gosselin for management of Pfizer PAT research chair and allowing me becoming 
a part of the team. 
 
I would like to thank Jean Maxime Guay for helping me with arranging experimental 
equipment and materials as well as for all the useful discussions during the development of 
this work. I would also like to thank all other colleagues from Pfizer including Antoine 
Cournoyer, Chi-Shi Chen, Pierre Philippe Lapointe Garant, Pierre Luc Bélanger and Alyssa 
Langlet for their timely help. 
 
I will be always thankful to Marc Couture, Jacques Gagné, Serge Gagnon for their cooperation 
in the preparation of my experimental setup and other logistics. I am grateful for your 
availability and accommodating my all ‘urgent’ requests. Marc, I will never forget the 
patience you showed when I used to practice my French with you- Merci beaucoup! I am also 
thankful to Sylvie Lebrun and France Auclair for your timely help and guidance in all 
administrative matters. Huge thanks to Fatiha and Amine for helping me with french 
translation. 
 
  vi 
I am grateful to members of the jury (Ryan Gosselin, Nicolas Abatzoglou, Jean-Maxime 
Guay, Lauren Briens and François Gitzhofer for agreeing to assess my work as well as for 
their valuable time. 
 
Last 3 years have been very memorable in the research lab due to all the nice colleagues I got 
to interact. Pedro Durão -thanks for helping me in my initial settlement as well as later 
working in the laboratory. Clémence and Oumaima -thank you for all your support especially 
to meet health care and childcare needs of my family. Francis and Philippe- thank you for your 
help with Matlab and all nice discussions we had. Marie José -thank you for reviewing my 
writings and all guidance. I am also thankful to other colleagues-Charlotte, Barbara, Azher, 
Yuwei for making this journey memorable. Along with the laboratory work, I spent most of 
my time in office with Mounia, Mauricio, Amine, and Frank -thank you for all nice 
discussions and friendship. 
 
I would also like to thank my friends outside of the university campus- Pavitran, Rajesh, 
Veeresh, Machindra, Michel, Kiran, Roopesh, Rajani, Charith, Diwakar, Shrivatsa, and all 
others (the list is truly long!).  I would always cherish the memories we made together. 
 
On the family side, I really appreciate all the sacrifices, companionship and support shown by 
my better half- Priyanka. I am sure; I would not have made my stay possible in Canada 
without you. While I had ups and downs in the laboratory work, you always sensed them very 
appropriately and helped me to sail through. I can’t forget to mention the little princes- 
Ananya who always made me rejoice and forget the unwanted at the end of each day. You 
both have been really a great driving force for me. 
 
While I am writing this part of my thesis, I remember all the efforts my parents put 
together to make me successful in my life. I could not have achieved this Ph.D. dream without 
your support and understanding when I choose to move far away from home. I would always 
owe you for every success in my life. 
 
  vii 
CONTENTS 
RÉSUMÉ ................................................................................................................................... iii 
ACKNOWLEDGMENTS ........................................................................................................... v 
LIST OF TABLES .................................................................................................................... xv 
LEXICON ............................................................................................................................... xvii 
LIST OF ACRONYMS ............................................................................................................ xxi 
CHAPTER 1 INTRODUCTION ............................................................................................. 1 
1.1 Context and problem to solve ................................................................................................ 1 
1.1.1 Pharmaceutical manufacturing regulations ........................................................................ 2 
1.1.2 Process analytical technology (PAT) initiative .................................................................. 4 
1.1.3 Pfizer research chair in PAT ............................................................................................... 5 
1.1.4 PAT in tablet manufacturing process ................................................................................. 6 
1.1.5 Role of feed frame in tablet compression ........................................................................... 7 
1.2 NIR chemical imaging (NIR CI) ........................................................................................... 8 
1.2.1 NIR CI acquisition .............................................................................................................. 8 
1.2.2 NIR CI set up .................................................................................................................... 10 
1.2.3 Spectral transformation of NIR images ............................................................................ 12 
1.3 NIR spectroscopy ................................................................................................................ 13 
1.3.1 NIRS brief theoretical background ................................................................................... 13 
1.3.2 NIRS data collection and pre-treatments .......................................................................... 15 
1.4 Definition of a current research project ............................................................................... 16 
1.5 The objective of the research work...................................................................................... 19 
1.6 Original contributions .......................................................................................................... 20 
1.7 Document plan ..................................................................................................................... 22 
CHAPTER 2 STATE OF THE ART ..................................................................................... 25 
2.1 Criticality of feed frame operation ...................................................................................... 25 
2.2 NIRS suitability for PAT ..................................................................................................... 27 
2.3 Pharmaceutical PAT applications of NIRS ......................................................................... 27 
2.4 NIRS PAT applications for feed frame monitoring............................................................. 29 
2.5 Pharmaceutical PAT applications of NIR CI ...................................................................... 32 
2.6 Chemometrics in NIRS and NIR CI-based PAT applications ............................................. 33 
 CONTENTS 
 
viii 
2.6.1 Univariate methods .......................................................................................................... 33 
2.6.2 Multivariate methods ........................................................................................................ 34 
CHAPTER 3 Concentration monitoring with NIR CI (area scan) in a tableting press ......... 41 
3.1 Introduction ......................................................................................................................... 45 
3.1.1 NIRS as PAT tool for tablet manufacturing ..................................................................... 45 
3.1.2 Near-infrared chemical imaging (NIR CI) in feed frame monitoring .............................. 46 
3.2 Materials .............................................................................................................................. 47 
3.3 Methods ............................................................................................................................... 47 
3.3.1 NIR penetration in samples .............................................................................................. 47 
3.3.2 Feed frame set-up ............................................................................................................. 48 
3.3.3 Data acquisition inside the feed frame ............................................................................. 49 
3.3.3.1 NIR probe ...................................................................................................................... 49 
3.3.3.2 NIR camera ................................................................................................................... 50 
3.3.4 Formulations ..................................................................................................................... 51 
3.3.5 Data acquisition ................................................................................................................ 52 
3.3.5.1 NIRS .............................................................................................................................. 52 
3.3.5.2 NIR CI (area scan) ......................................................................................................... 53 
3.3.6 Data treatment .................................................................................................................. 53 
3.3.7 Data analysis by PCA and PLS ........................................................................................ 55 
3.4 Results and discussion ......................................................................................................... 56 
3.4.1 Sample volume ................................................................................................................. 56 
3.4.2 Qualitative NIRS analysis ................................................................................................ 58 
3.4.3 Qualitative NIR CI (area scan) analysis ........................................................................... 58 
3.4.4 Quantitative analysis ........................................................................................................ 60 
3.4.5 Average sample image analysis ....................................................................................... 64 
3.5 Conclusion ........................................................................................................................... 66 
CHAPTER 4 In-line monitoring of Ibuprofen during and after the tablet compression using 
NIRS………….. ........................................................................................................................ 69 
4.1 Introduction ......................................................................................................................... 73 
4.1.1 PAT for in-line feed frame monitoring ............................................................................ 73 
4.1.2 PAT for in-line tablet monitoring..................................................................................... 74 
  ix 
4.1.3 PAT for combined feed frame and tablet monitoring ...................................................... 75 
4.2 Materials .............................................................................................................................. 76 
4.2.1 Formulation composition .................................................................................................. 76 
4.3 Equipment and Methods ...................................................................................................... 77 
4.3.1 Feed frame monitoring (in-line) ....................................................................................... 78 
4.3.2 Tablet-monitoring (in-line) ............................................................................................... 79 
4.3.3 Tablet testing (off-line) ..................................................................................................... 79 
4.3.4 NIRS data acquisition and pre-treatment.......................................................................... 80 
4.3.5 NIRS wavelength selection .............................................................................................. 81 
4.3.6 PCA and PLS analysis ...................................................................................................... 83 
4.3.7 Kinetics ............................................................................................................................. 84 
4.3.8 Sample volume inside the feed frame............................................................................... 85 
4.4 Results and discussion ......................................................................................................... 86 
4.4.1 Tablet off-line testing ....................................................................................................... 86 
4.4.1.1 UV assay testing of tablet sub-samples ......................................................................... 86 
4.4.1.2 NIRS testing of tablet sub-samples ............................................................................... 86 
4.4.2 In-line NIRS qualitative testing inside the feed frame and tablets ................................... 88 
4.4.2.1 Qualitative testing inside the feed frame ....................................................................... 89 
4.4.2.2 Qualitative testing of tablets .......................................................................................... 91 
4.4.3 In-line NIRS quantitative testing inside the feed frame and in tablets ............................. 91 
4.4.3.1 Quantitative analysis inside the feed frame ................................................................... 91 
4.4.3.2 Quantitative tablet testing .............................................................................................. 93 
4.4.3.3 Comparison of off-line and in-line PLS in tablet monitoring ....................................... 94 
4.4.4 In-line concentration change kinetics ............................................................................... 95 
4.4.4.1 Kinetics inside the feed frame ....................................................................................... 95 
4.4.4.2 Kinetics in tablets .......................................................................................................... 96 
4.4.4.3 Comparison of kinetics inside the feed frame and inside the tablets............................. 98 
4.4.5 Sample volume inside the feed frame............................................................................... 98 
4.5 Conclusion ........................................................................................................................... 99 
CHAPTER 5 In-line concentration monitoring in a multicomponent blend inside the tablet 
press using NIR CI (area scan) ................................................................................................ 101 
 CONTENTS 
 
x 
5.1 Introduction ....................................................................................................................... 105 
5.1.1 NIR CI in feed frame monitoring ................................................................................... 105 
5.2 Materials ............................................................................................................................ 105 
5.3 Methods ............................................................................................................................. 105 
5.3.1 Selection of suitable bandpass NIR filter ....................................................................... 106 
5.3.2 Data Acquisition ............................................................................................................. 108 
5.3.3 Data treatment and analysis ............................................................................................ 109 
5.4 Results and discussion ....................................................................................................... 109 
5.4.1 Comparison of NIR CI (area scan) and NIRS PLS models ........................................... 109 
5.4.2 Comparison of NIR CI (area scan) predicted concentrations with tablet assay ............. 112 
5.5 Conclusion ......................................................................................................................... 113 
CHAPTER 6 Simultaneous multiple components concentration monitoring inside the tablet 
press using NIRS and NIR CI (line scan) ............................................................................... 115 
6.1 Introduction ....................................................................................................................... 119 
6.1.1 RTRt in tablet manufacturing ......................................................................................... 119 
6.1.2 NIRS in feed frame monitoring ...................................................................................... 120 
6.1.3 NIR CI in feed frame monitoring ................................................................................... 120 
6.1.4 NIRS and NIRCI for concentration monitoring inside feed frame ................................ 121 
6.2 Materials and methods ...................................................................................................... 122 
6.2.1 Materials ......................................................................................................................... 122 
6.2.1.1 Formulation composition ............................................................................................ 122 
6.2.2 Equipment and Methods ................................................................................................. 124 
6.2.2.1 Feed frame monitoring (In-line) .................................................................................. 124 
6.2.2.2 NIRS data acquisition and pre-treatment .................................................................... 125 
6.2.2.3 NIR CI (line scan) data acquisition and pre-treatment ................................................ 126 
6.2.2.4 NIRS Wavelength selection ........................................................................................ 127 
6.2.2.5 PLS calibration and validation models ........................................................................ 129 
6.2.2.6 Comparison of NIRS and NIR CI (line scan) predictions inside feed frame .............. 130 
6.2.2.7 Sample volume inside feed frame ............................................................................... 130 
6.3 Results and discussion ....................................................................................................... 131 
6.3.1 Off-line NIRS PLS calibration models .......................................................................... 131 
  xi 
6.3.2 Off-line NIR CI (line scan) PLS calibration models ...................................................... 132 
6.3.3 Comparison of NIRS and NIR CI (line scan) for concentration prediction ................... 134 
6.3.4 Calibration model transfer off-line (lab) to in-line (production) .................................... 136 
6.3.5 Comparison of NIRS and NIR CI (line scan) predictions inside feed frame ................. 137 
6.4 Conclusion ......................................................................................................................... 139 
CHAPTER 7 CONCLUSION .............................................................................................. 141 
CHAPTER 8 FUTURE PLAN ............................................................................................ 145 
ANNEXES .............................................................................................................................. 147 
REFERENCES ........................................................................................................................ 155 
  xii 
LIST OF FIGURES 
Figure 1.1 : Schematic presentation of a feed frame with 2 paddle wheel ................................. 8 
Figure 1.2 : Schematic reflection of NIR CI [22] ..................................................................... 10 
Figure 1.3 : Schematic representation of hyperspectral NIR CI [20] ...................................... 11 
Figure 1.4: Schematic representation of unfolding hyperspectral image [20] ......................... 13 
Figure 1.5: Different functional groups and their NIR absorbance range [27] ....................... 14 
Figure 1.6: Chemical structure of Ibuprofen and Ascorbic acid [28][29] ............................... 15 
Figure 1.7: NIR CI using a single filter (A) and spectrograph (B) ........................................... 18 
Figure 2.1: Experimental NIR set up at feed frame [16] .......................................................... 31 
Figure 3.1: Sample tray (a) complete view, and (b) cross-section ........................................... 48 
Figure 3.2: Feed frame set-up: (a) Material flow, and (b) NIRS and NIR CI (area scan) 
locations .................................................................................................................................... 49 
Figure 3.3: NIR CI (area scan) inside the feed frame: without a flat insert (a-top view, b-
schematic vertical cross-section), and with a flat surface (c-top view, d-schematic vertical 
cross-section) ............................................................................................................................ 51 
Figure 3.4: (a) NIR reflectance spectra of individual components and composite samples, (b) 
SG second derivative pretreated spectra of individual components and composite samples ... 54 
Figure 3.5: Histogram of a binary image ................................................................................. 55 
Figure 3.6: NIR penetration in samples: (a) PCA score plot NIRS, and (b) NIR CI (area scan) 
histogram ................................................................................................................................... 57 
Figure 3.7: PCA score plots of NIRS data (Markers with different color represent % w/w 
content of ascorbic acid in the respective sample) ................................................................... 58 
Figure 3.8: Pixel intensity histograms of calibration samples (Color represents % w/w content 
of ascorbic acid in the respective sample) ................................................................................ 59 
Figure 3.9: PCA score plot of NIR CI (area scan) (Markers with different color represent % 
w/w content of ascorbic acid in the respective sample) ............................................................ 60 
Figure 3.10: Predicted concentrations versus sample in test I with the combined NIRS/NIR CI 
(area scan) model (Color represents % w/w content of ascorbic acid in the respective sample)
 ................................................................................................................................................... 63 
  xiii 
Figure 3.11: Trial 2 average sample images (a-f represent the average image of 3%, 4%, 6%, 
8%, 9%, and 12% w/w ascorbic acid samples respectively, The blue to red color bar 
represents decreasing pixel intensity) ....................................................................................... 65 
Figure 3.12: Subsections of the image used in the PLS analysis .............................................. 65 
Figure 4.1: NIRS location on the feed frame............................................................................. 78 
Figure 4.2: Raw NIR reflectance spectra of Ibuprofen pellets, placebo, and 18 % w/w 
Ibuprofen blend compositions ................................................................................................... 81 
Figure 4.3: MSC treated full NIR spectra and a selected range of 1100-1250 nm for off-line 
tablet analysis (a-b), feed frame analysis (c-d) and in-line tablet analysis (e-f) respectively. . 82 
Figure 4.4: Plot of UV assay results versus off-line NIRS-predicted Ibuprofen concentrations 
in tablet sub-samples ................................................................................................................. 88 
Figure 4.5: (a) Score plot of PC1 for PCA using full NIR spectra (1100-1701 nm). (b) Score 
plot of PC1 for PCA using selected NIR spectra (1100-1250 nm) inside the feed frame ......... 90 
Figure 4.6: PC1 values for all tablets using NIR spectra in the 1101-1250-nm range ............ 91 
Figure 4.7: NIRS PLS-predicted concentrations inside the feed frame and UV assay of tablet 
sub-samples ............................................................................................................................... 92 
Figure 4.8: NIRS PLS-predicted Ibuprofen concentrations in tablets (average of 28) and UV 
assay values (no averaging was performed) of tablet sub-samples .......................................... 93 
Figure 4.9: PLS-predicted tablet concentrations with off-line and in-line NIRS ...................... 94 
Figure 4.10: Differences in feed frame depth at the first and second wheel ............................. 97 
Figure 4.11: Ibuprofen concentration comparison inside the feed frame and tablets with 
expected concentration as well as UV assay values of tablet sub-samples ............................... 98 
Figure 5.1: NIR CI (area scan) of 18% w/w Ibuprofen powder blends taken with different 
bandpass filters ........................................................................................................................ 106 
Figure 5.2: NIR CI (area scan) showing different pixel intensities as a function of different 
Ibuprofen concentration .......................................................................................................... 108 
Figure 5.3: NIR CI (area scan) predicted Ibuprofen concentrations inside the feed frame, the 
expected and NIRS predicted concentrations .......................................................................... 110 
Figure 5.4: Variance in NIRS and NIR CI (area scan) predicted Ibuprofen concentrations 
inside the feed frame ................................................................................................................ 112 
Figure 6.1 : NIRS and NIR CI (line scan) location on the feed frame .................................... 124 
 LISTE OF FIGURES 
 
xiv 
Figure 6.2: a) Location of the observation window on the feed frame, b) NIR CI (line scan) 
output image and c) NIR spectra obtained by averaging all of the image pixels. .................. 127 
Figure 6.3: Savitzky-Golay second derivative spectra of Ibuprofen and Ascorbic acid ......... 128 
Figure 6.4: a) NIRS spectra of key ingredients of the tablet composition and b) NIRS spectra 
c) NIR CI (line scan) spectra of all blends in off-line trial ..................................................... 129 
Figure 6.5: NIRS PLS predicted a) Ibuprofen and b) Ascorbic acid concentrations in 
calibration and validation samples ......................................................................................... 132 
Figure 6.6: NIR CI (line scan) PLS predicted a) Ibuprofen and b) Ascorbic acid 
concentrations in calibration and validation samples ............................................................ 133 
Figure 6.7: Variance in predicted Ibuprofen concentrations comparing NIR CI (line scan) and 
NIRS PLS models .................................................................................................................... 135 
Figure 6.8: Variance in predicted Ascorbic acid concentrations comparing NIR CI (line scan) 
and NIRS PLS models ............................................................................................................. 136 
Figure 6.9: a) Plot of NIR CI (line scan) (in the middle section) and NIRS predicted 
concentrations for Ibuprofen b) Plot of NIR CI (line scan) (in middle sections) and NIRS 
predicted concentrations for Ascorbic acid ............................................................................ 138 
Figure A.8.1: MicroNIR in SS housing ................................................................................... 147 
Figure A.8.2: Working principle of the linear variable filter (LVF) ....................................... 147 
Figure A.8.3: Schematic representations of LVF principle .................................................... 148 
Figure A.8.4: Schematic representations of NIR CI scanning and output .............................. 150 
Figure A.8.5: Spectrograph side view ..................................................................................... 150 
Figure A.8.6: Spectrograph front view (slit is enlarged for visibility) ................................... 150 
 
 
 
 
 
  xv 
LIST OF TABLES 
Table 2.1 : Representative applications of NIRS-based Chemometric techniques during tablet 
manufacturing process .............................................................................................................. 37 
Table 3.1: Sample compositions in trials 1 and 2 ..................................................................... 52 
Table 3.2: Summary of PLS performance indicators ................................................................ 61 
Table 3.3:  Summary of PLS-predicted concentrations ............................................................. 62 
Table 3.4 :  Average predicted concentrations in different image sections .............................. 66 
Table 4.1: Formulation composition with five different Ibuprofen levels (all concentration 
values are in % w/w) ................................................................................................................. 77 
Table 4.2: NIR spectral acquisition parameters ....................................................................... 78 
Table 4.3: Summary of different PLS models ............................................................................ 84 
Table 4.4:  RMSE values at selected wavelength ranges .......................................................... 87 
Table 4.5: Standard deviation of tablet concentrations by NIRS and UV assay ....................... 95 
Table 4.6:  Kinetics of blend concentrations inside the feed frame .......................................... 96 
Table 4.7: Kinetics of blend concentrations in tablets .............................................................. 97 
Table 8: Mean and standard deviation of NIR CI (area scan) and NIRS model predicted 
concentrations ......................................................................................................................... 111 
Table A.9: Properties of Micro NIR spectrophotometer ......................................................... 148 
  xvii 
LEXICON 
Term Definition 
 
Tablet 
 
 
 
 
Tablet press 
 
 
Hopper 
 
 
 
Feed Frame 
 
 
 
Turret 
 
 
Die 
 
 
 
 
Paddle wheel 
 
 
 
Segregation 
 
A pharmaceutical solid dosage form containing a 
medicament or medicaments with or without 
suitable excipients which is prepared by 
compression of the defined powder blend 
 
An equipment used to make the tablets using a 
defined powder blend 
 
A piece of equipment which holds bulk powder 
above the tablet press and delivers it to feed 
frame to fill the dies 
 
Part of the tablet press that receives the powder 
coming from the hopper and distributes to the 
dies 
 
A set of 3 concentric wheels which are used to 
install upper punches, dies and lower punches 
 
A cavity on die table/turret in which the powder 
coming from the feed frame enters to be 
compressed. It decides the size and shape of the 
tablet. 
 
A circular wheel with peripherally attached small 
paddles that keeps the powder circulating inside 
the feed frame in order to fill into the dies 
 
It is the tendency of particles to separate from 
bulk according to their individual physical 
properties such as size, shape, density, etc. 
  
 
 
  xix 
LIST OF SYMBOLS 
Symbol Definition            Units 
Ia  
Ib 
Is 
Ib 
R 
ŷ 
𝑦0 
A 
k 
t 
R 
B 
C 
Measured intensity of reflected light  
Reflectance measured from high reflectance standard 
Measured intensity of light reflected from the sample 
Measured instrument response in the dark 
Measured diffuse reflectance 
Predicted relative concentration 
Initial Concentration 
Theoretical Concentration Difference 
First-Order Rate Constant 
Time 
NIRS Sample Area 
NIRS Penetration Depth 
Sample Bulk Density 
gray levels 
gray level 
gray level 
gray level 
gray level 
% w/w 
% w/w 
% w/w 
% w/w per min 
min 
cm
2
 
mm 
g/mL 
  xxi 
LIST OF ACRONYMS 
 
Acronym Definition 
US FDA 
EMEA 
MHRA 
MHLW 
WHO 
ICH 
PAT 
CGMP 
CQA 
CPP 
QbD 
NIRS 
NIR CI 
MVDA 
UV 
DEM 
SNV 
MSC 
API 
PLS 
PCA 
PCR 
FPA 
PCs 
RTRt 
AA 
DCP 
MCC 
R
2
adj  
RMSEC 
RMSECV 
RMSEP  
SG 
LIF 
RGB 
rpm 
RMSE 
NIPALS 
 
United States Food and Drugs Administration 
European Medicines Evaluation Agency 
Medicines and Healthcare Products Regulatory Agency 
Ministry of Health, Labour, and Welfare 
World Health Organization 
International Conference on Harmonization 
Process Analytical Technology 
Current good manufacturing practices 
Critical Quality Attributes 
Critical Process Parameters 
Quality by Design 
Near-infrared spectroscopy 
Near-infrared chemical imaging 
Multivariate Data Analysis 
Ultra-violet 
Discrete Element Method 
Standard Normal Variate 
Multiplicative Scatter Correction 
Active Pharmaceutical Ingredient 
Partial Least Squares 
Principal Component Analysis 
Principal Component Regression 
Focal Plane Arrays 
Principal Components 
Real Time Release Testing 
Ascorbic Acid 
Dicalcium Phosphate Dihydrate 
Microcrystalline Cellulose 
Adjusted Coefficient of Determination  
Root Mean Square Error in Calibration 
Root Mean Square Error in Cross-Validation 
Root Mean Square Error in Prediction 
Savitzky-Golay 
Light-Induced Fluorescence 
Red-Green-Blue 
Revolutions per Minute 
Root Mean Square Error 
Nonlinear Iterative Partial Least Squares 
 
  1 
CHAPTER 1 INTRODUCTION 
1.1 Context and problem to solve 
The availability of safe and efficacious medications is nothing less than the basic needs 
ofe all human beings. Consequently, regulatory authorities at regional, national and 
international levels have been established to govern the quality, safety, efficacy and 
availability aspects of the medicinal preparations all over the world. United States Food and 
Drugs Administration (US FDA), European Medicines Evaluation Agency (EMEA), Health 
Canada, Medicines and Healthcare Products Regulatory Agency (MHRA) and Ministry of 
Health, Labour and Welfare (MHLW-Japan) are among the leading regulatory bodies which 
have pioneered the way medicinal preparations are made available to respective regional 
populations. In addition to these regional agencies, international bodies such as World Health 
Organization (WHO), International Conference on Harmonization (ICH), play a vital role in 
different aspects of pharmaceutical regulations related to drug product research and 
development, registration, manufacturing, and distribution. 
 The pharmaceutical industry has become highly regulated as a result of the collective 
efforts of these regulatory authorities. From time to time, different regulations have been 
enforced with the intent of having a positive impact on the quality of medications but certain 
numbers of associated disadvantages were also noticed over the years, e.g., as a part of 
regulatory framework, manufacturers are required to validate manufacturing process on 3 
consecutive batches and follow the same process during routine manufacturing to ensure 
consistent quality of pharmaceuticals. Any change in the manufacturing process after the 
process validation would call for the regulatory submissions and review depending on the 
extent of change [1]. This being a time consuming and resource intensive process, historically 
pharmaceutical manufactures had been reluctant to introduce new changes or improvements in 
the manufacturing process following the first regulatory approval. However, this hesitancy to 
introduce improvements/innovations in pharmaceutical manufacturing is undesirable for the 
purpose of availing safe and efficacious medications. Consequently, in order to promote 
voluntary innovation in product and process development, process analysis and process 
control; the FDA has recently undertaken different initiatives such as quality by design, 
process analytical technologies [2] and at the same time introduced real-time release concept 
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[3] to reward manufacturers for their efforts for implementing innovation in the product 
development and manufacturing. 
 The mutually beneficial nature of these regulatory initiatives has changed the mindset of 
pharmaceutical manufacturers which has triggered a paradigm shift in pharmaceutical research 
and development as well as manufacturing. One aspect manufacturing process improvement is 
implementing process analytical technologies (PAT) for better understanding, monitoring, and 
control of different stages of pharmaceutical manufacturing. Development of a PAT 
application for a particular manufacturing process requires through preparatory work 
comprising but not limited to activities such as assessing feasibility of suitable PAT tool 
depending upon physical nature of materials during manufacturing process, sample 
presentation to data collection tool, development and validation of chemometric models, 
analyzing results for understanding the process dynamics, etc. The context of present work lies 
in such preparatory work, which is aimed at developing PAT application for in-line 
concentration monitoring inside a tableting feed frame. 
1.1.1 Pharmaceutical manufacturing regulations 
 Historically, the quality of pharmaceutical drug products was overseen by most of the 
drug regulatory authorities, including United States Food and Drug Administration (US FDA), 
using a two-way strategy [4]. That is: (a) assessment of the information submitted by 
pharmaceutical manufacturers in the drug approval application and (b) inspecting the 
manufacturing facility for conformance with the current good manufacturing practices 
(CGMPs). 
 Conventional pharmaceutical manufacturing is generally accomplished using batch 
processing with laboratory testing conducted on collected samples to evaluate quality. This 
conventional approach has been successful in providing quality pharmaceuticals to the public. 
However, significant opportunities now exist for improving pharmaceutical development, 
manufacturing, and quality assurance through innovation in product and process development, 
process analysis and control. Unfortunately, the pharmaceutical industry has generally been 
hesitant to introduce innovative systems into the manufacturing sector for a number of 
reasons. One reason often cited is regulatory uncertainty, which may result from the 
perception that the existing regulatory system is rigid and unfavorable to the introduction of 
innovative systems [2]. The industry’s hesitancy to broadly embracing innovation in 
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pharmaceutical manufacturing is undesirable from a public health perspective. However, to 
exploit scientific innovations and technological advances in last few years, FDA reinforced 
drug approval and quality assessment process in August 2002 by launching a new initiative 
entitled “Pharmaceutical CGMPs for the 21st Century: science-based policies and standards in 
the drug regulatory approach [5]. 
 Around the same time, the International Council on Harmonization (ICH) of technical 
requirements for registration of pharmaceuticals for human use published series of guidelines 
detailing the change in the regulatory expectations for new product registration applications. 
ICH Q8 (R2) suggested the contents of pharmaceutical development section [3] of the product 
registration dossier, which is intended to provide information and understanding gained on 
product and its manufacturing process to the regulatory agencies. A more scientific approach 
to drug product development over the earlier empirical development was expected on the part 
of pharmaceutical manufacturers. Further emphasis on product and process understanding in 
terms of critical quality attributes (CQAs) and critical process parameters (CPPs) was 
introduced in 2007 as a part of quality by design (QbD) philosophy. A systematic approach to 
mitigate quality risks were outlined in quality risk management ICH Q9 [6] while effective 
quality management to enhance the quality and availability of medicines around the world in 
the interest of public health was outlined in ICH Q10 [7]. These regulatory changes 
throughout the product lifecycle were expected to facilitate innovation and continual 
improvement and strengthen the link between pharmaceutical development and manufacturing 
activities. 
 In line with QbD philosophy US FDA issued Guidance for Industry; PAT -A framework 
for innovative pharmaceutical development, manufacturing, and quality assurance in 
September 2004. In this guidance [2], process analytical technology (PAT) was put forth as a 
new regulatory framework to encourage the voluntary development and implementation of 
innovative pharmaceutical development, manufacturing and quality assurance. In November 
2011, FDA announced the complete implementation of QbD starting from January 2013, 
expecting all companies to file new registration applications using QbD principles. 
 In view of increased requirements in the drug regulatory submissions, pharmaceutical 
manufacturing is undergoing a phenomenal change. The present work constitutes to one aspect 
of this change i.e. the development and implementation of PAT. 
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1.1.2 Process analytical technology (PAT) initiative 
 Pharmaceutical manufacturers are expected to demonstrate an enhanced knowledge of 
product performance over a range of material attributes, manufacturing process options and 
process parameters in the quality by design paradigm. Product and process understanding can 
be gained by application of, e.g., formal experimental designs, PAT, and/or prior knowledge. 
PAT is a system for designing, analyzing, and controlling manufacturing through timely 
measurements (i.e., during processing) of critical quality and performance attributes of raw 
and in-process materials as well as processes with the goal of ensuring final product quality 
[2]. 
 In the expression ‘Process Analytical Technology’, the term ‘analytical’ is taken in the 
broad sense. It includes all chemical, physical and microbiological techniques as well as 
mathematics and risk analyses. The ideal analytical tools are those that allow for non-
destructive and non-invasive real-time measurement. The FDA suggests four types of PAT 
tools (PAT toolbox) to measure, understand, track, and control a process. These tools are: 
 Analyzers quantifying critical process parameters, i.e. spectrometers measuring the 
spectroscopic response of a powder blend over time to assess mixture composition 
change over time, e.g., time and revolutions of the blender are critical process 
parameters while blend concentration is a critical quality attribute for in-process 
powder blend.  
 Statistics used in the design of experiments, i.e. factorial plans and all other techniques 
for evaluating as well as understanding the influence of critical parameters and their 
interactions with the process  
 Process control, i.e. multivariate analysis and control strategies to control the process 
based on in-line measurements of the process parameters and product characteristics  
 Knowledge management and continuous improvement, i.e. mathematical models and 
protocols being updated as more information is gathered during the regular 
manufacturing of the product.  
A PAT application is defined as a combination of two or more of these tools to ensure proper 
monitoring and process control [2].  Such PATs can be implemented during the manufacturing 
operations of different dosage forms such as tablets, capsules, liquids, injectable, semisolids 
like creams, ointments, etc.  
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1.1.3 Pfizer research chair in PAT 
Practical implementation of PAT tools during regular manufacturing operations requires a 
thorough study of all process parameters and validation of calibration models. Despite a 
certain number of successful PAT implementations, there is still a need for much information 
to be gained and exchanged between regulatory agencies as well as pharmaceutical 
manufacturers in the implementation of PAT assisted quality by design approach. An 
important reason for this is the lack of knowledge as well as practical experience in risk-based 
process design because industries had been using trial and error principles in the past. In this 
context, there is a need for collective efforts from all parties like industry, academia as well as 
drug regulatory bodies. As a result of such a process, Université de Sherbrooke and Pfizer 
have combined their efforts by creating a research chair on PAT in Pharmaceutical 
Engineering. This Chair has defined the following strategic objectives [8]: 
 Develop knowledge on- Physicochemical phenomena governing the behavior of processes 
involved in the industrial pharmaceutical production (where PAT may be applied) and 
Criteria of “phenomenological or stochastic model-based technology transfer” (i.e. scale-
up and implementation of new technologies on which PAT may be applied) 
 Improve the control of processes and products based on PAT 
 Consolidate the research component in the field of processes in the Department of 
Chemical and Biotechnological Engineering of Université de Sherbrooke and develop a 
critical mass of research on PAT in Pharmaceutical Engineering.  
One of the ongoing projects under this research chair is to understand the powder 
behavior inside the feed frame using different PAT tools. Earlier work [9] used PAT tools like 
NIRS, RGB camera and LIF for concentration monitoring of the multivitamin product. Present 
work aims to broaden the earlier knowledge gained on using NIRS as process analyzer for 
feed frame as well as to evaluate the feasibility of new tool (Near-infrared chemical imaging- 
NIR CI) for the purpose of monitoring powder behavior inside the feed frame. 
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1.1.4 PAT in tablet manufacturing process 
The tablet is one of the most common pharmaceutical dosage forms, preferred by 
manufacturers as well as patients. Over the years, the tablet manufacturing process has been 
evolved into a well-defined sequence of manufacturing operations. Tablet manufacturing is 
generally categorized in two ways- one based on wet granulation and another on dry 
granulation or direct compression. Depending upon the mode of granulation chosen, typical 
processes during manufacturing are weighing and dispensing, milling, sifting, mixing, 
granulation, drying, sizing, mixing or lubrication, compression followed by coating (film 
coating or sugar coating). To ensure a safety and effectiveness to the patients, a tablet 
formulation must deliver a constant amount of active in each dosage unit. Consequently, the 
powder composition of tablet formulation must be uniform in active content.  However, during 
these dynamic operations, powder undergoes high levels of stress and strain, which can cause 
variable content uniformity of the active ingredients during any or all of the tableting 
processes. 
 In order to assure the quality of the blend during the tablet compression, conventionally 
the blend uniformity is examined at the end of final blending just before the tablet 
compression; additionally, the tablets are also analyzed for assay and content uniformity [10] 
at the end of the manufacturing process. These analyses only test the quality of the powder 
blend and end product. They barely help avoid adverse quality phenomena like segregation, 
since they don’t significantly add to the product and process understanding. Furthermore, it is 
hard to trace quality issues back to their source if encountered at the end of such testing. In 
order to build a quality into the product instead of testing it, CQAs needs to be monitored 
during all the manufacturing operations and it can be done via the application of suitable PATs 
during different manufacturing operations. 
 Literature shows the implementation of off-line [11][12][13] as well as in-line 
[14][15][16] PAT for different stages of the tablet manufacturing operations for process 
monitoring and quality assessment. In the initial work, mostly off-line PAT developments 
have been reported however the advances in spectroscopic technology and availability of more 
adaptable process analyzers have led to the development of in-line PAT tools for continuous 
process monitoring. Most of the earlier work concentrated on generally regarded critical 
process operations of tablet manufacturing such as blending, granulation, and final product 
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testing for content uniformity. However, with the further understanding of the tablet 
manufacturing process and PAT implementation, other complex processes such as 
compression, coating have been evaluated by PAT implementation. In-line concentration 
monitoring of powder circulating inside the tablet feed frame has also been reported recently. 
1.1.5 Role of feed frame in tablet compression 
 During the tablet manufacturing process, among all of the unit operations, consistent 
filling of the tablet press die with a uniform weight of powder is often both critical to quality 
and rate-limiting for the entire process. Uniform die filling in terms of powder weight and 
contents is, therefore, a crucial control variable. The amount of powder entering the die prior 
to compression determines the weight and overall drug content of individual tablets. 
Moreover, the effect of inconsistent die filling on quality is felt in less obvious ways i.e. 
content non-uniformity is perceived only after assaying the compressed tablets. Tablet presses 
use cam tracks for movement of upper and lower punches to control operations such as die fill, 
weight adjustment, pre-compression, compression as well as ejection of tablets. At the given 
settings of cam track parameters, the force at which an individual tablet is compressed 
depends on the amount of powder in the die [17] [18]. As a result, several final properties of 
the tablets including its density, porosity and the amount of elastic stress stored in the compact 
are affected by the amount of powder in the die.  
 In order to produce tablets with a uniform weight and content, there are two main 
requisites for a pharmaceutical powder blends. First - good flow (i.e. no bridging or rat holing 
in the hopper) and second - uniform content (i.e. no segregation of the active ingredient inside 
the hopper and feed frame). Granulation of powder blends helps to achieve good flow as well 
as content uniformity, however for high speed, high throughput manufacturing; this flow is not 
sufficient. Manufacturers often use mechanical assistance in the form of paddle feeders to 
maintain an adequate supply of powder to fill the dies at high speed and multiple compression 
stations machines 
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Figure 1.1 : Schematic presentation of a feed frame with 2 paddle wheel 
 The force feeder (referred to as feed frame henceforth) help to alleviate issues of tablet 
weight uniformity, however, paddles at a higher rotation speed (as shown in figure 1.1) might 
shear the material to a higher extent. Powder circulation at high speeds can lead to excessive 
lubrication and issues with a hardness of tablets. At the same time, a circulatory motion may 
lead to powder segregation [17][19] as the powder inside feed frame is a composite of 
materials having different density, particle size, shape and varied physicochemical properties. 
1.2 NIR chemical imaging (NIR CI) 
 NIR CI is a comparatively newer technique for pharmaceutical PAT applications where 
sample under test is in continuous motion. NIR CI applications for process monitoring has 
been limited due to practical difficulties associated with accommodating the NIR chemical 
imaging unit on manufacturing equipment, controlling uniform and reproducible sample 
presentation as well as coping with time required for imaging while the sample is still moving. 
Conventionally NIR CI represents a distribution map of chemical/analyte obtained from NIR 
hyperspectral imaging, however with recent advances in technology similar sample 
information can be obtained with newer and faster adaptions of this methodology. Following 
section briefly reviews NIR CI technology and its pharmaceutical applications. 
1.2.1  NIR CI acquisition  
 The instrumentation for acquiring hyperspectral NIR CI involves the coupling of a 
lens/microscope with a NIR spectrometer. There are two main types of NIR-CI systems [20] 
[21] : 
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a) Area scan imaging or staring imager system 
b) Line mapping or push-broom system 
Area scan imaging is considered as a real NIR CI technique when compared to line mapping 
system. Though the 2 techniques have different ways of data acquisition still the output result 
for both of these techniques is a hyperspectral data cube and the same chemical image will be 
obtained for a sample using the same instrument settings and data processing method. 
a) Area scan imaging 
 The area scan imaging system does not contain any moving parts and generates images 
at each selected wavelength rather than collecting NIR spectra directly from the line of pixels. 
Area scan imaging measures the NIR absorption intensity values in each pixel of the defined 
sample area at one particular wavelength at a time. The imaging technique uses two-
dimensional focal plane arrays (FPA), i.e. cameras having thousands of individual detector 
elements (pixels). The number of pixels in an image is thus fixed for area scan imaging 
systems and the pixel size is defined by the magnification optics (e.g. 9.8 mm/pixel 
magnification setting would cover  40 X 20 mm sample area using 320X256 pixels). The 
spectral information is obtained by changing the wavelength of light using tunable filters, e.g. 
liquid crystal or acoustic optical tunable filters. The NIR absorption intensity is measured in 
every pixel for each individual wavelength, and wavelength is sequentially changed by the 
tunable filter. Images at each individual wavelength are built up like a deck of cards to 
generate the hyperspectral data cube [20]. 
b) Line Mapping 
 The line mapping principle is based on a step-and-acquire acquisition mode. The sample 
area and pixel size are initially decided which fixes a number of pixels in the image. For each 
acquisition, diffuse reflectance spectra are collected from a line of pixels. With a very accurate 
positioning of a sample stage, the sample is moved and another line of spectra are obtained. In 
this way, a grid of spectral information is build up from all lines of spectra until spectra from 
all sample area are obtained to constitute the hyperspectral data cube. 
 In the present work, images acquired with definite bandpass wavelength filters on the 
NIR camera are referred as ‘area scan’ images while those acquired using spectrograph on 
NIR camera are referred as ‘line scan’ images. 
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1.2.2  NIR CI set up 
 During NIR CI acquisition, the sample surface is illuminated using a NIR light source 
and diffusely reflected light is captured using imaging optics on a focal plane array detector 
(Figure 1.2). Between the sample and imaging sensor, a suitable imaging optics and 
wavelength filter is used which helps to record images at different wavelength ranges. 
 
Figure 1.2 : Schematic reflection of NIR CI [22] 
 NIR CI gives spectral information of the sample similar to a near-infrared spectroscopy 
and spatial information of the sample similar to digital imaging since for a given sample NIR 
CI records spectral and spatial information simultaneously and provides a NIR spectrum for 
each pixel of the sample image. The result is a three-dimensional data set called as a 
hyperspectral data cube. The x, y-axis of the hyperspectral cube represents spatial information 
and z-axis represents wavelength.  Hyperspectral data cube gives typical chemical images 
which provide information on the distribution of different chemical components in the sample 
surface. The major advantage of NIR CI over the conventional NIR spectroscopy is that it not 
only helps to identify and quantify surface components but it helps to know their spatial 
distribution from within the sample. This can be related to the quality of the product [20]. 
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Figure 1.3 : Schematic representation of hyperspectral NIR CI [20] 
 As shown in figure 1.3, a hyperspectral data cube can either be seen as a set of array of 
spectra arising from every single pixel of an image or it can be seen as a set of images from 
which a spectrum can be generated for each pixel. Selecting a single pixel from (XY-
coordinate) through the z-plane will give the spectrum recorded at this particular spatial 
location. This spectrum provides the spectral signature of chemical components present in that 
exact part of the sample. Whereas selecting one of the images from hypercube at a specific 
wavelength (z-value) will show the intensity values for all pixels at that wavelength. This is 
called a single wavelength image. The single wavelength image can be used for finding the 
spatial distribution of components which absorb at that particular wavelength. The 
hyperspectral data cube is often visualized as an image using either a grey scale or color scale 
to represent intensity, for example, the average absorbance intensity value for each pixel 
(spectrum). 
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 In the present work, NIR CI refers to NIR images taken over a particular wavelength 
band using the spectral filter on the NIR camera (area scan images) or NIR images taken over 
900-1700 nm range using spectrograph on the NIR camera (line scan images). NIR images 
taken this way do not give hyperspectral images however they offer the advantage of faster 
scan which is really helpful for in-line applications in testing moving material samples. 
1.2.3  Spectral transformation of NIR images 
There are 3 steps in the NIR CI processing: 
a) Spectral correction 
 Instrument response is removed by measuring the intensity of light (𝐼𝑎) diffusively 
reflected from of a high-reflectance standard that reflects almost 100 % light at each 
wavelength and instrument response (𝐼𝑏) when there is no NIR light to illuminate the sample. 
The intensity of light reflected from the sample is then measured (𝐼𝑠). The final NIR diffuse 
reflectance raw data (𝑅) is calculated as the ratio between the sample and the background 
measurements, while instrument response in the absence of NIR light is subtracted from both 
of them. 
𝑅 =
(𝐼𝑠−𝐼𝑏)
(𝐼𝑎−𝐼𝑏)
        (1.1) 
b) Conversion to absorbance 
 The diffuse reflectance data (𝑅) is organized in a three-dimensional structure (i.e. 
hyperspectral cube). This type of correction is also applied for NIRS data. Prior to data 
analysis, all raw reflectance data (𝑅) are transformed into absorbance (𝐴) by the relation 𝐴 = -
log10 𝑅 = log10 (1/ 𝑅). Assuming the path length (𝜄) on average is constant for the NIR diffuse 
reflectance mapping measurements of the sample, a linear relationship then exists between 
absorbance (𝐴) and analyte concentration (𝑐) by Beer-Lambert’s law: 
𝐴 = 𝐿𝑜𝑔10 (
1
𝑅
 ) = 𝜀 ×  𝜄 × 𝑐     (1.2) 
𝜄 Represents the path length of the sample (cm) and  
𝜀 is the molar absorptivity (L mol-1 cm-1) specific to each analyte at a specific wavenumber. 
c) Unfolding of 3D hyperspectral cube 
 The three-dimensional hyperspectral data cube achieved from the NIR CI needs to be 
unfolded for the purpose of data analysis. 
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Figure 1.4: Schematic representation of unfolding hyperspectral image [20]  
 The hyperspectral image data is unfolded from 3D data cube to a 2D matrix (as shown in 
figure 1.4), in which each row is a spectrum from one of the pixels. After data processing has 
been done the resulting 2D matrix suitable multivariate analysis method (PCA, PLS or PCR) 
is selected for further analysis. 
1.3 NIR spectroscopy 
 NIRS is one of the most frequently used techniques for sample data collection in 
pharmaceutical PAT applications. The suitability of a NIRS procedure is dependent upon 
many factors, including the instrumentation, applied chemometrics as well as the sound 
understanding of the physicochemical basis of the measurements [23]. The following sections 
contain a brief review of NIR spectroscopy basics, its use in monitoring various 
pharmaceutical processes as well as recent applications in the feed frame monitoring. 
1.3.1  NIRS brief theoretical background 
NIRS is generally chosen as the method of sample analysis because of its speed and non-
destructive characteristic towards the analyzed sample. Over time, instrument improvements 
and the development of fiber optics have made it possible to delocalize measurements [24].  
The frequency range of the NIR from 800-2500 nm mainly covers overtones and 
combinations of the lower-energy fundamental molecular vibrations that include at least one 
X–H bond vibration. Overtones (electron excitations to higher energy levels) are similar to 
octaves in a musical scale, like harmonics of the fundamental vibrational frequencies. 
Combination bands are the sum of two different vibrations corresponding to different chemical 
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bonds.[25] These bonds are significantly weaker in absorption compared with the fundamental 
vibrational bands from which they originate.  
The functional groups showing NIR absorbance are mostly those involving the hydrogen 
atom: C–H, N–H, and O–H (Figure 1.5). Thus, NIRS represents in effect the chemical 
spectroscopy of the hydrogen atom in its various molecular manifestations  [26]. NIR light is 
absorbed to different extents by the sample at frequencies similar to vibrational frequencies of 
the NIR active chemical bonds present in the sample. 
 
Figure 1.5: Different functional groups and their NIR absorbance range [27] 
 In terms of the analytical specificity, NIRS is sensitive to the frequency and intensity of 
these X–H NIR absorption bands and their near neighbors in the molecular structure. The local 
electronic environment has a particularly strong influence on the X–H bond force constants 
which helps to derive remarkably high information content in NIR spectra. Furthermore, some 
particular functional groups (e.g. O–H, N–H) are very strongly affected by both intermolecular 
and intramolecular H-bonding effects, with sometimes dramatically influences the intensity 
and band-shapes in the NIR. 
 In the present research work, Ibuprofen and Ascorbic acid have been used as 
representative pharmaceutical actives. Both these molecules show NIR absorbance owing to 
their chemical structure. As shown in the figure 1.6, these molecules have NIR responsive 
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chemical bonds in different configurations such as C–H, O–H, CH=CH, CH–CH3, etc. 
(Ibuprofen) and C–H, O–H, CH=CH, etc. (Ascorbic acid). In addition, constituent excipients 
such as Mannitol also show NIR absorbance due to chemical bonds such as C–H, O–H. 
 
Figure 1.6: Chemical structure of Ibuprofen and Ascorbic acid [28][29] 
 The absorptivity of vibrational overtone and combination bands is much weaker in NIRS 
spectra of the condensed phase (i.e. sample in the solid or liquid state) hence physically thick 
samples can be measured without sample dilution or the need to resort to difficult short-path 
length sampling techniques. As a result, conventional sample preparation is redundant which 
favors the NIR PAT applications requiring direct measurement of the sample either in situ or 
after removal of the sample from the process [25] [26]. 
1.3.2  NIRS data collection and pre-treatments 
 NIR spectral data in PAT applications is recorded in one of the 2 modes, i.e. 
transmission (absorbance spectra) or reflectance mode (diffuse reflectance spectra). Although 
transmission mode allows probing the bulk sample in contrast to dominantly surface signal in 
the reflectance mode but the useful spectral range is mostly limited and spectra may contain 
more noise than reflectance spectra [30]. For chemometric model development, either full 
range of spectral analyzer or selective wavelength range region around the active ingredient 
peak can be used. Unnecessary too high or too low wavelength ranges may compromise model 
performance thus wavelength selection must be tested with respect to the performance of the 
model [15]. Recent study [31] reports selection of spectral wavelength representing specific 
bond frequency characteristic of the active molecule. It was further showed that selection of 
proper pre-treatments is necessary for data treatment on case by case basis. 
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 NIR spectral baselines are mostly affected by different particle sizes, density differences, 
sample movement (wave behavior) in non-contact type measurements, NIR source intensity 
variations, etc. Most of the artifacts in the spectral data can be removed by use of suitable 
spectral pre-treatments [32]. Standard normal variate (SNV), Savitzky-Golay smoothing, 
derivatives, detrending, multiple scatter correction (MSC), centering and scaling to unit 
variance are some of the frequently used spectral pre-treatments (Appendix III) for NIRS data 
[33] obtained in pharmaceutical PAT applications. SNV helps to remove baseline differences 
due to changes in NIR path-length. Mathematically it is row-wise centering and scaling of 
NIR spectra. Derivatives (mostly first and second derivative) are used to remove peak overlap 
as well as to remove constant and linear baseline drifts between different spectra. Savitzky-
Golay smoothing is generally used after derivatives to smoothen the spectral appearance. De-
trending removes a linear or polynomial fit from the spectra to remove tilted baseline 
variations. MSC removes baseline offsets and multiplicative scatter effects by means of 
regressing sample spectra against reference spectra and then correcting the sample spectra 
using slope and intercept of this linear fit. 
 Following the spectral pre-treatments, NIR spectra are further analyzed using univariate 
or multivariate chemometric methods. 
1.4 Definition of a current research project 
As described in section 1.1.5, the feed frame plays an important role in the tablet 
manufacturing process since it helps in tablet weight and content uniformity as well as it is the 
last piece of equipment allowing access to flowing powder before compressing the tablets. At 
this point the tablet mass and content (potency) become fixed; thus, it is important to maintain 
consistent powder fill weights into the tablet dies as well as avoid any segregation of the 
powder blend in the process [4]. To date, a lot of attention has been paid to mixing inside the 
blenders [14][34][35][36][37][38][39], granulation [40][41][42][43], drying and milling 
process [44][45][46][47][48] during tablet manufacturing but limited studies have been 
directed to understand and control the powder blend behavior inside the feed frame. 
Some researchers have studied [18][19][49][50][51] the impact of various feed frame 
parameters on the powders and subsequently compressed tablets mainly using computer-aided 
simulations or experimental designs, however, in-line feed frame monitoring was not 
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achieved. Very recently, NIRS-based PAT tools for concentration monitoring inside the feed 
frame have been reported. Although concentration monitoring inside the feed frame was 
successful, poor correlation between the NIR spectral intensity and actual tablet concentrations 
was seen due to the location of NIR probe, powder mass buildup inside feed frame, varying 
powder to probe distance [15] and speed of paddle wheels [16]. NIRS-based PATs for 
monitoring the powder circulation inside the tablet feed frame has been successful only in the 
specific experimental configurations (e.g. specific powder to probe distance, probe location, 
paddle speed, etc.). Furthermore, the NIR probe monitors a powder blend over a small area 
(e.g. 2×2 mm
2
), which may or may not appropriately represent the overall bulk powder 
concentration, potentially limiting the detection of segregation if present. Owing to aforesaid 
limitations in the available knowledge base on NIRS PAT methods for feed frame monitoring, 
current research project addresses the need for further studies on NIRS using contact type NIR 
probe with larger probe head (15×4 mm
2
) specifically meant for feed frame monitoring 
methods. In addition to this, attempts have been made to find another robust tool for feed 
frame powder monitoring as well as detecting the presence of adverse quality phenomenon 
such as segregation. Consequently, the present work aims to evaluate the performances of NIR 
CI compared to NIRS, while consolidating knowledge on NIRS-based feed frame monitoring. 
Use of NIR CI is proposed as it can prove useful for in-line feed frame monitoring due 
to recent developments in high-speed image acquisition capabilities while limiting the 
shortcomings (e.g. smaller tested sample area, baseline variations) of NIRS PAT methods. 
NIR camera with definite wavelength bandpass filter gives a ‘area scan’ image of the sample 
(Figure 1.7 A) where each pixel in the image represents the local composition at the specific 
location of the sample, e.g., a 256×320 pixel image gives sample information in the form of 
81920 data points. NIR camera equipped with spectrograph acquires a ‘line scan’ image of a 
sample (Figure 1.7 B), where the 256 vertical pixels represent spectral information while the 
320 horizontal pixels represent spatial information of the powder sample. 
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Figure 1.7: NIR CI using a single filter (A) and spectrograph (B)  
Both the NIRS probe and NIR camera are placed close to each other on the second 
wheel of the feed frame (refer to figure 1.1) to facilitate comparison of predicted powder 
concentrations. The second wheel is selected for placement of these tools owing to the design 
of the feed frame as well as the feasibility of accommodating these tools on the tablet press 
(Manesty Novapress 37-station rotary tablet press).  
The feasibility of using NIR CI as a process analytical tool for feed frame monitoring is 
evaluated using a simple blend comprising 3 ingredients while later studies are performed 
using pharmaceutically relevant multicomponent blends (more than 6 components) at 
pharmaceutically relevant concentrations. Ascorbic acid and Ibuprofen are selected as model 
pharmaceutical active ingredients (APIs). Feed frame monitoring is performed in two ways- a) 
off-line (i.e. away from compression machine) and b) in-line (i.e. at the compression machine) 
to evaluate the performance of selected process analytical tools as well as to transfer the 
calibration models to validation sets. This kind of study is important considering the 
possibility of making off-line calibration models using a very small quantity of the active 
ingredients allowing lots of saving on time and experimental resources. 
NIR CI data acquisition inside the feed frame is optimized to improve signal-to-noise 
ratio which is later compared against the NIRS as well as tablet assay results. According to the 
composition of the powder blend, a suitable combination of tools e.g., NIR camera with single 
bandpass filter or a spectrograph is evaluated for in-line feed frame monitoring. The feasibility 
of NIR imaging to be used alone or in combination with NIRS, for better process 
understanding and control is also evaluated. NIR CI is evaluated not only for powder 
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concentration monitoring but also for probing the powder segregation owing to spectral and 
spatial information gathered from comparatively larger sample area (e.g. area scan NIR image- 
40×20 mm or line scan NIR image-35×3 mm) than NIRS. NIR CI (line scan) - based 
concentration predictions are compared with NIRS at a similar spatial location to verify 
comparability of these tools for feed frame concentration monitoring. 
NIRS is evaluated for feed frame monitoring as well as concentration monitoring in the 
subsequently compressed tablets in order to verify comparison of feed frame concentration 
monitoring against tablet concentrations. This comparison is further tested with ultra-violet 
(UV) spectroscopic assay results of stratified tablet samples collected during the compression 
run. Powder concentration change kinetics inside the feed frame and the tablets are compared 
to see the average time taken to exhibit the feed frame concentration changes in tablets at 
given tablet compression rate and feed frame paddle speed. Such information is very useful 
during industrial tablet compression to avoid mixing of uniform content tablets with non-
uniform tablets in the event of segregation phenomenon during the tablet compression; e.g., at 
the end of compression [52]. 
 In addition to process analytical tool selection for feed frame monitoring, other 
parameters like sample presentation and data acquisition methods, data pre-treatment, 
wavelength selection, qualitative and quantitative chemometric modeling which are equally 
important points for the development of a suitable in-line feed frame monitoring method are 
studied through this project work. 
1.5 The objective of the research work 
The global objective of the present work is to develop a robust methodology (PAT) for 
monitoring powder concentrations inside the feed frame during the tableting process. My 
research hypothesis is: at the present state of available PAT tools for feed frame monitoring, it 
may be possible to introduce new tools alone or in combination with existing ones to monitor 
the composition of pharmaceutical powder mixtures in-line inside the feed frame during 
tableting process. NIR CI is selected (owing to spectral and spatial information from an 
increased sample area in comparison to NIRS) for evaluation as a potential PAT tool. NIRS is 
selected as reference method being already reported for feed frame monitoring. There are 
several individual objectives as listed below: 
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 Evaluate the feasibility of NIR CI (area scan image format) in comparison to NIRS for feed 
frame monitoring using simple powder blends. 
 Evaluate NIR CI (based on spectral and spatial information) as a process analytical tool to 
gain additional process information in terms of local concentration changes and increased 
sample volume 
 Compare NIR CI and NIRS-based concentration predictions inside the feed frame with the 
subsequently compressed tablet concentrations using prototype pharmaceutical composition 
comprising single active ingredient of interest 
 Gain understanding of concentration change kinetics inside the feed frame and in 
subsequently compressed tablets. 
 Evaluate NIR CI (line scan format) in comparison to NIRS for feed frame powder 
concentration predictions in a complex pharmaceutical composition involving 2 active 
ingredients of interest. 
 Evaluate PLS calibration model transfer from laboratory to production 
1.6 Original contributions 
This research work has resulted in the development of additional knowledge base for the 
purpose of implementing NIR-based  PAT tools (NIR CI and NIRS) for monitoring of powder 
blend concentrations inside the tablet feed frame. Original contributions of this Ph.D. thesis 
work have been presented in the form of 3 research articles (one published, second submitted 
and third in the process of submission). 
Paper 1 
Evaluation of NIR CI feasibility in feed frame environment and its concentration 
prediction performance in comparison to NIRS in the article titled- Concentration monitoring 
with near-infrared chemical imaging in a tableting press 
Implementing NIR CI for feed frame monitoring was perceived to be a challenging task 
due to the continuous and wavy movement of the powder inside the feed frame as well as due 
to first time implementation of NIR CI in feed frame setting. Sample presentation was 
successfully optimized to get suitable signal-to-noise ratio in NIR CI data as well as NIR CI 
was found equally capable to predict powder concentrations inside the feed frame. NIR CI was 
reported advantageous over NIRS owing to the potential of probing local concentration 
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variation (i.e. segregation) inside the feed frame since NIR CI captured larger area of powder 
sample inside the feed frame. 
Paper 2 
Comparison of in-line feed frame concentration monitoring against in-line concentration 
monitoring of subsequently compressed tablets and chemical assays of stratified tablet 
samples in the article titled- NIRS In-line monitoring of Ibuprofen during and after tablet 
compression using Near-Infrared spectroscopy 
NIRS-based in-line concentration monitoring inside feed frame and tablets (using 
different NIR probes) was compared using off-line NIRS and UV assay testing of stratified 
tablet samples. NIRS-based concentration predictions and concentration change kinetics inside 
the feed frame was compared with the subsequently compressed tablets. A delay in the onset 
of the concentration change in the tablets was seen in comparison to feed frame and it was 
reported due to the position of NIR probe as well as the design of feed frame. Except for the 
delay, concentration predictions in the feed frame as well as in tablets matched closely with 
UV assay of the stratified tablet samples. 
Paper 3 
Evaluating performance of NIR CI against NIRS for a complex blend with 2 actives and 
NIR responsive excipients in the article titled- Simultaneous monitoring of Ibuprofen and 
Ascorbic acid concentration inside the feed frame using Near-infrared imaging and 
spectroscopy 
Following the positive outcome of initial feasibility in NIR CI implementation, more 
complex blend was evaluated using NIR CI in line scan format giving output similar to NIR 
probe. NIR CI offered an opportunity to evaluate radial segregation inside the feed frame as it 
sampled the powder across the width of the feed frame. In addition, PLS calibration model 
transfer from laboratory to production was demonstrated. 
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1.7 Document plan 
CHAPTER 1 
This chapter introduces the topic of this Ph.D. in reference to global and specific context to 
pharmaceutical manufacturing. 
CHAPTER 2 
The state of the art, which enumerates background concepts related to present work as well as 
summarizes earlier research work in the area of implementing PAT in pharmaceutical 
manufacturing with specific emphasis on tablet manufacturing and monitoring feed frame of 
the tablet press. 
All of the research work performed under this Ph.D. project is presented in 4 different 
chapters. 
CHAPTER 3 
Evaluates the feasibility of NIR CI (single filter NIR images) in comparison to already known 
PAT technology (i.e. NIRS) for feed frame monitoring while using comparatively less 
complex blends (single active and 2 other non-active ingredients) than a typical 
pharmaceutical tablet composition. Initial challenges in implementing NIR CI inside the feed 
frame and resulting modifications in the experimental set up are discussed. In addition to 
successful concentration prediction, NIR CI ability to identify local concentration variations 
has been reported. 
CHAPTER 4 
Following a successful feasibility study (chapter 3), concentration monitoring of a single 
model drug (Ibuprofen) in a pharmaceutically relevant blend composition was evaluated, 
during the compression (NIR CI + NIRS inside feed frame) and after the compression (NIRS 
in tablets). Chapter 4 reports NIRS-based studies inside feed frame and tablets, subsequently, 
chapter 5 reports NIR CI-based studies inside the feed frame. Different NIR probes were used 
to monitor powder blends and tablets in an in-line manner. Tablet samples selected during the 
entire compression were also tested in an off-line manner. Concentration predictions for 
powder blends and tablets using NIRS PLS models were compared against the UV method 
assay results of stratified tablet samples taken during the compression process. This chapter 
not only compares different NIRS probes and sample presentations but also establishes a link 
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between feed frame concentration monitoring and tablet assays, showing how the feed frame 
powder concentrations represent assay results of subsequently compressed tablets. 
CHAPTER 5 
Powder concentration prediction inside the feed frame using NIR CI (by definite bandwidth 
filter) was found to be slightly less efficient than NIRS due to lower signal-to-noise ratio in the 
presence of multiple ingredients as well as lower specificity of the filters owing to broad range 
of wavelengths which are allowed to pass through the filter (filter width is 20-60 nm). 
Following these results, it was hypothesized that spectrograph based NIR images could be 
more precise and may lead to the higher signal-to-noise ratio. 
CHAPTER 6 
Having evaluated NIR CI feasibility against NIRS using simple blends (chapter 3) and 
later linking feed frame monitoring with tablet assays (chapter 4), chapter 6 discusses in detail 
about monitoring complex formulation composition containing 2 active ingredients and 5 
other excipients inside the feed frame using NIR CI while keeping NIRS as a reference. NIR 
CI was obtained in ‘line scan’ format using spectrograph (instead of bandwidth filters) 
achieving spectral information similar to NIRS. PLS calibration model transfer from lab to 
production and from batch to batch has been reported. In addition to successful concentration 
prediction inside feed frame, NIR CI also gives the opportunity to predict concentration along 
the width of the feed frame giving an opportunity to verify spatial segregation phenomenon 
inside the feed frame. 
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CHAPTER 2 STATE OF THE ART 
The main focus of the present Ph.D. project involves developing NIR CI-based methods 
for monitoring the powder concentrations inside the feed frame in comparison to NIRS. As 
such these tools alone do not have any utility in process monitoring, however, data generated 
by their implementation for process monitoring can be used to infer process status, e.g. active 
concentration within or out of pre-determined limits, segregation etc. Different chemometric 
techniques are used for the purpose of relating gathered data to the process parameter of 
interest. Consequently, process monitoring via PAT tools needs a proper understanding of the 
operating principles of the analytical tools, their suitability for gathering sample data based on 
chemical composition of powder samples to be monitored, spectral data acquisition, pre-
treatment, and analysis as well as the design of rational experimental protocol to understand 
the process dynamics. This chapter reviews the earlier research work done to probe the feed 
frame role in tablet compression, basics of referred PAT tools i.e. NIRS and NIR CI, their 
applications in pharmaceutical process monitoring and different chemometric methods used 
for data analysis. 
2.1 Criticality of feed frame operation 
 Conventionally, the feed frame has been added into the compression machine with the 
intention of beneficially impacting the tableting process; however, in reality, it can hamper the 
quality adversely if not operated properly, e.g., segregation inside feed frame [19][53]. 
Consequently understanding the functioning of the feed frame, its impact on product quality as 
well as continuous quality monitoring inside feed frame is necessary. However, the feed frame 
is not easily accessible for exploring process dynamics due to its design and location on the 
tablet press. As a result, researchers frequently used [19] [50] [53] computer-based simulations 
(e.g. DEM- discrete element modeling) to better understand the material dynamics inside the 
feed frame without actual experiments. One of the main phenomena known to adversely affect 
quality is particle size segregation inside the feed frame and during the die filling stage. In the 
work of Méndez et al [19], velocity profiles and particle vectors showed the percolation 
phenomenon as the most significant segregation mechanism. Paddle wheel speed was 
demonstrated to be the most important factor to control particle size segregation inside the 
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feed frame, underlying the importance of the feed frame speed during commercial tablet 
compression whereas a general practice the machine operators choose the feed frame speed to 
obtain uniform weight tablets. 
         DEM simulations performed [50] to evaluate the impact of varying particle, process, and 
equipment parameters on powder flow characteristics inside a single paddle wheel feed frame 
of a laboratory-scale tablet press showed widely varying particle flow patterns and residence 
time distributions at varying paddle wheel shape, rotation direction, and rotation speed. Faster 
paddle wheel speeds generally lead to more uniform tablet masses whereas slower paddle 
wheel speeds perform less work on the particles (a surrogate for attrition) and move the 
particles a smaller distance (a surrogate for the extent of lubrication) in the feed frame before 
they enter a die and are compressed into a tablet. 
          Simulation studies helped to forecast the potential impact of feed frame parameters on 
the blend flowing through it, however, in practical situations still the understanding was not so 
clear. In addition, diverse quality issues starting from tablet compression feasibility to content 
uniformity of tablets have led to seek much attention from pharmaceutical formulation 
researchers. As a result, cause and effect type studies analyzing the impact of different feed 
frame parameters on subsequently compressed tablet properties have been carried out. One 
such study performed by Mendez et al [18] described the powder phenomena inside the feed 
frame between 24-72 revolutions per minute of a paddle wheel. Within the experimental 
ranges studied it was found that:  
(a) The total shear applied to the powder was seen higher at lower die disk speeds and higher 
feed frame paddle speeds,  
(b) The die weight variability increased as the die disk speed increased at constant feed frame 
speed,  
(c) The average residence time decreased as the feed frame and die disk speeds increased,  
(d) The flow properties improved as a consequence of the shear applied. 
          Powder lubrication inside the feed frame and the subsequent effects on tablet hardness 
and dissolution has been studied [54]. Results show that large amounts of total shear applied 
reduced the dissolution rate of drugs, tablet hardness, and increased the powder flow. The 
shear applied inside the feed frame had a small effect on tablet hardness and dissolution results 
in case of non-lubricated material.  
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Most of the findings in feed frame based studies may and may not be generalized as 
material attributes (density, particle size, shape, segregation tendency, comparative 
proportions, etc.) are also required to be considered case by case basis. As a result, an in-line 
analysis (while compression is ongoing) of powder materials flowing inside the feed frame 
would be an ideal way of feed frame testing and it could also help to control the compression 
process via feedback controlled mechanism. Although initial work in this manner necessitates 
exhaustive time and resources, few researchers in the recent time have tried to develop NIRS-
based in-line monitoring methods to understand bulk phenomenon going inside the feed 
frame. Relevant studies are discussed later in section 2.4. 
2.2 NIRS suitability for PAT 
 NIRS is one of the most widely used PAT tools that has been used at various stages of 
process manufacturing, from raw material verification, moisture content monitoring in drying 
processes, and end-point monitoring in blending to active-ingredient tablet assay. 
Conventional NIR spectrometers are typically expensive and bulky systems designed with 
Czerny Turner grating-based systems or Fourier-transform technologies [26]. Fourier-
transform infrared technologies, in particular, require high precision and costly mechanical 
components. However, in recent times, technological advances have led to the development of 
cost-effective and easy to use a type of NIR spectrophotometers. The design of these 
spectrophotometers is such that they can be used for online analysis of many processes of 
pharmaceutical manufacturing. Smaller sizes, reduced scan times, adaptability to wireless data 
transfer, the possibility of using at the exact location on a running machine, easy calibration 
and operation are certain favorable points for the rapid rise in NIR probe type spectrometers 
use in pharmaceutical industry.  
Advanced designs of the light source, filters, optics, and detectors have helped to reduce 
the size of spectrophotometers. A detailed description of NIR probe technology is presented in 
Appendix I. 
2.3 Pharmaceutical PAT applications of NIRS 
There are multiple possibilities to use NIR spectroscopy at different manufacturing 
operations for the purpose of in-process quality control as well as final product testing. The 
most common application of NIR spectroscopy in pharmaceutical manufacturing operations is 
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concentration monitoring of active pharmaceutical ingredients. Literature search suggests use 
of NIR spectroscopy  in monitoring the API concentration during the blending operation [34] 
[35] [36] [37], granulation [40], flow in hoppers or inside blender [13] [55], as well as 
assessing tablet uniformity, hardness, coating thickness and dissolution [56] [57]. Sample 
presentation to NIR probe/spectrophotometer is a most critical aspect to obtain the 
reproducible results. All of the aforesaid applications mostly tested the sample in the form of 
steady surface and thus reproducible and uniform NIR spectra were obtained for every sample. 
On the contrary, dynamic process samples like in the case of feed frame, NIR spectra 
measurement is more challenging. However, as mentioned earlier, advances in detectors, light 
sources and filters have to lead to flexibility in developing NIR applications for dynamic 
pharmaceutical manufacturing processes. As a result, NIR spectroscopy has been explored 
recently as a PAT tool in the monitoring of pharmaceutical powders on-line in feed frame, 
immediately before compression into tablets. 
NIR, with its unique features like high-speed sampling and rapid spectral acquisition, 
can be used to the assesss distribution of individual blend components with high accuracy 
during blending. NIR analysis can be beneficial on many aspects of pharmaceutical blendings, 
such as: (a) Real-time quality monitoring; (b) Improved process efficiency as well as a 
performance by selecting adequate process parameters e.g. blending time; (c) Quality by 
design initiatives during the development of blending processes for new formulations. 
PLS calibration models spanning the wide concentration range of blend components 
have provided accurate and robust concentration predictions in blending operations [37][36].  
Along with concentration predictions, NIR spectroscopy applications have been 
developed to monitor the content uniformity of low dose dry powder blends and to provide an 
insight into the fundamental mechanisms of dry powder blending and segregation. The 
rotational speed of the blender has been found to greatly affect the blending and segregation. 
Some speeds promote segregation while others promote mixing or change the mode of 
segregation. Axial segregation was promoted by the blender speeds which promoted the 
difference between the ‘angle of repose’ of the two powders [34]. 
NIR-spectroscopy based applications were used for the real-time monitoring of critical 
parameters during the continuous wet agglomeration. In a continuous wet granulation process,  
the solid-state characteristics and particle size of the granules were analyzed in real-time and 
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the critical process parameters influencing these granule characteristics were identified [40]. 
The temperature of the granulator barrel, the amount of granulation liquid added and, to a 
lesser extent, the powder feed rate were the parameters influencing the solid state of the active 
pharmaceutical ingredient (API). NIR probe was inserted inside a cuvet to make reproducible 
measurements.  
NIR spectroscopy tools can also be used in analyzing and predicting powders flow 
parameters such as angle of repose, compressibility index (Carr’s index) and Hausner ratio. 
Correlation between the reference method values indicating powder flow characteristics and 
the near-infrared spectrum was performed by partial least squares (PLS) for pharmaceutical 
blended powders consisting of paracetamol [13]. NIR-based in-line powder flow 
characterization in pharmaceutical formulations is also reported [57].
 
Application of NIR 
spectroscopy based models at multiple stages during tablet manufacture is possible, e.g. blend 
homogeneity, content uniformity of tablets as well as tablets coating thickness [58]. Along 
with chemical analysis, physical parameters such as tablet hardness has been reported [56]. 
Performance of the chemometric models was improved by spectral pre-processing. 
An in-line NIRS method for determining the drug content of powder mixtures and 
tablets during a continuous tableting process have been reported [59]. It must be noted that the 
quantitative in-line monitoring of pharmaceutical products using NIR spectroscopy may be 
particularly problematic because the spectra of drugs and excipients are themselves 
complicated, and the pharmaceutical processes may further complicate the NIR spectra of 
production samples. However, the most recent generations of NIR instrumentation are 
expected to simplify both qualitative and quantitative applications and thus further enhance the 
utility of NIR spectroscopy for use in monitoring the challenging pharmaceutical processes. 
Recent advances in technology like in tunable wavelength filters, detectors, etc. have made it 
possible to make miniature NIR spectrophotometers that are fit to use in-line and on-line 
applications in continuous pharmaceutical manufacturing processes. 
2.4 NIRS PAT applications for feed frame monitoring 
 Studying the tablet compression process has great significance in the pharmaceutical 
industry since most of the drugs are available in the tablet dosage form. Feed frame of the 
tablet press is used to fill powder into the empty dies during the tablet compresssion. Die 
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filling is one of the key steps to control final tablet properties such as weight, hardness and 
content uniformity. Powder flowing through feed frame is subjected to centrifugal motion, 
shear and compressive stress due to the motion of feed frame wheels.  Thus, resulting 
turbulent movement of the material can lead to segregation of powders inside the feed frame 
which means that irrespective of powder content uniformity until hopper, eventually there may 
be content uniformity issues in the final tablets. In this reference, understanding, monitoring 
and controlling powder flow inside the feed frame is of most importance to tablet 
manufacturing process. 
 In order to understand and monitor the die filling process via in-line NIR measurements, 
analysis of different factors that could affect the NIR spectra acquisition is important. The 
spectral baselines are mainly affected by mass hold-up inside the feed frame and different 
paddle wheel speeds [15]. Peaks and troughs in the powder mass formed by the action of the 
paddles are observed inside the feed frame. In non-contact type spectral measurements, the 
distance from the powder bed to the NIR probe decreases with increasing paddle wheel speed 
leading to changes in spectral baseline variations. A difference in the average predicted 
concentration was observed due to changes in powder dynamics at different paddle wheel 
speeds. A change in powder agitation also provokes differences in powder bed density 
affecting the concentration prediction. 
 As a result of powder movement inside the feed frame, variations in the physical 
properties of the powder blends is pronounced. In order to develope the NIR-based feed frame 
monitoring approach as a robust application, sample presentation is a critical aspect that needs 
to be examined and controlled. Studies conducted [60] using specially designed experimental 
set ups to provide fundamental understanding on sample presentation, showed that with the 
optimized probe distance, suitable spectral preprocessing and averaging, the spectral artifacts 
caused by the moving dynamics can be significantly reduced. 
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Figure 2.1: Experimental NIR set up at feed frame [16] 
 Stepwise understanding and subsequent improvement in the spectral data acquisition 
techniques have shown positive outcomes e.g. NIR spectrometer mounted on the feed frame 
[61] acquired high-quality NIR spectra despite being obtained from the fast-moving blend. As 
shown in figure 2.1, the NIR probe was installed into the feed frame showed excellent 
correlations between the NIR signal and weight corrected tablet potency from stratified tablet 
samples (4 samples within 1
st
 min, 3 samples in 2
nd
 min, 1 sample at each min until 10 min of 
tablet compression) collected over time [16]. A similar correlation was also found at higher 
feed frame paddle wheel speeds, however for lower feed frame paddle wheel speed a bias 
between weight corrected tablet potency and the NIR signal was observed; suggesting need to 
optimize certain process parameters such as paddle wheel rotational speed and NIR probe 
location for different tablet press geometries to ensure that the NIR process spectra can be 
related to tablet potency. Other parameters such as particle size differences in the active and 
excipients, differences in relative humidity and paddle speed have been reported [31] as 
potential variables to be considered in off-line PLS calibration model development for 
monitoring the continuous manufacturing operation at tablet feed frame. Application of 
NIR spectroscopy in the monitoring of active concentration inside feed frame is still an 
emerging application. Constant circulatory motion and the oscillatory sample presentation to 
the NIR probe appear to be a major hurdle in addition to NIR probe on the feed frame. In order 
  
 
32 
to have a better understanding of feed frame dynamics, more studies are still required to be 
performed, both in academic as well as the industrial setting. 
2.5 Pharmaceutical PAT applications of NIR CI 
NIR CI is a comparatively new PAT tool being used for pharmaceutical manufacturing 
applications when compared to the NIRS using probes. The major advantage of NIR CI is its 
capability to give both spatial and spectral information of the sample under test. Visualizing 
the distribution of the physical or chemical property in the sample is valuable for in-process 
and final product understanding during formulation development and also for troubleshooting 
quality defects
52
.  
 Quality defects in medicines are not acceptable as they can prove life threatening at the 
same time the cost of drug recall as a result of quality defects is very high;  e.g. Drug product 
recalls due to sub-potent or super potent strength compared to the labeled strength is classified 
as class I recall. Such recalls are potentially life threatening and could cause a serious risk to 
health when drug contained in the dosage form is potent [62]. In the context of drug product’s 
quality, conventional single point NIRS has been successful for estimating the global content 
of the physical or chemical property [63] however, spatial segregation that may lead to content 
uniformity issues in the dosage forms such as tablets may not be well detected 
 NIR CI PAT implementation in pharmaceutical manufacturing is still in the 
development phase but the number of its applications and chemometric methods to analyze 
NIR CI are increasing recently. NIR CI-based methods has been used in the determination of 
end point of the mixing in blender [64] [65][66][38][67][68], where notable advantage of NIR 
CI over NIRS is to have more statistical confidence in the end point determination since it 
provides information from a large area of the sample. In addition, NIR CI applications has also 
been used to determine tablet uniformity [69], process related troubleshooting [70], 
distribution map in tablet [71][72][73] blending simulations for early phase development,  
quantification and distribution of pharmaceutical major and minor ingredients in tablets [74]. 
Some novel applications like the study of polymer film formulations [75], quantification of 
polymorphic forms [76], water content analysis in continuous freeze drying process [77], 
assay of roller compacted ribbons and subsequent tablet formulations [78] have also been 
reported using the NIR CI. 
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2.6 Chemometrics in NIRS and NIR CI-based PAT applications 
 Chemometrics is a branch of science that derives data by the application of mathematical 
and statistical methods, for the extraction of useful information from physical and chemical 
phenomena involved in a manufacturing process [79].  
 Chemometrics is used for multivariate data collection and analysis, calibration, process 
modeling, pattern recognition and classification, signal correction and compression, and 
statistical process control. Both predictive and descriptive analysis may be handled by 
chemometrics. The predictive analysis includes numerous system properties that are used in a 
model with the intent of predicting the target properties, desired features, or behavior of 
interest. The descriptive issues include properties of the investigated systems that are modeled 
in order to learn the underlying relationships and the system structure, which leads to the 
model identification, composition, and understanding. 
 Chemometric methods employed for analysis of NIRS and NIR CI derived data are  
categorized as univariate methods and multivariate methods 
2.6.1  Univariate methods 
 For univariate analysis, a 2-D image plane from the hyperspectral data cube or a spectral 
intensity at a particular wavelength in a NIR spectrum is selected. This method is useful when 
NIR images at specific absorbance intensities or spectral data at the specific wavelength are 
available. It is the easiest and fastest way to analyze hyperspectral image or NIR spectral data. 
However, it is necessary for the analyte of interest to have a specific absorption band in the 
NIR region and it is not interfered by the other components of the blend. Univariate profile of 
API spectral intensity at a single wavelength as a function of its concentration has been 
reported [61]. However, this is not always the case since pharmaceutical samples are more 
complex. Most of the times though active have a specific absorption band but the excipients in 
the blend had more broad bands that overlap with the active. As a result univariate methods 
are not much use in NIRS and NIR CI-based PAT applications, instead, multivariate methods 
are mostly used. 
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2.6.2  Multivariate methods 
 The drawbacks of univariate methods such as background variation and other 
interferences could be overcome by multivariate techniques. The advantage of multivariate 
analysis is that the entire spectrum can be used and interferences can be separated from the 
information of interest. There are multiple multivariate analysis methods available, however, 
only the methods used in the present work are discussed shortly in the following paragraphs. 
a) Principal component analysis (PCA) 
 PCA seeks to extract the major systematic variation in a data matrix. It reduces a large 
dataset containing an important number of variables to only a few, called principal 
components (or PCs). The principal components are new uncorrelated linear combinations of 
the original variables. The first principal component (PC1) describes the largest variation in 
the data set, the second PC the second largest variation and so forth. A loading is produced for 
each PC. Loadings provide information about the relation between the original variables and 
the PCs. The loadings look similar to original spectral features and most of the times are 
similar to the pure spectrum of a compound if a principal component mainly explains the 
variation for this pure compound. Using a score value a score images for each PC are 
produced as the final result from a PCA analysis. 
 The 2 limitations seen in PCA on NIR-CI data are that a principal component score 
image cannot be unambiguously assigned to a specific active ingredient because it is difficult 
to associate the loadings with the pure compound spectra and numbers of PCs are often not in 
accordance with the number of chemical compounds in the sample. 
b) Partial Least Squares (PLS) 
 PLS is a regression method that is used to relate two data matrices X (spectra) and Y 
(reference values). PLS need a calibration data in a range of concentrations in order to predict 
concentration of the unknown using the PLS model. In a PLS model, only components that are 
used in the calibration model are modeled.  
 In the PLS model building another major requirement is to get the most accurate Y 
matrix (reference values). Theoretical concentrations used as reference values may not take 
into account practical changes or process related variation in concentrations from batch to 
batch.  
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 PLS models are characterized based on values of different parameters related to model 
fit and errors in concentration predictions as described below. 
a) Root Mean Square Error of Calibration (RMSEC) [33] 
 This model parameter measures the average difference between predicted and measured 
response values at the calibration stage;  
𝑅𝑀𝑆𝐸𝐶 =  √∑
(?̂?𝑖− 𝑦𝑖)
2
𝑁
𝑁
𝑖=1        (2.1) 
where  ?̂?𝑖 represent model predicted values of i
th
 dependent variable and y represent expected 
values of dependent variable in the calibration data set, N is total number of samples. 
b) Root Mean Square Error Prediction (RMSEP)[33] 
 RMSEP measures the average difference between predicted and measured response 
values at the validation stage;  
 𝑅𝑀𝑆𝐸𝑃 =  √∑
(?̂?𝑖− 𝑦𝑖)
2
𝑁
𝑁
𝑖=1       (2.2) 
c) Root Mean Square Error Cross Validation (RMSECV) [33] 
 RMSECV measures the average difference between predicted and measured response 
values of samples from the calibration set that were placed aside; 
𝑅𝑀𝑆𝐸𝐶𝑉 =  √∑
(?̂?𝐶𝑉,𝑖− 𝑦𝑖)
2
𝑁
 𝑁𝑖=1       (2.3) 
where ?̂?𝐶𝑉,𝑖 represents model predicted values while 𝑦𝑖 represents expected concentration for 
i
th
 sample. 
d) Hoteling’s distance (T2) 
 T
2
 is a non-euclidean distance of each sample in relation to the average of all samples. If 
a predicted concentration value of a sample is beyond the 95% limit, it indicates that the 
sample is different from the others, but it does not necessarily mean that it is not part of the 
model. 
𝑇𝑖
2 = (𝑥𝑖 −  ?̅?)𝑆𝑥
−1(𝑥𝑖 −  ?̅?)
𝑇      (2.4) 
where S
-1
 is the inverse of the variance-covariance matrix of X; 𝑥𝑖 is i
th
 sample and ?̅? sample 
group mean. 
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e) Q – Residuals (Q) 
Q is off the plane distance of samples relative to the plane formed. Most of the time, samples 
whose distance is beyond the 95% limit, may represent an outlier of data, that is, a sample that 
is not part of the model and should be ignored while model building/validation. However, its 
interpretation must be carefully made as it might represent an unpredictable behavior of the 
system. Q residual is calculated as squared predicted error (SPE) [80]. 
𝑆𝑃𝐸 (𝑄) = ∑ (𝑥𝑖𝑗 − ?̂?𝑖𝑗)
2𝑖
𝑗=1      (2.5) 
where 𝑥𝑖𝑗 is an element of X and ?̂?𝑖𝑗 is an element of ?̂? (model predicted) 
f) R
2 
- Coefficient of Determination 
R
2 
is PLS model fit value which represents how well the model fits to calibration data set. 
𝑅2 = 1 − 
𝑆𝑆𝐸
𝑆𝑆𝑇
        (2.5) 
𝑆𝑆𝐸 =  ∑ (𝑦𝑖 − ?̂?𝑖)
2𝑁
𝑖=1        (2.6) 
𝑆𝑆𝑇 =  ∑ (𝑦𝑖 − 𝑦)
2𝑁
𝑖=1        (2.7) 
Where SSE is sum squares explained, SST is sum square total, 𝑦 is mean of all expected 
concentrations.  
R
2 
is calculated according to a number of latent variables selected in the model, in such cases 
R
2 
is called as
 
an
 
adjusted R
2 
square (𝑅𝑎𝑑𝑗
2 ). 
𝑅𝑎𝑑𝑗
2 = 1 − {
𝑆𝑆𝐸
𝑁−𝑘−1
} / {
𝑆𝑆𝑇
𝑁−1
}       (2.8) 
where k is number of latent variables selected in the PLS model. 
 Following tables summarize few representative NIRS (table 2.1) and NIR CI (table 2.2) 
applications in pharmaceutical tablet manufacturing operations and different chemometric 
techniques used therein. 
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Table 2.1 : Representative applications of NIRS-based Chemometric techniques during tablet manufacturing process 
Application in  respective tablet 
manufacturing operation  
Chemometric 
method 
Conclusion(s) 
Reference 
number 
a) Blending 
Monitoring of powder blending operation 
using multi-point NIRS measurements 
PLS 
Powder loading order, as well as fill level, resulted in varying 
blending dynamics in different zones where convective and diffusive 
mixing effects dominate 
[81] 
On-line monitoring of powder blend 
homogeneity by NIRS in V blender 
Spectral STD 
Calculation of moving block spectral standard deviation (STD) 
successfully determined the end point of the powder blending 
[82] 
Development of NIR-based blend 
uniformity method for multiple structurally 
similar actives 
PCA, PLS 
PCA/PLS score patterns can be used not only for selecting model 
parameters but also for the interpretation of models. NIR method 
shows satisfactory specificity and accuracy for all active 
concentrations 
[83] 
Evaluating the influence of mass flow and 
rotation speed in blending  using NIRS  
PLS 
Flow and stirring rate variations caused different powder flow 
dynamics, which were reflected on the NIR measurements and PLS 
[84] 
Blend uniformity end-point determination 
using near-infrared spectroscopy and 
multivariate calibration 
PLS 
NIRS-based PLS method predicted blending end point successively 
over 3 years and was verified against HPLC assay of the blend as 
well as tablet samples 
[85] 
b) Granulation 
Real-time assessment of granule and tablet 
properties using in-line data from a high-
shear granulation process 
PLS 
Compared to process data such as power consumption and 
temperature, NIRS spectral data correlated better to granule and 
tablet properties.  
[86] 
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Application in  respective tablet 
manufacturing operation 
Chemometric 
method 
Conclusion(s) 
Reference 
number 
Real-time monitoring of granule properties 
during high shear wet granulation  
PCA, PLS 
Granule properties can be correlated with the granulation process at 
the same time end point can be determined using NIRS data  
[87] 
c) Drying and milling 
Monitoring granulation drying using NIRS PLS
 
Special NIR probe can help to reduce variations due to density 
change while inferring about the moisture content of granules 
[88] 
In-line real-time NIR granule moisture 
measurements of a continuous granulation–
drying–milling process 
PLS
 
NIR spectra show changes in granule moisture as the drying 
progresses as well as it also helps to understand the role of inlet air 
temperature on the total moisture content of the granules 
[89] 
d) Tablet assay/uniformity 
The concentration profile of active and 
excipient in a tablet by NIR CI 
SMCR*
 
NIR CI can not only predict concentration but show distribution and 
crystal structure change of API in sustained release waxy matrix 
[90] 
Quantification of meloxicam and excipients 
in intact tablets by NIRS 
PLS 
NIRS PLS predicted concentrations of tablet ingredients matched 
closely with the HPLC-based assay of the respective ingredients 
[91] 
Theoretical analysis of tablet hardness 
prediction using NIRS 
PCR 
The regression factors contain both chemical and physical 
information enabling hardness and porosity predictions 
[92] 
e) Coating 
In-line NIR spectroscopy application for the 
monitoring of tablet film coating in an 
industrial scale process 
PCA, PLS 
Factors such as temperature, moisture, coating growth, change of 
tablet bed density have an impact on NIR spectra which allowed 
successful monitoring of tablet coating process 
[93] 
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Application in  respective tablet 
manufacturing operation 
Chemometric 
method 
Conclusion(s) 
Reference 
number 
Applicability of NIRS for monitoring film 
coating and curing process of the prolonged 
release coated pellets 
PLS 
NIRS is useful in curing monitoring as well as to predict drug release 
from the pellets but owing to its higher sensitivity to moisture, 
results were not accurate for pellets with a higher moisture content 
[94] 
Effect of sampling frequency for real-time 
tablet coating monitoring using near-infrared 
spectroscopy 
PLS 
Predicted moisture and coating level predictions from the spectral 
data model depend on the frequency of NIR testing in the in-line 
tablet coating process 
[95] 
* SMCR-self modeling curve resolution 
Table 2.2: Representative applications of NIR CI-based Chemometric techniques during tablet manufacturing process 
 
Application in  respective tablet 
manufacturing operation 
Chemometric 
method 
Conclusion(s) 
Reference 
number 
a) Blending 
Assessment of powder blend uniformity: 
Comparison of real-time NIR blend 
monitoring with stratified sampling in 
combination with HPLC and at-line NIR CI 
 
 
PLS 
 
Blending end point suggested by NIRS-based blend monitoring 
matched with end points determination by NIR CI and HPLC 
analysis of stratified blend samples 
[96] 
Critical evaluation of methods for end-point 
determination in pharmaceutical blending 
PLS 
Powder blend homogeneity as predicted by NIRS and NIR CI was 
similar giving similar values of time required for blending end point  
[97] 
b) Granulation 
Visualization and understanding of the 
granulation liquid mixing and distribution 
during continuous granulation using NIR CI 
Univariate 
linear 
regression 
Increased screw speed and lower moisture content resulted in a 
narrower residence time distribution. Increased moisture content and 
higher kneading results in uniform distribution of granulation liquid. 
[98] 
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*SD- standard deviation, CLS- classical least squares, MCR: Multivariate curve resolution  
 
Application in  respective tablet 
manufacturing operation 
Chemometric 
method 
Conclusion(s) 
Reference 
number 
Linking granulation performance to 
residence time and granulation liquid 
distribution 
PLS 
NIR CI successfully shows moisture distribution in the granules 
helping to understand solid-liquid mixing during the granulation 
process 
[99] 
c) Tablet assay/uniformity 
Continuous monitoring of API content, API 
distribution and crushing strength after 
tableting via NIR CI 
SD*, PLS 
models 
NIR CI helps to gather data allowing intra and inter tablet variation 
of drug distribution and hardness as compared to single point NIRS 
testing  
[100] 
Quantitative testing and distribution 
homogeneity assessment in pharmaceutical 
formulations using NIR CI 
PLS 
NIR CI data not only helps to find API distribution but also helps in 
quantitative concentration prediction 
[101] 
Comparison of marketed tablet dosage forms 
for content uniformity using NIR CI  
MCR* 
NIR CI helps to find active distribution map for tablets manufactured 
by different manufacturers as well helps to decide content uniformity 
[102] 
A Quantitative Method using NIR CI to 
determine the surface composition of tablets 
PLS 
Averaging predicted concentration in all image pixels gives tablet 
API content at the same distribution maps asses the homogeneity 
[103] 
d) Coating 
Quantification of components in coated 
pharmaceutical tablets using NIR CI 
CLS* 
The coating applied on the tablet represents about 30 % mass 
fraction of the sampled tablet which interfered in the estimation of 
tablet assay. 
[104] 
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CHAPTER 3 Concentration monitoring with NIR CI 
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Summary 
Content:  
In order to evaluate the feasibility and suitability of NIR CI (area scan) for feed frame 
monitoring, it is necessary to verify its performance against known PAT methods of feed 
frame monitoring. In the present work, NIR CI (area scan) is evaluated for detecting Ascorbic 
Acid (model API) concentrations qualitatively and quantitatively in a comparatively simple 
blend comprising only 3 ingredients, while NIRS is used as reference method. Additional 
aspects for NIR CI (area scan) such as data acquisition, tested sample volume and the 
possibility to find local concentration changes are also explored. 
Results: 
NIR CI (area scan) implementation inside feed frame is found feasible at the end of the study. 
NIR CI (area scan) performed closely to NIRS for concentration differentiation qualitatively 
as well as quantitatively. In addition to increased tested sample volume, it also shows the 
possibility to explore local concentration variations; in these aspects, (i.e. sample volume and 
segregation testing) NIR CI (area scan) appeared promising over NIRS. 
Contributions to the thesis:  
Current experimental work helped to present proof of concept for implementing NIR CI (area 
scan) for monitoring the feed frame. The initial challenges in NIR CI (area scan) 
implementation such as controlling sample presentation and data acquisition were successfully 
addressed. Concentration monitoring in off-line tests using comparatively simple blends was 
successful, which open the doors to challenge this method using more complex blends while 
performing the tests in an in-line manner. 
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Abstract 
 Monitoring powder potency and homogeneity are important in achieving real-time 
release testing in a continuous tablet manufacturing operation. If quality related issues are 
encountered, monitoring powder potency inside feed frame offers the last opportunity to 
intervene in the process before tablet compression. Feed frame monitoring methods based on 
near-infrared spectroscopy (NIRS) have been increasingly reported in recent years. New 
process analytical tools with the potential of being deployed alone or in combination with 
NIRS for feed frame monitoring are now available commercially. The present study evaluated 
the potential of near-infrared chemical imaging (NIR CI) for in-line monitoring of a prototype 
pharmaceutical composition containing ascorbic acid (AA), microcrystalline cellulose and 
dicalcium phosphate. NIRS was the reference method. In-line calibration models based on 
partial least square regression were developed and validated with a range of AA 
concentrations. The ability of NIRS and NIR CI (area scan) to predict concentrations in test 
runs was ascertained both independently and in combination. NIR CI (area scan), with a single 
bandpass filter, predicted AA concentrations – present at commercially relevant 
concentrations – with acceptable accuracy. Comparative results showed that NIR CI (area 
scan) has the potential for in-line monitoring of blend concentrations inside feed frames. In 
addition to the advantage of increased sample size, it also has the potential to detect 
segregation inside feed frames. 
 
Keywords: NIRS; NIR CI (area scan); PAT; feed frame; in-line monitoring 
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Résumé français: 
 Le contrôle de la concentration et de l’homogénéité des poudres est important pour la 
réalisation libération en temps réel des lots dans une opération de fabrication de comprimés en 
continu. Si des problèmes reliés à la qualité sont rencontrés, le contrôle de la concentration de 
la poudre dans le plateau d’alimentation de la presse offre une dernière opportunité 
d’intervenir dans le procédé avant la compression. Les méthodes de contrôle du plateau 
d’alimentation basée sur la spectroscopie proche infrarouge (NIRS) ont de plus en plus été 
rapportées ces dernières années. De nouveaux outils analytiques de procédés ayant le potentiel 
d’être déployés seuls ou en combinaison avec la NIRS pour le contrôle plateau d’alimentation 
sont maintenant disponibles sur le marché. La présente étude a évalué le potentiel de 
l’imagerie chimique infrarouge (NIR CI global) pour le contrôle en ligne d’une composition 
pharmaceutique prototype contenant de l’acide ascorbique (AA), de la cellulose 
microcristalline et du phosphate bicalcique. La NIRS a été la méthode de référence. Des 
modèles de calibration en ligne basés sur la régression par moindres carrées partielles ont été 
développés et validés sur une plage de concentration de l’AA. Les capacités de la NIRS et de 
la NIR CI (global) de prédire les concentrations lors des tests ont été vérifiée pour les deux 
méthodes séparément et en combinaison. La NIR CI (global), avec un unique filtre passe-
bande, a prédit les concentrations d’AA – présent à des concentrations commercialement 
appropriées – avec une précision acceptable. Des résultats comparatifs ont montré que la NIR 
CI (global) a le potentiel pour le contrôle en ligne de mélanges de concentrations dans les 
plateaux d’alimentation. En plus de l’avantage de l’augmentation de la taille d’échantillon, elle 
a aussi le potentiel de détecter la ségrégation dans le plateau d’alimentation. 
 
Mots-clés: Spectroscopie proche infrarouge (NIRS); l’imagerie chimique en proche infrarouge 
(NIR CI global); PAT; plateau d’alimentation; contrôle en ligne des concentrations 
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3.1 Introduction 
 Pharmaceutical regulatory authorities require compliance of every manufactured product 
batch with pre-approved specifications before its release to market. Compliance is crucial for 
the safety and efficacy of patient medications. Conventionally, the batch release takes place 
after all quality testing of representative samples has been completed, which could lead to 
considerable lag time and significant costs. The real-time release of pharmaceuticals is 
becoming possible by taking advantage of recent technological advances as well as 
recommendations from regulatory agencies for continuous process monitoring [105]. Product 
and process information collected during manufacturing can ensure that it complies with 
intended quality standards. Such information could be obtained by measuring the critical 
quality attributes (CQAs) of raw materials, in-process materials and critical process 
parameters (CPPs) during different manufacturing stages. Process analytical technology (PAT) 
tools enable CPP and CQA measurements in-line, on-line and at-line during the manufacture 
of different dosage forms, such as tablets, capsules, and liquids [2].  
3.1.1 NIRS as PAT tool for tablet manufacturing 
 Pharmaceutical tablet production involves material handling through a series of steps, 
including sieving, mixing, particle size enlargement/granulation, drying, compression, sorting, 
and packing [106]. These different operations can elicit significant changes in material 
attributes which must be monitored to ensure final product quality. Near-infrared spectroscopy 
(NIRS)-based PAT applications have been developed for monitoring operations, like blending 
[36] [34] [107] [81], granulation [40][43][47], drying [44] [108] and continuous mixing 
followed by compression [59], coating [55] and end product testing [56][58][91][92], where it 
has proven to be advantageous over conventional in-process sampling and testing methods. 
In addition to these key operations, consistent die-filling is important to meet tablet quality 
attributes. The feed frame helps maintain a constant supply of materials for die-filling during 
compression: it is the very last place to access powder just before compression. Powders 
undergo continuous shearing inside feed frames, which may cause component segregation 
[109]. From the real time release testing (RTRt) perspective, if blend concentration is ensured 
by meeting required specifications inside the feed frame, then monitoring tablet weight alone 
would be sufficient for tablet assay in RTRt. However, a number of undesirable phenomena 
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occurring inside the feed frame (e.g., material segregation) may impact final product quality 
[19]. Thus, process compliance inside the feed frame is a must to determine final product 
quality. 
 Continuous material movement inside the feed frame evokes significant changes in 
physical properties (e.g., density) which, in turn, poses a challenge for the development of 
successful PAT methods for in-line feed frame monitoring [60]. Such powder flow 
phenomena occurring inside the feed frame, e.g. density variations [15] and segregation [52], 
have been explored with NIRS. Despite challenges related to sample presentation, NIRS has 
been useful in in-line concentration monitoring inside the feed frame [15][16][61]. 
3.1.2 Near-infrared chemical imaging (NIR CI) in feed frame monitoring 
 The effective sample size is an important parameter for successful in-line feed frame 
monitoring. In a NIRS-based powder sample testing, it can be estimated with certain 
parameters, such as NIR beam diameter, its penetration depth and powder density [35][110], 
NIRS-based PAT methods verify content uniformity based on a small blend area (i.e., often a 
circular expanse 4-6 mm in diameter) illuminated by NIR beam [35]. Because of low sample 
scrutiny levels, it is possible for segregation, if present, to remain unnoticed. This limitation 
may be eliminated by NIR CI, which acquires chemical information over larger sample areas 
(e.g., 5×2 cm) using larger sensor arrays (e.g., 256×320 pixels) as compared to NIRS probes 
(e.g. 128×1 pixels). In addition, spatial and spectral information could potentially enhance 
process understanding as well as impart confidence in process data interpretation, e.g., for 
end-point determination of blending [63][65][39][68]. NIR CI-based applications developed 
with the aim of pharmaceutical quality assurance have been successful in analyzing the 
distribution of ingredients in tablets [64][74][73], their content uniformity [70], dissolution 
rates [111] as well as testing for counterfeit products [112] [113]. To the authors’ knowledge, 
NIR CI for in-line feed frame monitoring has not yet been reported. 
 The main purpose of the present study is to determine the operational feasibility of NIR 
CI in a dynamic feed frame environment with a bench top feed frame set-up. NIR CI, with 
selected wavelength band filters, gives greyscale images that could help monitor the 
concentration and spatial distribution of NIR-active materials. NIRS served as a reference 
method, validating the state of mix and NIR CI results since it has already been undertaken for 
feed frame monitoring [114]. Sample volume was estimated both for NIR CI and NIRS. NIR 
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data were evaluated for qualitative and quantitative differentiation of powder blends according 
to various ascorbic acid (AA) concentrations. AA values with NIR CI were compared against 
NIRS and combined NIRS/NIR CI data. NIR CI potential to quantify segregation was also 
assessed. Its capability could constitute a major advancement in feed frame monitoring. 
3.2 Materials 
 All samples in this study consisted of AA (DSM, Jiangsu), microcrystalline cellulose 
(MCC, Avicel PH 101
®
, FMC biopolymer) and dicalcium phosphate (DCP, Di tab
®
, 
Innophos) at different relative AA concentrations. MCC, DCP and AA particle sizes were 77-
156, 150-420 and 150-850 µm, respectively. Particle size specifications according to supplier 
certificates of analysis were: d90 within 77-156 for MCC, d80 within 150-425 for DCP, d70 
within 150-850 and d20 above 850 µm for Ascorbic acid. All the materials used in this study 
were taken from a single lot of respective materials thus particle sizes were essentially 
maintained constant, however significantly varying particle sizes between different lots of any 
of the materials may impact the performance of calibration model. 
3.3 Methods 
3.3.1 NIR penetration in samples 
 Sample volume estimation is important to ensure the required level of scrutiny for blend 
homogeneity [26]. In addition, regulatory specifications of tablet uniformity are dependent on 
the number of units sampled. Sample volume estimation in feed frame monitoring is necessary 
to predict tablet uniformity based on feed frame concentrations. 
Sample volume could be estimated for each NIR CI (area scan) and NIRS measurement with 
the following equation 3.1 [26]: 
𝑆𝑎𝑚𝑝𝑙𝑒 𝑣𝑜𝑙𝑢𝑚𝑒 = 𝐴 × 𝐵 × 𝐶    (3.1) 
where A is the sample area tested by the respective tool, B is NIR penetration depth, and C is 
sample bulk density. 
 NIR penetration depth inside samples is required to ascertain feed frame sample volume. 
A modified experimental protocol was set-up for this purpose based on the variable layer 
thickness method proposed by Berntsson et al [110].  They have reported that sample 
reflectance increases with increasing powder thickness until the latter reached an optically-
thick level. Changes in reflectance at different powder thicknesses could be traced as a result 
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of NIR penetration in samples. In the present work, repeated NIR CI (area scan) at 2 mm and 
higher thickness showed no differences in pixel intensities: thus, this thickness was considered 
as equal to or greater than that of optically-thick samples. Actual NIR penetration was 
determined by comparing pixel intensities at lower than 2-mm thickness to 2-mm or higher 
sample thickness.  
 A plastic tray (Figure 3.1a) 5×4 cm in size was cast and divided into 2 halves (sections 1 
and 2). These 2 halves were identical except for their depth, which differed by 2 mm (Figure 
3.1b). The purpose of this set-up was to compare pixel intensities acquired from sections 1 and 
2. When sufficient powder is placed in the tray, both sections should present similar responses 
in terms of pixel intensities; if not, the base of the tray will impact the signal of the shallower 
section (more NIR light will be reflected back to the NIR camera sensor if the light passes 
through the sample to the reflective surface of the base, thus pixels will have higher intensity). 
 
Figure 3.1: Sample tray (a) complete view, and (b) cross-section 
 Tray lids of different thickness (0.5, 0.75, 1.0, 1.5, 2.0 and 2.5 mm) were cast. When no 
lid was placed on the tray, section 1 had no depth, whereas section 2 was 2 mm deep. Section 
1 depth becomes 0.5 mm with the 0.5-mm lid placed on the tray, while it becomes 2.5 mm for 
section 2. Each time a new lid was placed on the tray, sample material (AA particle size 354-
420 µm) was filled in the tray and any excess above the tray lid level was gently scraped off.  
3.3.2 Feed frame set-up 
This study was conducted in the feed frame of a Manesty Novapress 37-station rotary tablet 
press. The experimental set-up comprised a fully functional feed frame without actual tablet 
compression. It helped to mimic powder movement in full-scale tablet manufacturing, but 
significantly reduced the amount of material and human effort required during trials. The feed 
frame consisted of 2 counter-rotating wheels (Figure 3.1a), each with 10 paddles. The second 
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wheel was located slightly lower than the first wheel to facilitate material movement inside the 
feed frame. The PAT tools NIRS and NIR CI (area scan) were placed above the second wheel 
(Figure 3.2b) just before the point where powder exits the feed frame and enters die cavities 
for compression. 
   
Figure 3.2: Feed frame set-up: (a) Material flow, and (b) NIRS and NIR CI (area scan) 
locations 
3.3.3 Data acquisition inside the feed frame 
 Two data acquisition tools were employed: a NIR probe (MicroNIR 1700, Viavi 
Solutions, Inc., Milpitas, CA, USA) and a NIR camera-(Bobcat 320, Xenics infrared solutions, 
Leuven, Belgium) with 25-mm infrared lens (Navitar, Rochester, NY,  USA). Both tools 
acquire NIR data in the 900-1,700 nm range, as described below.  
3.3.3.1 NIR probe 
 The NIR probe was equipped with a spectroscope (resolution: 6.2 nm) that discretized 
spectrum into 128 levels. The probe’s tip was slightly tilted in the direction of material flow, 
while keeping the observation window (5×15 mm) flat, and was mounted on a micrometer. 
This allowed the measuring tip to precisely touch the powder bed during measurements 
without reaching the paddle wheel. In this manner, NIR measurements helped to minimize 
baseline shifts due to powder wave behavior inside the feed frame, since there was no change 
in the path-length of the NIR radiation; however, baseline shifts due to changes in powder 
density caused by moving feed frame paddles were present. 
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3.3.3.2 NIR camera  
 The NIR camera was not equipped with a spectroscope: it integrated all energy levels 
into a single grey-scale image (320×256 pixels). However, different wavelength bandpass 
filters (Spectrogon Inc., Mountain Lakes, NY, USA) were affixed in front of the lens to 
capture narrow wavelength ranges chosen for specific active ingredients. Filters with 
wavelength ranges of 1240 ± 40 nm, 1460 ± 11 nm, 1600 ±63 nm and 1653 ± 19 nm were 
tested for their suitability to differentiate Ascorbic acid from other components of the powder 
blend in NIR chemical imaging. A suitable filter was expected to selectively allow passage of 
wavelength ranges absorbed by Ascorbic acid (where MCC and DCP do not show NIR 
absorbance) to the NIR camera sensor, thus image pixels representing Ascorbic acid would 
appear darker than the pixels representing other components of the blend. As a result, NIR 
chemical imaging in the present work refers to a grey scale NIR image captured over a 
selective NIR wavelength span. The set-up was adapted for proper and constant powder 
presentation. Moved around by the paddles, large crests and troughs were formed at the 
surface of the powder (Figure 3a, 3b), impacting image acquisition. As can be observed from 
the comparison of Figure 3.3a and 3.3c; NIR chemical image quality is hampered due to self-
shading of material in the presence of crest and trough pattern caused by feed frame paddle 
wheel. A flat insert (2.5 × 5.0 cm) was added to the feed frame surface to constrain these 
variations in front of the camera to capture the moving powder surface (Figure 3.3c, 3.3d). It 
was positioned 2.5 mm inside the powder whereas the lower tip of the NIR probe was situated 
at 5 mm inside the powder.  
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Figure 3.3: NIR CI (area scan) inside the feed frame: without a flat insert (a-top view, b-
schematic vertical cross-section), and with a flat surface (c-top view, d-schematic vertical 
cross-section) 
3.3.4 Formulations  
 Two sets of experiments, each with 7 samples (with different AA concentrations), were 
carried out on 2 different days. Both experiments analyzed the same concentrations, sample 
volume and blending time. AA concentrations were increased in a stepwise manner via 3% 
concentration increments between consecutive blends in order to develop the quantitative 
model. For the sake of simplicity, the first and second experimental sets will be referred to as 
trials 1 and 2. The purpose here was to prepare and validate quantitative models in trial 1 and 
to evaluate them for prediction of similar concentrations in trial 2. 
Samples with 5 different concentrations (0, 3, 6, 9 and 12% w/w AA) from trial 1 were used 
for the development of the calibration model based on partial least square (PLS) regression. 
Performance of PLS calibration model was tested in 3 ways: 
 Test set I (300×76), with 4 and 8% w/w AA powder samples from trial 1, which 
represented model applicability for samples from the same trial. 
 The test set II (300×76), with 4 and 8 % w/w ascorbic acid samples from trial 2, 
represented model applicability to test 1 concentration but in a second trial set. 
 The test set III (750×76), with 0, 3, 6, 9 and 12 % w/w AA samples from trial 2, 
represented model applicability to concentrations as in calibration samples but in a 
second trial set. 
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(300 and 700 represent the number of samples while 76 represents the number of 
histogram bins in NIR CI (area scan), for NIRS 76 is replaced by 80 i.e. number of 
wavelengths) 
Table 1 lists the different sample compositions analyzed in this study.  
Table 3.1: Sample compositions in trials 1 and 2 
Ingredients Mass concentrations (% w/w) 
 Trial 1 – Calibration  
Trial 2 – Test III 
Trial 1 – Test I 
Trial 2 – Test II 
Ascorbic acid 0.0 3.0 6.0 9.0 12.0 4.0 8.0 
MCC 54.5 53.0 51.5 50.0 48.5 52.5 50.5 
Dicalcium phosphate 45.5 44.0 42.5 41.0 39.5 43.5 41.5 
 
 Sample quantities were selected on the basis of feed frame working volume, obtained 
(550.0 g) by adding material slowly inside the closed feed frame until it was full and no more 
material was accepted inside. Samples were prepared by mixing excipients and AA granules 
together in a 3-liter V-blender (Patterson Kelley Blend Master, East Stroudsburg, PA, USA.) 
for 10 min. Blending time was kept constant for all samples to ensure uniform blending. The 
samples were charged and circulated inside the closed feed frame for 10 min at 20 revolutions 
per minute (rpm) of the paddle wheels. In total, 200 signals (each of NIR spectra and NIR CI) 
were recorded at a rate of 1 acquisition per rotation of the paddle wheel. 
3.3.5 Data acquisition 
3.3.5.1 NIRS 
 Spectral integration time was 5 ms for NIRS signals, with 50 spectra averaged to obtain 
output signals. An external mechanism was triggered each time to initiate spectral acquisition. 
Before the acquisition, the NIR probe was calibrated between 0 and 100% reflectance. For the 
0% set-up, a NIR spectrum was acquired in the absence of infrared light while for the 100% 
set-up, NIR spectrum was recorded pointing the NIR beam at 100% reflectance reference. 
Every raw spectrum (R) acquired during the trials was corrected (C) with the 0% and 100% 
reflectance standards according to equation 3.2: 
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𝐶 =
(𝑅−𝐷)
(𝐵−𝐷)
         (3.2) 
where D is 0% reflectance (dark) and B is 100% reflectance reference (bright)  
3.3.5.2 NIR CI (area scan) 
 Sample presentation to the camera was properly controlled to ensure image-to-image 
data comparability. Sample-to-camera distance, optics, illumination and sample surface 
settings were kept constant. In addition, all NIR images were corrected for NIR source 
intensity variation over time using a white reference. For this purpose, a white reference was 
placed across the vertical axis on one corner of the flat insert. A ratio between the mean 
intensity of all the pixels representing this white reference in the respective image and the first 
image was used to correct the respective image for variation in the NIR light intensity. This 
ratio was multiplied to all pixel intensities in the NIR chemical image being corrected. 
 Considering differences in the NIR absorption of AA and other components (MCC, 
DCP), a 1,632-1,671-nm filter was selected to capture NIR images since it offered a 
comparatively greater contrast in pixels representing AA and other components (other 
components reflected more at selected NIR wavelengths). 
3.3.6 Data treatment 
 All NIR spectra and image data obtained from the trials were analyzed by in-house 
MATLAB Scripts as well as the PLS Toolbox (Eigenvector Research, Inc., Manson, WA, 
USA.). NIRS spectra were evaluated with different pretreatments, such as standard normal 
variate (SNV), Savitzky-Golay (SG) second derivative, mean centering and scaling to unit 
variance. 
 NIR spectra of all individual components combined other components and composite 
sample (12% w/w AA) were acquired (Figure 3.4a). The diffuse reflectance intensity of all 
ingredients (AA, MCC, and DCP) kept on increasing roughly to 1,614-1,651 nm and then 
decreased. However, distinct spectral features started to appear only after 1,100 nm as the 
other components (MCC, DCP) absorb less than AA.   
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Figure 3.4: (a) NIR reflectance spectra of individual components and composite samples, (b) 
SG second derivative pretreated spectra of individual components and composite samples 
 Baseline shifts in raw spectra were removed to a significant extent as a result of 
pretreatments by SNV and SG second derivative (second order polynomial and 15 points). 
Color-coded plots of SG second derivative pretreated spectra (Figure 3.4b) in the 1,100-1,590 
nm range revealed differences in the spectral signature of different samples over the entire 
range of selected spectra. As a result, all wavelengths in this spectral range were used in the 
principal component analysis (PCA) and further PLS analysis. 
 NIR chemical images with single filter do not contain any spectral information (as in the 
case of a spectrograph) but provide a 2D representation of the sample as seen over the 
particular wavelength band allowed by selected filter. Pixel intensities are influenced by the 
presence of NIR-active and NIR-non-active material: consequently, the distribution of pixel 
intensities could quantify content in a spectral format in a way similar to NIRS. Consequently, 
intensities of all pixels in NIR images were expressed in the form of intensity histograms, 
which classified them into different bins based on their intensity.  
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Figure 3.5: Histogram of a binary image 
 Figure 3.5 depicts the histogram of a grayscale schematic image of the feed frame in 
which the X-axis represents 8-bit image intensity, and the Y-axis embodies the proportion of 
pixels in each respective bin. Darker pixels are placed in bins close to the origin on X-axis 
while brighter pixels are placed away from the origin.  
3.3.7 Data analysis by PCA and PLS 
 PCA and PLS were undertaken for data analysis. Initially, exploratory PCA was 
conducted to check if individual blend concentrations could be identified by respective 
signals. Thereafter, the quantitative relationship of NIR CI (area scan) with respective sample 
concentrations was evaluated against NIRS and the combination of NIR CI (area scan) with 
NIRS by PLS. 
 PLS models were statistically compared by R
2
adj (coefficient of determination in the 
calibration model), root mean square error of calibration (RMSEC) and root mean square error 
of cross-validation (RMSECV). 10 repeats were used in cross-validation.  Root mean square 
error of prediction (RMSEP), the mean value and standard deviation of predicted 
concentrations were compared in tests 1, 2 and 3. In the end, the average NIR image of each 
sample blend and PLS concentration predictions were evaluated in different sections of NIR 
images. 
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3.4 Results and discussion 
3.4.1 Sample volume 
 Sample volume was estimated by NIRS and NIR CI (area scan), starting with the 
assessment of NIR penetration. In the case of NIRS, multiple spectra were collected for 
analysis of each specific thickness sample (90×128). Spectral variations among different 
thickness samples were evaluated by PCA of complete spectra. SNV followed by mean 
centering was used as a spectral pre-treatment in order to maintain baseline variations caused 
by different levels of NIR light penetration. Principal component 1 (PC1), which represents 
90.19% of total variance, explained the baseline variations seen among these spectra. PC1 
versus sample plots (Figure 3.6a) showed that PC1 values kept on increasing with increasing 
sample thickness and later reached a plateau of around 1.5 mm in depth. Since there was no 
difference in spectra baseline beyond 1.5 mm thickness, it was concluded that NIR 
penetration, in this case, was 1.5 mm.  
 In the case of NIR CI (area scan), unpaired t-tests of pixel intensities were performed on 
2 tray sections. The null hypothesis was rejected (at alpha value of 0.05) in samples 2.0-0.0 
mm, 2.5-0.5 mm and 2.75-0.75 mm thick, but was accepted for all remaining thickness 
samples (3.0-1.0 mm, 3.5-1.5 mm and 4.0-2.0 mm), indicating that there were no differences 
in pixel intensities of the 2 sections with thickness more than 0.75 mm. Thus, it was concluded 
that NIR penetration in NIR CI (area scan) was 0.75 mm. Figure 3.6b depicts NIR images 
taken at different thickness combinations and corresponding pixel intensity histograms.  
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Figure 3.6: NIR penetration in samples: (a) PCA score plot NIRS, and (b) NIR CI (area scan) 
histogram 
 Bulk material density was found to be 0.48 g/cm
3
. Effective sample area was 3.5×2.0 
cm, as seen on NIR CI (area scan). Sample volume estimation was based on equation (1) for 
NIR CI and NIRS. It was found that the sample per image was 252 mg in NIR CI (area scan) 
while the sample per spectrum was 54 mg in NIRS. NIR penetration inside the sample was 
higher in NIRS than in NIR CI (area scan), however, sample volume with NIR CI (area scan) 
was estimated to be about 5 times higher than with NIRS. As an example, for a 250-mg tablet, 
each NIR CI (area scan) would represent a sample equivalent to tablet weight, but 5 spectra 
would be required to exemplify the same sample in NIRS. Considering the possibility of 
further increasing flat insert size, sample volume in NIR CI (area scan) could be adjusted to 
suitably represent tablet weight greater than 250 mg. 
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3.4.2 Qualitative NIRS analysis  
 Differentiation between calibration samples was evaluated by NIRS spectra collected 
inside the feed frame. PCA was performed on NIRS spectral data to highlight qualitative 
differences between the different samples.  Savitzky-Golay (SG) second derivative, SNV 
followed by mean centering was used as spectral pre-treatment. The PCA score plot illustrated 
in Figure 3.7 shows clusters for samples with different concentrations.  
 
Figure 3.7: PCA score plots of NIRS data (Markers with different color represent % w/w 
content of ascorbic acid in the respective sample) 
 PC1 captured 75.36% of total variance while PC2 captured 10.16%. PC1 correlated with 
AA concentrations in samples on the basis of PC1 score versus sample plot. Samples with 0, 3 
and 6% w/w AA were well separated. While still present, the separation between samples 6, 9 
and 12% w/w was not as clear. However, it showed that with NIRS data, we can see a 
difference between the calibration samples. Because of this finding, it seemed reasonable to 
quantitatively analyze NIRS data (discussed in Section 2.5) but, first, differentiation of 
calibration samples in NIR CI (area scan) data needs to be done. 
3.4.3 Qualitative NIR CI (area scan) analysis 
 NIR CI (area scan) data were converted to histograms before qualitative PCA. 
Separation of the samples into different groups based on NIR CI (area scan) data was 
compared with separation of these blends in NIRS data. 
  
 
59 
a) Histogram comparison in NIR CI (area scan)  
 The histograms of calibration samples in Figure 3.8 indicate that NIR CI (area scan) was 
able to distinguish samples with different AA concentrations.  
 
Figure 3.8: Pixel intensity histograms of calibration samples (Color represents % w/w content 
of ascorbic acid in the respective sample) 
 Two major trends were apparent in the comparative distribution of all histograms, i.e., 
vertical and horizontal shifts. All histograms were produced from same size images: thus, each 
histogram was made of the same number of pixels representing the sample. In this scenario, a 
vertical shift in histograms indicates an overall increase in the number of darker or brighter 
pixels based on the corresponding horizontal shift direction. A horizontal shift to the left 
suggests an increase in darker pixels, while a shift to the right signposts an increment of 
brighter pixels which, in turn, respectively correlate with higher and lower AA concentrations 
in samples. 
Histograms of 0% w/w Ascorbic acid samples are located farthest of all on the right side and 
have the highest peak height, indicating the comparatively narrower distribution of brighter 
pixels. In contrast, histograms of 12% w/w samples are located farthest on the left with the 
lowest peak height, signifies a larger number of darker pixels and comparatively wide pixel 
distribution.   
b) PCA with NIR CI (area scan) 
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 The PCA score plot of histogram data (Figure 3.9) of calibration samples showed 
differences in the form of distinct cluster points. Mean centering and scaling to unit variance 
was used for data pre-treatment. PC1 captured 80.83% of total data variance and is correlated 
with AA concentrations in samples. 0%, 3% and 6% w/w samples were very well separated, 
but there was little overlap in 9 and 12% of them.  
 
Figure 3.9: PCA score plot of NIR CI (area scan) (Markers with different color represent % 
w/w content of ascorbic acid in the respective sample) 
 In NIR CI (area scan), samples with 6, 9 and 12% w/w AA were well separated while 3 
and 6% w/w AA samples were less clearly separated in contrast to NIRS data. However, 
individual observations in all samples show spread around the group cluster in both NIRS and 
NIR CI (area scan) data. Overall, PCA disclosed that NIR CI (area scan) was able to represent 
differences within calibration samples slightly better than NIRS because of larger sample size. 
3.4.4 Quantitative analysis 
 The quantitative relationship between NIR CI (area scan) (750×76) and AA 
concentration was studied in PLS-based models. PLS-predicted concentrations in NIR CI (area 
scan) were compared with NIRS (750×80) and combined NIRS/NIR CI (area scan). A 
combined data matrix (750×156) of spatial and spectral information on each sample was 
obtained by horizontal concatenation of selected NIRS/NIR CI (area scan) data. 
 NIR CI (area scan) data were centered and scaled to unit variance before subjecting 
them to PLS modeling. The PLS model was developed with NIRS data, using SNV, SG 
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second derivative (second order polynomial and 15 points) and mean centering pretreatment. 
For PLS models with combined NIRS/NIR CI (area scan) data, respective data was pre-treated 
individually and then combined. NIRS data was pre-treated with SNV, SG second derivative 
(2
nd
 order polynomial with 15 points), centered and scaled to unit variance, while NIR CI (area 
scan) data was centered and scaled to unit variance. 
a) Quantitative model comparisons 
 All PLS models were cross-validated with random subsets during model development. 
Table 3.2 summarizes the different datasets of the PLS model parameters.  
Table 3.2: Summary of PLS performance indicators 
PLS model Model 
parameters 
PLS model  
NIRS NIR CI (area 
scan) 
Combined (NIRS/NIR CI 
(area scan)) 
Calibration 
R
2
adj
 
 0.96 0.95 0.98 
RMSEC* 0.71 0.81 0.50 
RMSECV* 0.71 0.82 0.51 
Test set I RMSEP* 0.72 0.98 0.53 
Test set II RMSEP* 1.68 1.89 0.75 
Test set III RMSEP* 2.53 2.02 2.18  
Number of latent variables 3 3 3 
* PLS model errors were expressed in % w/w of ascorbic acid. 
 Overall, R
2
adj statistics of PLS models based on all 3 types of datasets (NIRS, NIR CI 
(area scan) and combined NIRS/NIR CI (area scan)) showed that PLS models fit well with 
calibration sample data. RMSEC and RMSECV values were higher in NIR CI (area scan), 
lower in NIRS, and even lower in the combined NIRS/NIR CI (area scan) model. For 
concentration prediction in trial 1 (test set I), the prediction error of NIR CI (area scan) was 
slightly higher than that of NIRS and the combined data model. Combining NIRS and NIR CI 
(area scan) did not improve concentration prediction in unknown samples.  
 Calibration models with respective datasets (NIRS, NIR CI (area scan) and combined 
NIRS/NIR CI (area scan)) elicited higher prediction error in trial 2 (test sets II and III) than in 
trial 1. However, the same calibration models with respective datasets (NIRS, NIR CI (area 
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scan) and combined NIRS/NIR CI (area scan)) predicted well in trial 1 (test set I), which had 
the same concentration as in test set II. Trials 1 and 2 were performed as separate runs on 2 
different days: thus, higher prediction error could have been the result of variables in data 
acquisition (such as sample presentation, illumination, NIR source variability, random error) 
or due to actual variations in the samples. Since data acquisition was carefully controlled and 
both NIRS and NIR CI (area scan) simultaneously showed higher prediction error, it was 
likely that unidentified experimental variables caused actual variations (segregation) in trial 2 
samples. However, this could be further evaluated on the basis of actual values of predicted 
concentrations. 
b) Quantitative result comparisons  
Unknown sample predictions with NIR CI (area scan), NIRS and combined NIRS/NIR CI 
(area scan) data models were compared according to average prediction values and standard 
deviation. Table 3.3 summarizes the predicted concentrations of unknown samples in test sets 
I, II and III. 
Table 3.3:  Summary of PLS-predicted concentrations 
Test sets Measured 
concentrations of 
samples 
(Ascorbic acid % 
w/w) 
The predicted average concentration of the sample 
(1 standard deviation) 
NIR CI (area 
scan) 
NIRS Combined 
(NIRS/NIR CI (area 
scan)) 
I 
4.0 
8.0 
3.32 (0.63) 
8.66 (0.77) 
3.84 (0.55) 
8.61 (0.60) 
4.06 (0.36) 
8.44 (0.49) 
II 
4.0 
8.0 
5.70 (1.10) 
8.20 (0.90) 
6.06 (0.58) 
10.78 (0.73) 
4.69 (0.36) 
7.45 (0.49) 
III 
0.0 
3.0 
6.0 
9.0 
12.0 
2.10 (1.30) 
5.00 (1.20) 
8.00 (1.20) 
9.00 (1.30) 
11.20 (1.10) 
1.18 (0.55) 
4.69 (0.51) 
8.25 (0.70) 
10.64 (0.77) 
12.06 (0.69) 
3.04 (0.24) 
4.55 (0.41) 
6.05 (0.40) 
8.18 (0.47) 
8.74 (0.46) 
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 In test set, I, average predicted concentrations with PLS models in all 3 test sets were 
within the limits of ±1% w/w. However, the standard deviation of predicted concentrations 
was lower with combined NIRS/NIR CI (area scan) than with individual NIRS and NIR CI 
(area scan). Between individual data models, NIRS showed a lower standard deviation than 
NIR CI (area scan). The distribution of observations in calibration and test samples can be 
seen in predicted concentrations versus sample plots of the NIRS/NIR CI (area scan) model 
(Figure 3.10). Individually, NIR CI (area scan) showed comparatively wider distribution 
around measured concentrations than NIRS and combined NIR CI (area scan)-NIRS 
predictions. This may have been due to the combined effect of the larger sample area, lower 
NIR penetration and the comparatively larger particle size of AA granules. Since NIR imaging 
mostly captured surface distribution, depending on granule size, partial or complete exposure 
of particles to the surface could possibly have led to differences in consecutive images. It 
should be noted that the differences were very small and mainly occurred in particular 
samples. Concentration differences between samples were very well captured at the 1% w/w 
level among calibration and test samples. 
 
Figure 3.10: Predicted concentrations versus sample in test I with the combined NIRS/NIR CI 
(area scan) model (Color represents % w/w content of ascorbic acid in the respective sample) 
 
 In test set, I, mean values of predicted concentrations showed that the NIR CI (area 
scan)-based PLS model was in close agreement with the NIRS and combined NIRS/NIR CI 
(area scan) models. One of the major highlights of this work was that NIR CI (area scan) can 
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monitor feed frame concentrations in capacity at least equal to the already known PAT 
tool(NIRS) for feed frame monitoring. Combination of NIR CI (area scan) and NIRS data 
does not seem to offer any advantage over the accuracy of the NIR CI (area scan) and NIRS 
models except for precision (standard deviation) of the predicted values. 
In the test set II and III concentration predictions, the standard deviation of predicted values 
followed the same trend (NIR CI (area scan) > NIRS > combined NIRS/NIR CI (area scan)) as 
in test set I. However, predicted concentrations were not very close to measured values. 
Average predicted concentration was found to vary in the range of ±2-3% w/w with all 3 types 
of data models. 
PLS-predicted concentrations in trial 2 were expected to be close to those in trial 1 considering 
their exactly identical composition and blending time (i.e., 10 min). However, in the NIR CI 
(area scan) data, few samples (8%, 9% and 12% w/w) were predicted close to measured values 
while others (4%, 0%, 3% and 6% w/w) were not well predicted. Similarly, NIRS and 
combined NIR CI (area scan)/NIRS gave a prediction error of about 2-3% in all samples, 
except for 12% w/w. Since sources of possible variation in NIRS data were removed by 
suitable data pretreatments, prediction bias veered towards other variables, influencing the 
NIRS data. This hints at another possibility: that there could have been actual variations within 
samples in trial 2, which might lead to variations in predictions. In the present case, tablet 
compression was not performed subsequently: otherwise, these variations could have been 
tested by tablet assay. However, NIR CI (area scan) could still be useful to further probe 
variations of predicted concentrations in trial 2, since changes in local concentrations could be 
studied.  
3.4.5 Average sample image analysis 
 The average NIR image of each sample was calculated in both trials 1 and 2. 
Considering the same mixing time, sample composition, particle size and operation parameters 
at the feed frame in both these trials, uniform, average images of individual samples were 
expected. Trial 1 produced uniform average images, but differences in average image intensity 
were observed in trial 2 (Figure 3.11a-f). The horizontal axis is essentially parallel to the 
paddle radius with the left side of the image located near the center of the paddle wheel. 
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Figure 3.11: Trial 2 average sample images (a-f represent the average image of 3%, 4%, 6%, 
8%, 9%, and 12% w/w ascorbic acid samples respectively, The blue to red color bar 
represents decreasing pixel intensity) 
 Average color-coded imaging established that the pixel intensity of average images 
changes progressively in samples from lower to higher AA concentrations. At the same time, 
pixels located in the upper right corner displayed higher intensity compared to the rest of the 
image. This could potentially indicate lower AA content in the upper right side of each 
sample. However, it was merely a qualitative observation, and quantitative analysis was used 
to confirm local variations in AA concentrations. 
 Each image was divided into 4 equal sections (Figure 3.12), and PLS concentration 
predictions were made for different image sections. 
 
 
Figure 3.12: Subsections of the image used in the PLS analysis 
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 Here, sections 1 and 3 represent the center of the feed frame, while sections 2 and 4 
represent the circumferential side of the feed frame. Table 3.4 enumerates different image 
sections and respective average predicted concentrations. 
Table 3.4 :  Average predicted concentrations in different image sections  
Sample  
(% w/w) 
PLS-predicted sample concentration (1 standard deviation) 
Section 1 Section 2 Section 3 Section 4 Average 
3.0 3.96 (1.62) 0.61 (1.30) 5.28 (1.28) 1.92 (1.17) 2.94 (1.34) 
4.0 4.69 (1.39) 1.43 (1.14) 5.22 (1.09) 1.51 (1.11) 3.21 (1.18) 
6.0 7.04 (1.50) 2.49 (1.35) 7.50 (1.19) 4.87 (1.15) 5.47 (1.30) 
8.0  9.31 (1.56) 5.76 (1.45) 9.53 (1.19) 7.84 (1.37) 8.11 (1.39) 
9.0 10.40 (1.45) 6.78 (1.52) 10.65 (1.12) 8.73 (1.21) 9.14 (1.33) 
12.0 8.79 (1.52) 7.23 (1.64) 11.61 (1.05) 10.78 (1.19) 9.92 (1.35) 
 
 It was observed that the section representing the upper right side corner of the image 
(section 2) consistently exhibited lower concentrations in all samples. Section 2 was followed 
by section 4, showing next lower concentrations. In contrast, the lower left corner of the image 
(section 3) presented higher concentrations in all samples, followed by section 1. Standard 
deviation values in each particular section were also higher, which signified image-to-image 
variations in samples. This change of local concentrations in different sections further supports 
the possibility of AA segregation in trial 2. 
3.5 Conclusion 
 The main aim of this study was to evaluate the possibility of NIR CI (area scan) as a 
PAT tool for in-line feed frame monitoring while using NIRS as the reference method.  
AA concentration predictions with the NIR CI (area scan)-based PLS models were found to be 
similar to those of the NIRS model. NIR CI (area scan) is better positioned to view 
concentration modifications over larger sample areas, and different image sections can be 
analyzed separately in the event of localized concentration changes. In the present set-up, 
sample volume tested by NIR CI (area scan) was 5 times higher than NIRS. Considering the 
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possibility of adjusting flat insert size, there is still the prospect of further increasing the 
sample size to meet unit dose samples at feed frame.  
The Comparative performance of the NIRS and NIR CI for feed frame monitoring is 
summarized below (Table 3.5). 
Table 3.5 : Comparative summary of NIR CI and NIRS 
Parameter NIRS NIR CI 
Wavelength range 900-1701 nm Based on selected NIR filter 
Sampling area 15 x 5 mm 35 x 20 mm 
NIR penetration 1.5 mm 0.75 mm 
Sample size in present setup 0.54 mg 2.52 mg 
Visual representation of sample No Yes 
Segregation testing Limited utility Potentially useful 
PLS model performance   
R
2
adj
 
 0.96 0.95 
RMSEC* 0.71 0.81 
RMSECV* 0.71 0.82 
RMSEP* 0.72 0.98 
 
An in-line feed frame monitoring system (NIR CI (area scan)) could help to obtain 
quantitative as well as visual presentations of powder composition which could be useful for 
real-time process monitoring by machine operators, e.g., end of material or obstruction of 
flow, segregation events, etc. This study indicates that NIR CI (area scan) alone or in 
combination appears to be a promising tool for in-line feed frame monitoring. NIR CI (area 
scan)-based concentration predictions may prove to be more representative since they gather 
information from comparatively larger sample area compared to NIRS, however, further 
studies are required to support this hypothesis. 
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CHAPTER 4 In-line monitoring of Ibuprofen during 
and after the tablet compression using NIRS 
Title in French:  
Suivi en ligne de l’Ibuprofen pendant et après la compression en utilisant la NIRS 
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Summary 
Content: 
Chapter 3 discussed the NIR CI (area scan) data acquisition methodology and compares its 
performance with NIRS using very simple blends. The concentration monitoring was 
performed in an off-line manner. Following this, NIR CI (area scan) is evaluated for its feed 
frame monitoring performance using a complex blend similar to the commercial composition 
used by the industrial partner running the in-line tests on the tablet press. In addition 
equivalency of feed frame to tablet, monitoring is evaluated by comparing the concentrations 
predicted by NIR CI (area scan) and NIRS inside the feed frame against the concentrations 
predicted by NIRS in simultaneously compressed tablet, stratified tablet sub-samples, and 
their UV spectroscopic assay values. 
 The signal-to-noise ratio in case of single filter NIR CI (area scan) for a complex blend 
was found slightly lower compared to NIRS while NIR CI (area scan) data over certain time 
range was lost due to electrical failure of experimental setup. Consequently, NIR CI (area 
scan) data was not presented in the submitted article; however it is presented in chapter 5. 
 
Results:  
NIRS-based concentration predictions inside the feed frame matched very closely with that of 
NIRS predicted average tablet concentrations (averaged to represent similar time frame). 
However, individual tablet concentrations showed a higher tablet-to-tablet variation which 
might have resulted due to variables related to NIR data acquisition, surface distribution of the 
active or actual concentration variations in the tablets. UV spectroscopic assay of some of the 
tablets also showed a similar level of variation indicating actual content variation.   
 
Contributions to the thesis:  
NIRS-based concentration predictions inside the feed frame were seen to adequately represent 
tablet concentrations giving confidence in feed frame monitoring for achieving higher quality 
control as well as helping in real-time release testing. In addition, NIRS was shown to capture 
low material levels inside the feed frame, helping in in-line qualitative process control. 
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Abstract 
 Near-infrared spectroscopy (NIRS) used as process analytical chemistry tool to monitor 
Active Pharmaceutical Ingredient concentrations during tablet manufacturing has been 
reported to enhance overall product quality assurance. NIRS applications in different 
manufacturing stages are facilitated by their ability to handle different sample presentations – 
be it solids, liquids, gels or powders. The present study evaluates NIRS suitability for 
monitoring Ibuprofen concentrations (coated pellets form) inside the feed frame of a tableting 
press as well as in output tablets. Process monitoring was undertaken with qualitative and 
quantitative chemometric analysis. NIRS-based predictions of concentrations both inside the 
feed frame and in tablets were compared to ultraviolet (UV) spectroscopy assays of temporally 
stratified tablet samples. Process dynamics were also compared in terms of concurrent 
concentrations change kinetics in the feed frame and in output tablets. 
 NIRS showed good sensitivity to Ibuprofen concentrations despite the use of coated 
pellets. Ibuprofen contents as low as 1.7% w/w were detected effectively. NIRS-based 
quantitative predictions in the feed frame and in tablets closely matched the UV assay values 
of sampled tablets. As anticipated from the 2-wheel feed frame geometry, upon the addition of 
each consecutive blend, results show that the predicted concentrations inside the feed frame 
were delayed compared with that of the tablets exiting the tablet press. For these tests, the 
delay was estimated to be 1.25 minutes. This finding highlights the importance of NIRS probe 
position inside the feed frame as a function of its geometry. Successive feed frame and tablet 
monitoring by NIRS could prove beneficial for real-time release testing of tablet formulations. 
 
Keywords: NIRS; PAT; feed frame; tablet; chemometrics; real-time release testing
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Résumé français: La spectroscopie proche infrarouge (NIRS) utilisée comme outil 
analytique de procédés pour le contrôle des concentrations des Ingrédients pharmaceutiques 
actifs durant la fabrication de comprimés a été rapportée comme améliorant l’assurance qualité 
globale du produit. Les applications de la NIRS dans différentes étapes de fabrication sont 
simplifiées par leur capacité de manipuler différents types d’échantillons – solides, liquides, 
gels ou poudres. La présente étude évalue l’adéquation de la NIRS pour le contrôle de la 
concentration de l’Ibuprofen (en forme de pastilles enrobées) dans le plateau d’alimentation de 
la presse à comprimer ainsi que dans les comprimés produits. Le suivi du procédé a été réalisé 
par analyse chimiométrique qualitative et quantitative. Les prédictions de concentrations 
basées sur la NIRS à la fois dans le plateau d’alimentation et dans les comprimés ont été 
comparées à des dosages obtenus par spectroscopie ultraviolette (UV) pour des échantillons de 
comprimés temporellement stratifiés. La dynamique du procédé a aussi été comparée en 
termes de cinétique de changements concurrents de concentrations dans le plateau 
d’alimentation et dans les comprimés produits. 
 La NIRS a montré une bonne sensibilité aux concentrations d’Ibuprofen malgré 
l’utilisation de pastilles enrobées. Des concentrations d’Ibuprofen aussi faibles que 1.7 % m/m 
ont été détectées. Les prédictions quantitatives basées sur la NIRS dans le plateau 
d’alimentation et dans les comprimés sont très proches des valeurs de dosages UV des 
comprimés échantillonnés. Comme anticipé pour la géométrie à 2-cuves du plateau 
d’alimentation, lors de l’addition de chaque mélange consécutif, les résultats montrent que les 
concentrations prédites dans le plateau d’alimentation ont été retardées comparées à celles des 
comprimés quittant la presse. Pour ces tests, le retard a été estimé à 1.25 minute. Ce résultat 
met l’accent sur l’importance de la position de la sonde NIRS dans le plateau d’alimentation 
comme fonction de sa géométrie. Le suivi efficace du plateau d’alimentation et du comprimé 
par NIRS peut être bénéfique pour la libération en temps réel des lots de comprimés. 
 
Mots-clés: Spectroscopie proche infrarouge (NIRS); PAT; plateau d’alimentation;  
chimiométrique; test de libération en temps réel (RTRt)  
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4.1 Introduction 
 Tablet dosage forms constitute a major portion of pharmaceutical solid oral dosage 
formulations available in the marketplace. As per the US Food and Drug Administration’s 
novel drug approval database, 23 of 45 new molecular entities were formulated as solid 
dosage forms in 2015, and 15 of the 23 were tablets [115]. Tablets offer patients ease of 
handling and administration while ensuring physicochemical and microbial stability benefits 
to manufacturers. Pharmaceutical organizations optimize tablet manufacturing in a product-
specific manner and follow stringent quality checks in the entire production process. However, 
quality issues impacting product composition and safety still arise. A summary of recent 
product recalls highlights incorrect potency (hyper or hypo) and cross-contamination as 
leading quality problems [116]. Such quality failure events underline the importance of 
process monitoring in all stages of manufacturing. Process analytical technology (PAT) tools 
help to monitor different production stages, ensuring the quality of intermediate as well as 
finished products [2]. During tablet manufacturing, subsequent feed frame and tablet 
concentration monitoring could increase confidence in tablet quality assurance and help 
pinpoint the causes of failed batches. 
4.1.1 PAT for in-line feed frame monitoring 
Near-infrared spectroscopy (NIRS)-based PAT has been reported to be successful in tablet 
manufacturing operations, such as granulation [117][43], drying [44][108], blending [81][36] 
and coating [55]. NIRS transitioning from off-line testing to in-line monitoring at various 
stages of tablet manufacturing has been made possible through a better understanding of 
manufacturing processes and NIRS parameters. Feed frame monitoring offers the unique 
advantage of measuring powder potency immediately before tablet compression. Quantifying 
powder blend concentration inside the feed frame could also ensure that tablet concentrations 
are within specified limits. 
Dynamic sample presentation inside the feed frame and other related variables, such as 
probe-to-powder/paddle distance, powder mass hold up, density changes due to paddle 
movement, paddle speed [15], as well as NIRS probe location [51], make in-line feed frame 
monitoring a challenging task. Ward et al. [16] reported correlations between NIRS signals 
and weight-corrected tablet assays at 3.5% w/w active concentration but suggested the need 
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for optimizing NIR probe location to avoid poor correlations at lower paddle speeds. Šašić et 
al. [61] demonstrated a linear relationship between the tablet potency and NIR spectral 
intensity at a single wavelength characteristic of the active pharmaceutical ingredient (API). 
They worked with 3.5% w/w API concentration and reported that this relationship cannot be 
satisfactorily applied to another trial because of spectral baseline variations in spite of the use 
of a 2nd derivative data pre-treatment. Mateo-Ortiz et al. [15] observed the superiority of in-
line partial least squares (PLS) calibration over off-line models for 5-15% w/w Paracetamol 
blends inside the feed frame. Most of earlier studies involved discrete concentration blends at 
API levels equal to or higher than 3.5% w/w. Recent work by Durão et al [118] showed 
successful implementation of different PAT tools such as light-induced fluorescence (LIF), 
NIRS and red-green-blue (RGB) imaging for quantitative composition monitoring of a multi-
vitamin powder blends inside the feed frame. Among the different components, NIRS 
precisely quantified Ascorbic acid and Ferrous fumarate in the concentration range of 5-15 
and 2-8% w/w respectively. Implementation of NIRS-based quantitative concentration 
monitoring inside the feed frame requires a thorough feasibility study based on the specific 
tablet formulation, taking into account factors such as the range of concentrations. In addition, 
the capability of NIRS-based quantitative regression models to capture subtle concentration 
changes requires investigation to discern powder segregation inside the feed frame. 
4.1.2 PAT for in-line tablet monitoring 
Off-line NIRS applications testing tablets for assay [56], content uniformity [58] and 
dissolution [109] have been reported in the literature. Off-line analysis has shown good 
correlations of NIRS and tablet properties but could not be undertaken for tablet monitoring in 
routine manufacturing operations due to limitations of time and resources. In recent years, 
increased flexibility of technology has made in-line tablet monitoring possible, e.g., in-line 
tablet monitoring immediately after compression. Karande et al. [119] reported the results of 
tablet quality testing via NIRS immediately after ejection from the dies, but the compression 
process was operated at much lower speeds than used in commercial production. They 
employed a 10-station compression machine functioning at 10 turret rpm. Järvinen et al. [59] 
demonstrated successful monitoring of tablets containing 20-30% w/w API in a continuous 
direct compression process. They performed tablet NIRS scanning at much higher rates 
(25,000-125,000 tablets/h) on the turret. In NIRS data analysis, they studied the average 
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spectra of 10 tablets and obtained good model fit (R
2
adj = 0.943, RMSEC = 0.75% - root mean 
square error of calibration) as well as prediction (RMSEP = 1.37% - root mean square error of 
prediction). However, by so doing, the model lost the ability to detect variations in individual 
tablet spectra, which would be likely during high-speed industrial compression processes. In 
light of these findings, we investigated the individual NIR spectra of tablets in PLS calibration 
model preparation as well as in tablet concentration predictions. 
During in-line tablet monitoring, size, shape as well as the high-speed movement of 
tablets on the turret can introduce spectral variations affecting the performance of quantitative 
models for monitoring concentrations. Thus, tablet NIRS testing, which simultaneously offers 
high-speed data acquisition and uniform sample presentation, needs to be evaluated. The 
present study reports on tablet NIRS testing at the end of tablet compression but before their 
final packaging.  
4.1.3 PAT for combined feed frame and tablet monitoring 
The objective of the present work is to evaluate the feasibility of using NIRS for in-line 
concentration monitoring (qualitative and quantitative) inside the feed frame as well as in the 
compressed tablets during tablet manufacturing process. To achieve this, 2 NIR probes were 
used. The first probe (Viavi PAT-U) was located inside the tablet feed frame to scan the 
flowing power while the second (VisioNIR) was located downstream of the tablet press to 
scan the resulting tablets. In order to verify the performance of the in-line NIRS probes, off-
line tablet analysis of selected tablet samples was performed using a standalone NIRS system 
(Bruker MPA) and UV assay tests. 
This work specifically focuses on evaluating the feasibility of NIRS for in-line monitoring 
of Ibuprofen concentrations in the form of polymer-coated pellets inside the feed frame and in 
compressed tablets. Ibuprofen concentrations were predicted by partial least squares (PLS) 
regression models. The accuracy of NIRS (including data modeling) to detect varying 
Ibuprofen concentrations was verified by comparing NIRS-predicted tablet concentrations 
through UV assays of selected tablet samples collected at respective time intervals. NIRS-
tested sample volume inside the feed frame was estimated and compared to equivalent tablet 
samples. 
Another objective is to study the kinetics of Ibuprofen concentration changes inside the 
feed frame and in the tablets for a set of given operating parameters in a tablet compression 
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machine. Ibuprofen concentrations inside the feed frame were altered from one blend to 
another by adding different blends successively in a predefined sequence in the hopper. As a 
result, concentration step changes presented a transition phase followed by a plateau for each 
new blend. Monitoring concentration kinetics during these phases is expected to help 
understand material mixing, die filling and material propagation inside the feed frame.  
4.2 Materials 
The materials used in this study comprised Ibuprofen-coated pellets (Adare 
Pharmaceuticals, Vandalia, OH, USA), mannitol (Roquette, Keokuk, IA, USA), 
microcrystalline cellulose (Avicel® PH 101, FMC BioPolymer, Philadelphia, PA, USA), 
sodium starch glycolate (Roquette, Lestrem, France), colloidal silicon dioxide (Aerosil® 200 
Pharma, Evonik Corporation, Parsippany, NJ, USA) and magnesium stearate (Mallinckrodt, 
St. Louis, MO, USA). Analytical grade reagents were used for UV spectroscopy testing of 
tablet samples.  
Particle size specifications of the ingredients are given here. For Ibuprofen pellets, 2% of 
the total mass was retained on mesh 40 (420 µm) while 5% of the total mass was passed 
through mesh 80 (177 µm). For mannitol, 87% of the total mass was retained on mesh 140 
(105 µm) while 12 % of the total mass was retained on mesh 35 (500 µm). In case of 
microcrystalline cellulose, 95% of the total mass pass through mesh 120 (125 µm) while 68% 
of total mass retained over mesh 325 (45 µm) 
4.2.1 Formulation composition  
Tablet composition in the present work consisted of different Ibuprofen concentrations 
available in pellet form coated with gelatin and cellulose acetate phthalate. Five blends were 
prepared with different contents of Ibuprofen pellets. All excipients other than magnesium 
stearate compensated for the change in weight of Ibuprofen pellets, as indicated in Table 4.1. 
Excipient concentrations were varied in proportion to the Ibuprofen level of the respective 
blend while magnesium stearate was maintained at the same concentration in all blends. Batch 
size was set at 12.0 kg because of equipment capacities, desired tablet compression rate and 
time required for concentration stabilization inside the feed frame. All ingredients except 
magnesium stearate were added in the V blender (Patterson Kelley, East Stroudsburg, PA, 
USA) and rotated for 15 min at 26 rpm. Magnesium stearate was then included, and mixing 
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was continued for 2 additional minutes. At the end of mixing, all blends were transferred to a 
double-lined polythene bag for tablet compression. 
Table 4.1: Formulation composition with five different Ibuprofen levels (all concentration 
values are in % w/w) 
Ibuprofen pellette 0.00 2.00 8.00 15.80 18.00 
Mannitol 82.37 80.40 75.66 69.12 67.4 
Microcrystalline cellulose 11.85 11.80 10.96 10.06 9.70 
Colloidal silicon dioxide 2.39 2.40 2.19 2.01 1.95 
Sodium starch glycolate 2.39 2.40 2.19 2.01 1.95 
Magnesium stearate 1.00 1.00 1.00 1.00 1.00 
 
 As listed in Table 1, Ibuprofen pellet contents were varied in the range of 0-18% which, 
in reality, corresponded to 0-15.3% w/w Ibuprofen, considering pellet assay value (85% w/w 
Ibuprofen). However, the blends are referred herein by % w/w Ibuprofen pellet contents. 
Random blend order was adopted during tablet compression, i.e., Ibuprofen blends were added 
to the hopper in 2, 8, 18, 0 and 15.8% w/w sequence. Consequently, the smallest step change 
was 6 % w/w (from 2 to 8 % w/w) while 18 % w/w (from 18 to 0 % w/w) was the largest. 
Such a sequence was purposefully adopted to check NIRS responses to the lowest and highest 
concentrations inside the feed frame as well as to clearly outline the 5 steady states and help 
quantify step-change dynamics. 
4.3 Equipment and Methods 
 Three NIR probes (Viavi inside the feed frame, VisioNIR for in-line tablet testing and 
Bruker for subsequent off-line tablet testing) with different specifications of NIR range, 
spectral resolution and integration time were used. Data acquisition parameters of respective 
NIR probe are summarized in table 4.2. 
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Table 4.2: NIR spectral acquisition parameters 
 
NIR 
probe 
Location 
Spectral 
range 
(nm) 
Spectral 
Resolution 
(nm) 
Integration 
time per 
spectrum 
(ms) 
Number of 
spectra 
averaged 
Total 
integration 
time (ms) 
Viavi 
PAT-U 
Inside the 
Feed 
frame 
915-1701 6 5 50 250 
Bruker 
MPA 
Off-line 
tablet 
testing 
800-2778 0.5 354 32 11,328 
VisioNIR 
In-line 
tablet 
testing 
850-1650 3 0.5 - 0.5 
 
Details of the NIRS probe set-up are provided in the following sub-sections. 
4.3.1 Feed frame monitoring (in-line) 
 A Manesty Novapress 37-station rotary tablet press with feed frame was employed in 
this study. Details of feed frame design appear in an earlier publication [20].  
  
 
Figure 4.1: NIRS location on the feed frame 
 A NIRS probe (Viavi PAT-U) was placed above the second wheel just before the point 
where powder exits the feed frame (Fig.4.1) and enters the die cavities for compression. The 
NIR probe tip was positioned with a micrometer 6 mm above the paddle wheel to ensure its 
contact with the powder while preventing contact with the paddle wheel. Data acquisition was 
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triggered by a sensor attached to the feed frame shaft. One NIR spectrum was recorded at each 
rotation of paddle wheel. NIRS probe parameters and acquisition settings are listed in Table 
4.2. 
 Tablets were compressed at a rate of 23,460 tablets/h. Feed frame paddle wheel rpm was 
adjusted at 13 rpm to obtain consistent tablet weight. Temporally stratified tablet samples (at 
intervals of 1 min in the stable phase and 15 s for 4 min 30 s in the transition phase) were 
collected during the entire compression cycle. Stationary and transition concentration phases 
were calculated on the basis of machine rpm, tablet weight and a total number of punch sets. 
312 tablets were sub-sampled to obtain 3 tablets per min from the samples collected during 
each stable phase. These 312 tablets are referred to as “tablet sub-samples” throughout this 
paper. The sub-samples were tested for Ibuprofen pellet content, by off-line (Bruker MPA) 
and in-line NIRS (VisioNIR) as well as UV spectroscopy. 
4.3.2 Tablet-monitoring (in-line) 
 A Teonys tablet-sorting machine (Proditec, Pessac, France) equipped with a line scan 
camera provided in-line tablet-monitoring. It was adapted to hold a NIRS probe (VisioNIR, 
Visiotec GmbH, Laupheim, Germany) for tablet NIRS scanning. All compressed tablets and 
sub-sampled (312) tablets were scanned in reflectance mode using acquisition parameters as 
shown in table 4.2. Tablets were passed below the NIRS probe on a conveyor belt. The tablet 
scanning rate depended on their distribution along the conveyor belt by the distribution system 
and the tablet dimension. Conveyor belt speed was set at 350 mm/s in the present work, 
resulting in NIRS scanning 10,800 tablets/h. 
4.3.3 Tablet testing (off-line) 
 A Bruker NIRS stand-alone system (Bruker multi-purpose analyzer, Bruker optics ltd, 
Milton, ON, Canada) provided off-line tablet NIRS analysis. All of the sub-sampled 312 
tablets were manually scanned in diffuse reflectance mode using acquisition parameters shown 
in table 2. 
 Ibuprofen contents in the tablet sub-samples were quantified by a UV method. A UV-
visible spectrometer (Ultrospec 2100 pro, Biochrom Ltd., Holliston, MA, USA) was used for 
wavelength selection and recorded the UV absorbance of tablet sample solutions. The aqueous 
solution of Ibuprofen pellets showed maximum UV absorbance at 264 nm wavelength. Thus, 
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the UV absorbance of all calibration standard solutions and each tablet sample solution was 
measured at the same wavelength (264 nm). The calibration curve prepared with standard 
solutions containing Ibuprofen concentrations in the range of 50-1500 µg/ml showed a 
regression coefficient of 0.9996, indicating good linearity between Ibuprofen concentrations 
and UV absorbance responses. The Ibuprofen contents (% w/w) of respective tablets were 
ascertained from this calibration curve. Solutions of 15.8 and 18% w/w Ibuprofen tablets were 
diluted to suitable concentrations to fall within the range of the calibration curve. The % w/w 
Ibuprofen pellet contents of each tablet were calculated by considering sample dilution factors 
as well as respective tablet weight. 
4.3.4 NIRS data acquisition and pre-treatment 
 Before spectral data acquisition, the NIR probes were calibrated between 0 and 100% 
reflectance. A NIR spectrum was acquired for the 0% set-up in the absence of infrared light, 
while a NIR spectrum was recorded for the 100% set-up by pointing the NIR beam at 100% 
reflectance reference. Every raw spectrum acquired during the trials was corrected with the 
0% and 100% reflectance standards according to equation 4.1: 
𝐶 =
𝑅−𝐷
𝐵−𝐷
         (4.1) 
where C is the corrected spectra, R is the raw spectra, D is the 0% reflectance (dark) standard 
and B is the 100% reflectance (bright) standard. 
 NIR spectra collected inside the feed frame contained Ibuprofen concentration 
information. In addition, they were influenced by other variables, such as material movement 
and particle size differences. In tablets, spectral signatures are influenced by tablet shape and 
surface (oblong or concave) as well as by small variations in hardness. Spectral pre-
treatments, such as standard normal variate, Savitzky-Golay second derivative, multiple 
scatter correction (MSC), centering and scaling to unit variance were evaluated before 
performing the qualitative and quantitative analysis. MSC followed by mean centering was 
selected as the optimum spectral pre-treatment for feed frame as well as tablet NIR spectra by 
comparing principal component analysis (PCA) parameters (score values and percent variance 
explained) for different spectral pre-treatments. 
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4.3.5 NIRS wavelength selection 
 The present work evaluated different regions of NIR spectra for inclusion in the 
qualitative and quantitative analysis of Ibuprofen content. NIR reflectance spectra of 
Ibuprofen pellets, Placebo blend (all components of tablet composition except Ibuprofen) and 
18% w/w Ibuprofen blends were recorded using Viavi PAT-U NIR probe. When plotted 
together, these spectra showed characteristic peaks of pure Ibuprofen pellets and their 
expression to a different extent in Placebo and 18% w/w Ibuprofen blend spectra (Fig.4.2). 
Characteristic peaks of pure Ibuprofen pellets were masked significantly in the composite 
blend, still, spectra in the range of 1100-1250 and 1350-1700 nm showed differences in the 
placebo and 18% w/w Ibuprofen blends.  
 
Figure 4.2: Raw NIR reflectance spectra of Ibuprofen pellets, placebo, and 18 % w/w 
Ibuprofen blend compositions 
 The pre-treated NIR spectra of respective powder and tablet samples, representing 
different % w/w Ibuprofen concentrations, were compared visually for all NIRS measurements 
(off-line tablets, in-line feed frame, and in-line tablets). Spectral regions showing the greatest 
intensity variations, in response to varying Ibuprofen concentrations, were evaluated for 
inclusion in qualitative and quantitative chemometric models. In the case of off-line NIR 
spectra of the tablet sub-samples, different spectral regions were compared on the basis of 
RMSE- root mean square error between PLS regression-predicted Ibuprofen concentrations 
and UV assay values of respective tablets. For in-line feed frame spectra, different spectral 
selections were compared on the basis of percent variance explained and score values versus 
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sample trends in PCA. The wavelength range for in-line NIR spectra of tablets was selected 
for off-line NIR spectra of tablets. 
  
Figure 4.3: MSC treated full NIR spectra and a selected range of 1100-1250 nm for off-line 
tablet analysis (a-b), feed frame analysis (c-d) and in-line tablet analysis (e-f) respectively. 
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 Off-line NIRS tablet analysis (Bruker) offered higher spectral resolution and larger 
wavelength spans than in-line feed frame and in-line tablet NIRS. Based on visual inspection 
of MSC treated full NIR spectra (Fig.4.3a), spectral data in the range of 1100-1250 (Fig. 4.3b), 
1321-1500, 1600-1901, 2101-2701, 1100-2701 nm and combined data on multiple selections 
were evaluated for inclusion in the PLS model. 
 MSC treated in-line feed frame spectra of different Ibuprofen blends were plotted in the 
range of 915-1701 nm. It showed spectral separation in the range of 1100-1701 nm (Fig.4.3c), 
with notable differentiation around 1100-1250 nm (Fig.4.3d). 
 For in-line tablet NIRS, spectral range between 1101-1252 nm was selected on the basis 
of spectral evaluation of earlier off-line tablet NIRS data. MSC treated spectral plot (Fig.4.3e) 
showed clear spectral differences in 1101-1252 nm range (Fig.4.3e) for NIR spectra of tablets 
having different Ibuprofen concentrations. Meza et al. [120] reported strong reflectance bands 
for Ibuprofen in the range of 1122 to 1235 nm which confirmed the present spectral variations 
as a result of different Ibuprofen concentrations in the blends/tablets. 
4.3.6 PCA and PLS analysis 
 After off-line NIRS and UV testing of tablet sub-samples, the in-line NIRS spectra of 
feed frame blends and compressed tablets were qualitatively assessed by PCA, followed by 
quantitative PLS analysis. PCA helped to compare and select different wavelengths and verify 
if process monitoring was possible in the absence of the quantitative model. PCA score value 
trends over time were followed for Ibuprofen concentration changes inside the feed frame as 
well as in tablets. Quantitative analysis of NIR spectra was performed by making PLS 
calibration models using selected NIR spectra and corresponding concentrations in each data 
set, later these models were used to predict concentrations in larger data sets as summarized in 
Table 4.3.  
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Table 4.3: Summary of different PLS models 
NIR 
spectra 
PLS calibration model Concentration 
prediction for 
X matrix Y matrix X matrix 
Off-line 
tablet 
testing 
Off-line NIR spectra of 
selected tablet sub-samples 
(105×283) 
(105 tablets × 283 
wavelengths) 
Weight-corrected UV 
assay values of 
respective samples 
(105×1)  
(105 tablet 
concentrations ) 
Off-line NIR spectra of 
all tablet sub-samples 
(312×283) 
(312 tablets × 283 
wavelengths) 
In-line 
feed frame 
monitoring 
Selected in-line spectra of 
stable concentration region 
(500×26) 
(100 spectra for each of 
the 5 concentrations × 26 
wavelengths) 
Corresponding expected 
concentration based on 
average UV assay tablet 
values (500×1) 
(100 expected 
concentration values for 
each of 5 concentrations) 
In-line spectra of all 
blend samples inside 
the feed frame 
(1804×26) 
(total 1804 in-line NIR 
spectra × 26 
wavelengths) 
In-line 
tablet 
monitoring 
In-line NIR spectra of 
selected tablet sub-samples 
(105×50) 
(105 tablets × 50 
wavelengths) 
Weight-corrected UV 
assay values of 
respective samples 
(105×1) 
(105 tablet 
concentrations) 
In-line NIR spectra of 
all tablet samples 
(51,459×50) 
(51459 tablets × 50 
wavelengths) 
 
4.3.7 Kinetics 
 A recent study [20] discussed the kinetics of concentration changes inside the feed frame 
by describing a continuously-stirred tank. Ibuprofen concentration changes inside the feed 
frame and tablets were evaluated per first-order rate kinetics, as per equation 4.2: 
?̂? = 𝑦0 + 𝐴𝑒
−𝑘𝑡       (4.2) 
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where ?̂? is predicted Ibuprofen concentration inside the feed frame or in tablets, 𝑦0 is 
Ibuprofen concentration before transition,  A is the theoretical value of Ibuprofen 
concentration difference before and after the  transition, k is the first-order rate constant, and t 
is time in minutes. 
PLS predicted concentrations inside the feed frame and in tablets were subjected to first-order 
curve fitting to evaluate concentration change rate constant k with in-house Matlab scripts 
(Mathworks, Natick, MA, USA). The time required for each concentration transition inside the 
feed frame and in tablets was estimated on the basis of respective k values. 
4.3.8 Sample volume inside the feed frame 
 NIR sample volume is an important parameter to study the level of scrutiny in in-line 
process monitoring since effective sample volume in blend uniformity analysis should be 
comparable to unit dose [32]. Sample volume was estimated by NIRS sample area/spot size of 
the NIRS probe, integration time, material bulk density and NIR penetration according to 
equation 4.3: 
𝑆𝑎𝑚𝑝𝑙𝑒 𝑉𝑜𝑙𝑢𝑚𝑒 = 𝑅 × 𝐵 × 𝐶      (4.3) 
where R is NIRS sample area, B is the NIRS penetration depth, and C is sample bulk density. 
Inside the feed frame, NIRS sample area was 15 × 5 mm and integration time for raw 
spectrum was 5 ms. Each NIR spectrum was obtained by averaging 50 raw spectra acquired in 
succession. Thus, the total integration time per NIR spectra was 250 ms. Sample area was 
calculated by considering material movement within this time based on feed frame rpm. NIR 
penetration depth was considered to be 1.5 mm as reported in an earlier work [110] performed 
on loose powder material using same NIR probe. Powder sample tested by each NIRS 
spectrum was compared with equivalent tablet size, considering an average tablet weight of 
1200 mg. The total amount of feed frame powder sample tested by NIRS over the entire tablet 
compression process was compared to total batch size to estimate the level of scrutiny inside 
the feed frame. 
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4.4 Results and discussion 
4.4.1 Tablet off-line testing 
4.4.1.1 UV assay testing of tablet sub-samples 
 The UV assay results of a few initial tablet samples in 8, 15.8, and 18% w/w Ibuprofen 
blends indicated lower Ibuprofen contents than the rest of the samples, while the first few 
tablet samples of 0% w/w Ibuprofen blends showed the presence of Ibuprofen pellets. 
Temporally stratified tablet samples were collected in 2 different phases, i.e., transition and 
stable concentration phases, considering that each transition phase would last for the time 
equivalent to compressing the volume of powder blend comparable to double the feed frame 
volume. Accordingly, tablet sub-samples were collected from stable-phase tablets and 
expected to have stable Ibuprofen concentrations, but the UV assay results of initial tablet 
samples showed that respective transitions were not completed when these tablet samples were 
collected. Thus, every transition took more than twice the feed frame volume to complete. 
This observation helped to understand the concentrations transition process inside the feed 
frame, as explained later in Section 4.4.4. The average Ibuprofen assay values of stable-phase 
tablets from each blend were considered as assay values of the corresponding blend and later 
used in the analysis of NIR spectra collected at feed frame and tablet monitoring. 
4.4.1.2 NIRS testing of tablet sub-samples 
 The PLS calibration model was built with the off-line NIR spectra of tablets which 
showed stable concentrations (105 tablets) in UV testing among the total sub-samples (i.e., 
312 tablets).  This model served to predict the % w/w of Ibuprofen concentrations in all 312 
tablet sub-samples. The PLS calibration model considered off-line NIR spectra as independent 
variables / X matrix (105 × 283) and the UV assay values of respective tablet samples as 
dependent variables / Y matrix (105 × 1), where 283 points represented wavelengths in the 
range of 1100-1250 nm, and 105 points represented the number of tablets used in the PLS 
calibration model. 
 PLS model-predicted Ibuprofen contents of the tablet sub-samples using different 
wavelength datasets were compared with UV assay values of the respective tablet samples. 
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The accuracy of PLS predictions was based on calculated RMSE values between PLS 
predictions and UV assay values, as depicted in Table 4.4 
Table 4.4:  RMSE values at selected wavelength ranges 
Wavelength range (nm) 
RMSE between tablet concentrations 
by UV assay and off-line NIRS 
1100-1250 1.30 
1321-1500 4.45 
1600-1901 3.77 
2101-2701 1.83 
1100-2701 2.28 
1100-1250, 1321-1500, 1600-1901, 2101-2701 2.00 
  
 Among all tested wavelength ranges, the 1321-1500 nm range showed the highest 
RMSE values while 1100-1250 nm showed the lowest RMSE values, indicating that the PLS 
model-predicted Ibuprofen content of tablets was close to their Ibuprofen UV assay values. As 
shown earlier in Figure 4.1, a characteristic Ibuprofen peak is present between 1100-1250 nm.  
Incorporating multiple wavelength selections in the PLS model improved concentration 
predictions, but it was still distant from the UV results compared to 1100-1250 nm. 
 The R
2
adj value for the PLS calibration model with 1100-1250 nm spectra using 2 latent 
variables was 0.96 with RMSEC, and RMSECV (using random-subset cross-validation) 
values of 1.12 and 1.14 showed that the model fitted well in the selected NIRS spectral range. 
Comparison of PLS-predicted concentration with the corresponding UV assay results (Fig.4.4) 
of the tablets demonstrated good agreement between off-line NIRS spectra and the UV assay 
of tablets. 
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Figure 4.4: Plot of UV assay results versus off-line NIRS-predicted Ibuprofen concentrations 
in tablet sub-samples 
 The low RMSE value (1.3% w/w Ibuprofen) in the case of the 1100-1250 nm range 
showed that NIRS-predicted % w/w Ibuprofen concentration in tablets and actual UV assay 
values were close in all blends, meaning that NIRS was suitable for Ibuprofen concentration 
predictions in tablets. The polymer coating on the surface of Ibuprofen pellets did not prevent 
successful quantification of Ibuprofen by the quantitative model based on NIR spectral data. 
Few tablets in the 18 and 15.8% w/w Ibuprofen blends had UV assay values lower than the 
rest of the group, which indicated tablet-to-tablet content variation as well as variation in the 
surface distribution of Ibuprofen pellets since NIRS PLS predictions of these tablets were 
close to the rest of the group. A small increase in Ibuprofen contents around the 200
th
 tablet 
was well matched in both UV assays and NIR PLS predictions, showing true Ibuprofen 
content change in the tablets. As a result, off-line tablet analysis by NIRS could be a good 
option for end-product quality control, but it will be time-consuming and practically 
challenging since every tablet has to be scanned manually. However, in-line NIRS testing of 
tablets would certainly be beneficial. In-line NIRS data collected inside the feed frame and in 
tablet monitoring were subjected to qualitative and quantitative analysis to verify NIRS 
potential for in-line process monitoring. 
4.4.2 In-line NIRS qualitative testing inside the feed frame and tablets 
 In-line NIRS inside the feed frame recorded a total of 1804 spectra over the entire 
compression run at a rate of 1 spectrum per 4.61 s, while in-line tablet NIRS recorded a total 
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of 51,459 spectra, one for each tablet. Spectral analysis was preceded by wavelength range 
and spectral pre-treatment selection.  
4.4.2.1 Qualitative testing inside the feed frame 
 PCA of complete NIR spectra (900-1701 nm) revealed that the 1
st
 and 3
rd
 principal 
components (PC1 and PC3), which captured 93.57% of total variance, mostly represented 
baseline variations in NIR spectra. PC1 captured baseline variations at the start and end of the 
process while PC3, in addition, disclosed baseline variations as a result of material level 
changes inside the feed frame. PC2 captured 6.09% of total variance, but its score values 
changed over time according to sequential Ibuprofen concentration changes inside the feed 
frame. Overall PC score values were higher at the beginning and end of compression with a 
sharp rise and fall in 2 instances in the middle of the compression process. This is because the 
feed frame was not completely filled, as NIR acquisition started at the beginning of 
compression while the feed frame at the end of compression had already commenced 
emptying when the last few NIR spectra were recorded. Material flow obstruction caused 2 
incidents of lower material level inside the feed frame whose time (between 20-30 min and 
70-80 min of compression) matched corresponding changes in PC score values. Reflectance 
NIR spectra plotted over time indicated baseline variations at corresponding time intervals. 
Thus, PC1 and PC3 were correlated to the spectral baseline variations caused by a material 
level change inside the feed frame.   
 This result demonstrated that spectral baseline variations caused by a physical change in 
the material level were significant and not completely removed by spectral pre-treatment.  
Including complete spectra in the analysis gave excessive emphasis to spectral changes 
elicited by factors other than concentration. In contrast, PC1 captured 79.01% of total variance 
(Fig. 4.5a) and correlated with concentration changes inside the feed frame upon removal of 
spectra with higher baseline variations from the start and end of the compression process. 
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Figure 4.5: (a) Score plot of PC1 for PCA using full NIR spectra (1100-1701 nm). (b) Score 
plot of PC1 for PCA using selected NIR spectra (1100-1250 nm) inside the feed frame 
 A second PCA was performed with the same spectral pre-treatment (MSC followed by 
mean centering) but using selective spectral range, i.e., 1100-1250 nm instead of full spectra. 
Selected wavelengths shifted the PCA focus from baseline variation to concentration changes 
inside the feed frame, since this region of NIR spectra represents Ibuprofen specific 
reflectance peaks. PC1 captured the highest total variance (86.60%) correlated with 
concentration changes inside the feed frame. PC2 captured the next highest variance (12.30%) 
correlated with material level changes, while PC3 captured the least variance (0.56%) 
containing, mainly, information related to baseline variations. Removal of the first and last 
few acquired spectra (when the feed frame was not completely filled) improved the PCA 
results, with PC1 capturing 99.19% of total variance (Fig. 4.5b), which clearly correlated with 
the switch between stable and transition phases of the different blends. PC1 score values also 
highlighted regions where the feed frame had less material. PCA scores for the 2% w/w blend 
showed gradual stabilization, indicating that material level inside the feed frame was stabilized 
after some time. Gradual score value changes on either side of all blend stable phases showed 
NIRS sensitivity to small traces of Ibuprofen inside the blends.   
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4.4.2.2 Qualitative testing of tablets 
 PCA of in-line tablet NIR spectra was performed in the 1101-1252-nm range since it 
was found to be suitable in off-line NIR testing of the same tablets. PC1 captured 61.53% of 
total variance (Fig. 4.6) and its values changed over time according to the blend Ibuprofen 
concentration changes occurring inside the feed frame. PC1 scores of a few tablets showed 
widely scattered values than the rest of the group, either because of spectral variations 
resulting from sample presentation to the probe, e.g., spectra taken from partial tablet area or 
actual concentration variation inside the tablets. Despite variations within the score values of 
individual tablets, all tablet batches were well distinguishable by the PCA scores. 
 
Figure 4.6: PC1 values for all tablets using NIR spectra in the 1101-1250-nm range 
4.4.3 In-line NIRS quantitative testing inside the feed frame and in tablets 
 After wavelength selection and qualitative analysis of in-line NIRS data on the feed 
frame and tablets, quantitative PLS analysis was performed to acquire actual concentration 
values of the feed frame blends and tablets. 
4.4.3.1 Quantitative analysis inside the feed frame 
 The PLS calibration model for the feed frame was built with spectra that showed stable 
PC1 score values among all spectra of respective blends in the 1100-1255-nm spectral range. 
The model with 2 latent variables showed R
2
adj value of 0.995. RMSEC and RMSECV values 
were 0.46 and 0.47% w/w Ibuprofen, respectively. Considered together, these values show a 
good fit between the PLS calibration model and the selected NIR spectra. Concentrations for 
all feed frame NIR spectra were predicted on the basis of this calibration model.  
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 NIRS PLS-predicted Ibuprofen concentrations versus time plots (Fig. 4.7) showed 
comparatively less scatter around expected concentrations in case of 2, 8 and 0% w/w 
Ibuprofen blends than in case of 18 and 15.8% w/w Ibuprofen blends. A valley of predicted 
concentrations (Fig. 4.7) seen during the transition between 2% and 8% blends (between 20 
and 30 min) and the stable phase of 18% blends (between 70 and 80 min) matched earlier 
PCA score plots (Fig. 4.4a) at respective times and showed the sensitivity of chemometric 
models to changes in material level inside the feed frame. Spectral baseline changes are 
significant as the material level drops inside the feed frame (i.e. the powder occupies a smaller 
portion of the volume) and cannot be completely removed by applied spectral pre-treatment. 
Thus, Ibuprofen concentrations at these points were erroneously predicted to be lower than the 
actual concentration. The transition between 18 and 0% blends took a longer time. In addition, 
it showed a small peak in concentration (between 80 and 90 min) during the transition. In this 
instance, no change in material level was seen during compression. Thus, the peak in 
Ibuprofen content of powder blend was ascribed to actually higher Ibuprofen content which 
was also verified in the UV assay results of tablet sub-samples collected at respective time 
intervals.   
  
 
Figure 4.7: NIRS PLS-predicted concentrations inside the feed frame and UV assay of tablet 
sub-samples 
 NIRS-predicted concentrations inside the feed frame and the Ibuprofen UV assay results 
of tablet sub-samples collected at corresponding times showed good agreement. A small 
increase in Ibuprofen concentration between 18 and 0% transition was equally detected inside 
the feed frame and by UV. This could be due to some leftover quantity of 18% w/w Ibuprofen 
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blend being released in main material flow from the hopper. The UV results indicate that the 
change in concentration was about 1% w/w, which suggests that NIRS can detect small 
concentration variations inside the feed frame.  
4.4.3.2 Quantitative tablet testing  
 The PLS calibration model was built with the UV assay results of 312 tablet sub-
samples and the corresponding in-line NIR spectra of tablets. R
2
adj value of 0.92 showed good 
agreement between the model and the tablets’ in-line NIRS data. RMSEC and RMSECV 
values were 1.83 and 1.87% w/w Ibuprofen, respectively. Adding more than 2 latent variables 
improved model fit to the data (increased R
2
adj and decreased RMSEC as well as RMSECV) 
but did not show any improvement in concentration prediction (based on RMSEP values). 
Therefore, only 2 latent variables were selected in the PLS calibration model. Ibuprofen 
concentration in all tablets (51,459) was predicted on the basis of this calibration model. 
 Machine-operating parameters suggested that 28 tablets were manufactured between 2 
NIR spectra recorded inside the feed frame, as a result for comparison with NIR-predicted 
Ibuprofen concentration changes inside the feed frame over time; an average concentration of 
28 consecutive tablets was used. 
 
Figure 4.8: NIRS PLS-predicted Ibuprofen concentrations in tablets (average of 28) and UV 
assay values (no averaging was performed) of tablet sub-samples 
 The Ibuprofen UV assay results of the tablet sub-samples showed fairly good agreement 
with the average Ibuprofen concentrations of 28 tablets over time when plotted together (Fig. 
4.8). However, the un-averaged NIRS PLS-predicted Ibuprofen concentrations of all tablets 
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(51,459) showed higher tablet –to– tablet variation similar to the variation shown by certain 
tablets in UV assay. The variation within NIRS results could be due to the difference in the 
surface distribution of Ibuprofen pellets, actual content variation (as indicated by UV assay of 
few samples) and spectral variations as a result of dynamic sample presentation. 
 The predicted % w/w Ibuprofen concentrations of 379 out of 51,459 tablets tested were 
far lower or higher than the average predicted concentrations of respective blends (beyond 2σ) 
and are considered outliers. It is very likely that these samples were not well positioned with 
respect to the NIR probe illumination spot, resulting in NIR spectra recorded from partial 
tablet area. The NIR spectra of these tablets were removed from further testing. 
 A small peak in predicted concentration during transition of 18 % to 0 % w/w Ibuprofen 
blends matched well in NIR PLS-predicted Ibuprofen in tablets and UV assay results of tablets 
sub-samples collected at respective time confirming that Ibuprofen concentration change was 
result of actual change in powder blend and not due to physical phenomenon affecting NIR 
spectra e.g. as low material level inside the feed frame.   
4.4.3.3 Comparison of off-line and in-line PLS in tablet monitoring 
 Plotting predicted tablet concentrations (312 tablets sub-samples) with off-line and in-
line NIRS PLS models (Fig. 4.9) showed prediction accuracy of the respective PLS model. 
 
 Figure 4.9: PLS-predicted tablet concentrations with off-line and in-line NIRS 
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 Ibuprofen concentration in tablets predicted by off-line NIRS was more closely spread 
near expected values than in-line NIRS. The RMSE value between the UV assay results and 
off-line NIRS-predicted concentrations was 1.30% w/w while RMSE between the UV assay 
results and in-line NIRS-predicted concentrations was 2.31% w/w, which shows that in-line 
NIRS-predicted concentrations are slightly over or under estimated than the actual UV assay 
values. The spread of individual tablet concentrations was quantified with standard deviations 
in all stationary phase tablets at each concentration (Table 4.5). While standard deviation of 
off-line NIRS closely matched the UV assay results, the standard deviation of in-line NIRS 
concentrations was higher than the respective values of off-line NIRS and UV assay. Since the 
same tablet samples were tested by all 3 methods (UV assay, in-line and off-line NIRS), 
standard deviation values indicated that factors, such as dynamic sample presentation and 
lesser spectral integration time in case of in-line analysis, led to slightly higher tablet-to-tablet 
variation in predicted % w/w Ibuprofen concentrations of the tablets.  
Table 4.5: Standard deviation of tablet concentrations by NIRS and UV assay 
Tablet sub-
sample testing 
method 
Standard deviation value for tablets with different % w/w Ibuprofen 
contents 
0 % w/w 2 % w/w 8 % w/w 15.8 % w/w 18 % w/w 
UV analysis 0.88 0.14 0.71 1.28 1.52 
Off-line NIRS 0.89 0.39 0.59 0.60 0.86 
In-line NIRS 1.21 0.61 1.35 1.40 1.59 
4.4.4 In-line concentration change kinetics 
 Concentration step changes of NIRS-predicted Ibuprofen concentrations inside the feed 
frame and tablets were found to obey first-order kinetics (2). The first-order rate constant (k) 
and its 95% confidence interval were calculated after curve-fitting (Tables 4.6 and 4.7).  
4.4.4.1 Kinetics inside the feed frame 
 First-order kinetic rate values k for different transitions are found in Table 4.6.  
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Table 4.6:  Kinetics of blend concentrations inside the feed frame 
Blend 
transition 
First-order rate 
constant (k) (min
-1
) 
95 % Confidence 
interval (min
-1
) 
Time required for 75 % 
transition (min) 
2-8 % w/w 0.196  0.185-0.206 7.098 
8-18 % w/w  0.359  0.350-0.369 3.878 
18-0 % w/w 0.352 0.343-0.361 3.951 
0-15.8 % w/w  0.280 0.276-0.284 4.976 
 
 The time required to achieve 75% of blend transitions (calculated from first-order rate 
equation (4.2)) inside the feed frame was observed to be different for all blends, leading to the 
conclusion that each incoming blend from the hopper does not follow the same kinetics inside 
the feed frame, despite having similar qualitative composition and constant compression 
machine settings. In a completely-filled feed frame, only a small portion of the total material 
present inside the feed frame enters the dies during each paddle wheel rotation. At a constant 
tableting rate and constant speed of the feed frame paddle wheel, a fixed amount of material 
was removed from the feed frame while the rest was circulated back to it. Material entering 
the dies could not be controlled selectively. Thus, the incoming material randomly mixes with 
the material already present inside the feed frame before replacing it completely. This could 
have led to random variation in first-order rate constants. Random mixing is more explicit at 
the second wheel due to the design of the feed frame as explained in the following section 
(3.4.2). In addition, blend flowability might impact the concentration change kinetics. 
However, in the present work, the flowability of all blends was considered to be the same and 
not tested separately owing to the fact that mannitol compensates for the major portion of the 
change in Ibuprofen pellet concentration, and its particle size is close to that of Ibuprofen 
pellets. 
4.4.4.2 Kinetics in tablets 
 To evaluate tablet and feed frame concentration changes on the same time scale, 
concentration kinetics inside the tablets were found from the predicted Ibuprofen 
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concentrations averaged over 28 tablets. The rate constant (k) values, confidence interval and 
time required for 75% completion of different transitions are summarized in Table 4.7.  
Table 4.7: Kinetics of blend concentrations in tablets 
Blend 
transition 
First-order rate 
constant (k) (min
-1
) 
95 % Confidence interval 
(min
-1
) 
Time required for 
75 % transition (min) 
2-8 % w/w  1.062 0.947-1.177 1.317 
8-18 % w/w 0.501 0.481-0.522 2.780 
18-0 % w/w 0.712 0.673-0.752 1.976 
 0-15.8 % w/w  1.220 1.124-1.315 1.171 
 
 
Figure 4.10: Differences in feed frame depth at the first and second wheel 
 The time required for 75% completion of concentration transitions in case of tablets did 
not show similar trends as the feed frame. Overall kinetics within the tablets appeared to be 
faster than in the feed frame. This could be due to the positioning of NIRS on the feed frame. 
The NIR probe was located at the second wheel (Fig. 4.10) while die-filling started from the 
first wheel. Most of the tablet mass was taken from the first wheel since empty dies first 
passed under the first wheel. In addition, feed frame depth was 12 mm at the first wheel and 
24 mm at the second wheel. The height of the individual paddles was 7.5 mm. Thus, the 
material had less space to escape the first wheel and was carried along the paddles. As a result, 
the existing material at the first wheel either filled the dies or was pushed on to the second 
wheel under paddle motion as well as pressure from the hopper material. Thus, it was likely 
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that the first wheel equilibrated faster with the incoming material than the second wheel where 
the material was removed comparatively slower by dilution with incoming material. 
4.4.4.3 Comparison of kinetics inside the feed frame and inside the tablets 
 The plot of Ibuprofen concentration changes versus time (Fig. 4.11) inside the feed 
frame and tablets showed that transition started slightly earlier in the tablets than in the feed 
frame. In addition, it took a little longer for completion inside the feed frame than in the 
tablets. NIR probe position should be optimized to observe concentration changes 
simultaneously with tablets since die-filling starts at the first wheel and the NIR probe is 
positioned at the second wheel. 
 
 Figure 4.11: Ibuprofen concentration comparison inside the feed frame and tablets with 
expected concentration as well as UV assay values of tablet sub-samples 
4.4.5 Sample volume inside the feed frame 
 Sample volume per NIR spectrum was determined to be 299.6 mg/spectrum (equation 
4.3). Thus, each spectrum represented about 0.25 dosage units. Considering the total number 
of spectra (1804) recorded throughout compression, the total sample tested by NIRS inside the 
feed frame was estimated to be 540.5 g, which represents 0.72% of the total batch size. The 
present study recorded only one NIR spectrum per revolution of the feed frame paddle wheel. 
The percentage of the total tested sample could be improved by increasing the frequency of 
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NIRS data acquisition. Sample volume per spectrum could be augmented by increasing 
integration time and averaging a large number of sub-spectra since powder blends inside the 
feed frame are moving continuously. However, the possibility of losing local variations as a 
result of excessive averaging should also be tested. 
4.5 Conclusion 
 The present work sought to evaluate the feasibility of near-infrared spectroscopy (NIRS) 
to monitor concentrations in a pharmaceutical tableting. The novelty of the work lies in the 
fact that 3 NIRS systems were used to monitor different aspects of the compression process: 1) 
in-line analysis of flowing powders inside the feed frame, 2) in-line analysis of all tablets 
produced and 3) off-line analysis of a sub-sample of the tablets. To achieve this, Ibuprofen 
was used as an Active Pharmaceutical Ingredient (API) in concentrations between 0 and 15.3 
% w/w.  
 NIRS responses to subtle concentration changes inside a feed frame and in the tablets 
during the compression process were evaluated through a series of controlled concentration 
step changes inside the press hopper. Multivariate partial least-squares (PLS) models were 
used to predict Ibuprofen concentrations inside the feed frame and tablets. These models were 
compared to UV assays of the tablets collected at different time points during compression. 
Process kinetics, in terms of the rate with which Ibuprofen concentrations would change in the 
flowing powder as well as in the tablets, were measured and compared.  
 Results highlight the feasibility of NIRS to accommodate different physical sample 
presentations, i.e. powders and tablets. A concentration difference as low as 1.7% w/w 
Ibuprofen was successfully detected despite Ibuprofen being present in coated particulate form 
and sample spectra being acquired in dynamic mode. Good agreement between NIRS-PLS 
model predicted concentrations inside the feed frame and tablets with the UV assay results 
substantiated the potential NIRS for feed frame- and tablet-monitoring. 
 Ibuprofen concentration changes, both in the feed frame and in the tablets, could be 
modeled using first-order kinetics. However, a difference of about 1.25 min was observed, 
tablets show transition onset 1.25 min ahead of the feed frame. This result indicates that NIR 
probe position inside the feed frame must be chosen based on the geometry of feed frame to 
better correlate with the concurrent tablet concentration dynamics or a delay to see 
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concentration change inside feed frame based on its location inside feed frame should be 
established case by case. NIRS also showed sensitivity not only for concentration changes but 
also for level changes inside the feed frame (i.e. void space), which could potentially be useful 
when seeking to control a commercial press. Finally, a combined feed frame and tablet 
monitoring could prove beneficial in the real-time release testing of batches. 
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CHAPTER 5 In-line concentration monitoring in a 
multicomponent blend inside the tablet press using 
NIR CI (area scan) 
Titre en Français:  
Suivi en ligne de la concentration d’un mélange multi composite par NIR CI lors de la 
compression 
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Summary 
Contents:  
NIR CI (area scan) has been successfully used to qualitatively and quantitatively differentiate 
different blends according to Ascorbic acid concentration in the blends (chapter 3) in off-line 
tests. The composition of the powder blends was comparatively simple since it only contained 
3 ingredients. However, average pharmaceutical tablet composition contains multiple 
ingredients; thus it is necessary to evaluate NIR CI for concentration monitoring in complex 
pharmaceutical blends. This chapter shows the in-line performance of NIR CI (area scan) for 
Ibuprofen concentration monitoring in a pharmaceutically relevant complex blend 
composition containing multiple non-active ingredients. 
 
Results:  
NIR CI (area scan) based PLS models suitably predicted Ibuprofen concentration changes. 
However, the signal-to-noise ratio for concentration predictions in respective blends was 
found lower than NIRS. The accuracy of NIR CI (area scan) data was negatively influenced by 
the presence of multiple pharmaceutical ingredients in the powder blend. 
 
Contributions to the thesis:  
Evaluation of NIR CI (area scan) for powder concentration prediction in a pharmaceutically 
relevant blend composition was demonstrated. Higher noise in NIR CI (area scan) data 
suggests that the complex nature of the powder blend poses a challenge for the NIR CI (area 
scan) data accuracy. This chapter suggests that NIR CI (area scan) could be suitable for feed 
frame monitoring if the signal-to-noise ratio in data collection is improved. One way of 
achieving this could be- to use a spectrograph in front of NIR camera (i.e. line scan) which 
would help to obtain spectral data with a precision close to NIRS (chapter 6). 
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Abstract 
 NIR CI (area scan) has been reported for in-line concentration monitoring inside a tablet 
feed frame using simple powder blends. In addition to quantitative concentration predictions, 
NIR CI (area scan) provides the possibility for qualitative process control in the event of 
material depletion, obstruction of material flow or segregation of powders inside the feed 
frame. Selectivity of NIR spectral filters can be challenged in the presence of multiple 
ingredients having NIR absorbance in the similar wavelength range, negatively affecting the 
concentration prediction by NIR CI (area scan). 
 The present work evaluates Ibuprofen concentration monitoring in a pharmaceutically 
relevant multi-component blend using NIR CI (area scan). Predictive models were built using 
Partial Least Square (PLS) analysis. Concentration predictions inside the feed frame were 
compared with corresponding NIRS-based concentration prediction inside the feed frame as 
well as UV assay results of the tablet samples. 
 Captured NIR CI (area scan) visually demonstrates the difference between the powder 
blends at different levels of Ibuprofen in their composition. NIR CI (area scan) PLS model 
predicted concentrations show that the broad changes in Ibuprofen concentration are 
successfully monitored by NIR CI (area scan) despite the presence of other multiple 
ingredients. Compared to NIRS PLS concentration predictions inside the feed frame and UV 
spectroscopic assay analysis, NIR CI (area scan)-based concentration predictions show a 
higher sample-to-sample variation which is due to lower signal-to-noise ratio in NIR CI (area 
scan) data. 
 
Keywords: NIRS; NIR CI (area scan); tablet; feed frame; segregation 
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Résumé français: 
 La NIR CI (area scan) est utilisée pour le contrôle en ligne d’une concentration dans des 
mélanges simples de poudres, dans une trémie d'alimentation de presse à comprimée. Outre 
des prévisions de données quantitatives, la NIR CI (area scan) offre la possibilité d'un contrôle 
qualitatif du procédé en cas d'épuisement de la matière, d'obstruction du flux de poudre ou dé 
mélange des poudres à l'intérieur de la trémie d'alimentation. La sélectivité des filtres 
spectraux NIR peut être remise en question en présence de multiples ingrédients ayant une 
absorbance NIR dans une gamme de longueurs d'onde similaire, interférant avec la prédiction 
de la concentration par NIR CI (area scan). 
 Le travail actuel estime la concentration d'ibuprofène dans un mélange pharmaceutique 
multi-composant approprié, en utilisant NIR CI (area scan). Les modèles prédictifs sont 
construits en utilisant l'analyse des Moindres Carrés Partiels (PLS). Les prévisions de 
concentration à l'intérieur de la trémie d'alimentation sont comparées avec celles basée sur la 
NIRS dans la trémie d'alimentation ainsi que les résultats d'analyse UV des échantillons de 
comprimés. 
 La NIR CI (area scan) permet de démontrer visuellement la différence entre les 
mélanges de poudre à différentes concentrations en ibuprofène. Les concentrations prédites 
par le modèle NIR CI (area scan) PLS montre que les importants changements de 
concentration en ibuprofène sont contrôlés avec succès par la NIR CI (area scan), malgré la 
présence de multiples autres ingrédients. Comparées aux prévisions de concentration obtenues 
par NIRS PLS et par analyse par spectroscopie UV à l'intérieur de la trémie d'alimentation, les 
prévisions de concentration basées sur la NIR CI (area scan) montrent une variabilité inter-
échantillon plus élevé, dû à un rapport signal sur bruit plus faible dans les données NIR CI 
(area scan). 
 
Mots-clés:  
NIRS; NIR CI (global); comprimé; plateau d’alimentation; ségrégation
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5.1 Introduction 
5.1.1 NIR CI in feed frame monitoring 
 NIR CI-based PAT applications searching for distributions of the active pharmaceutical 
ingredient in a tablet formulation [121], finding spatially resolved hardness maps across the 
surface of tablets [122] as well as in determining blending operation end point [38] have 
already been explored. Powder compositions in these studies were complex and 
pharmaceutically relevant; however sample data acquisition conditions were comparatively 
more stable, e.g. tablets were scanned in single unit format by manually placing them under 
imaging unit while in case of blending end points determination, the blender was stopped 
when NIR images were acquired. Contrary to most pharmaceutical operations involve moving 
samples which pose a challenge in NIR CI applications measuring the powder samples in-line. 
The quality of NIR CI data may be compromised in in-line measurements due to lower signal-
to-noise ratio as compared to measurements in stationary samples. NIR CI (global) using a 
wavelength bandpass filters [123] has been already reported in chapter 3 for feed frame 
concentration monitoring owing to both spectral and spatial information which could detect 
adverse quality phenomenon like segregation. An earlier study [124] also shows detection of 
ingredients in tablet samples using NIR CI. Chapter 3 demonstrated the NIR CI (global) 
application in feed frame monitoring testing the moving powder samples; however powder 
samples used therein were less complex in terms of composition. In this regard, it is necessary 
to evaluate NIR CI (global) for monitoring pharmaceutically relevant compositions containing 
active of interest along with other pharmaceutically accepted components. 
5.2 Materials  
 Materials, formulation composition, sample preparation and tablet compression 
sequence used in this work are same as chapter 4. 
5.3 Methods 
 NIR camera was used with a single bandpass filter (discussed below) suitable for 
capturing Ibuprofen in the presence of other ingredients of the blend composition. Feed frame 
set up was similar to chapter 3; however, measurements were made in an in-line manner.  
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5.3.1 Selection of suitable bandpass NIR filter 
 Different NIR filters were evaluated to obtain NIR (area scan) images showing the 
proper contrast in image pixels representing NIR absorbing and non-absorbing materials 
within the NIR wavelength range permitted by the bandpass filter. The NIR camera records 
images capturing reflected NIR light from the sample surface, consequently, image pixels 
representing NIR absorbing materials appear darker while pixels representing non absorbing 
materials appear brighter on the recorded NIR image.  
 
    
1200-1280 nm 
Mean- 13481  
1450-1470 nm 
Mean- 9945.6 
1537-1663 nm 
Mean-11245  
1632-1671 nm 
Mean- 11914 
 
  
 
 
  1537-1663 nm with 
added Ibuprofen pellets 
Mean- 11744 
 
Figure 5.1: NIR CI (area scan) of 18% w/w Ibuprofen powder blends taken with different 
bandpass filters 
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 Figure 5.1 shows NIR CI (area scan) of 18% Ibuprofen blend captured with different 
filters. In the present work, Ibuprofen is the active of interest upon which filter selection is 
dependent, i.e. if Ibuprofen shows NIR absorbance with certain wavelength filer then other 
ingredients of the powder composition should not absorb NIR radiation in the same 
wavelength range and vice versa; in order to provide useful pixel contrast in the captured NIR 
CI (area scan) leading to higher signal-to-noise ratio.  
 Reflectance spectra of Ibuprofen pellets (Figure 5.1) do not show significant NIR 
absorption peaks in the range of 900-1600 nm except for 2 small absorption peaks between the 
ranges of 1150-1250 nm. NIR absorbance increases beyond 1600 nm. In comparison to NIR 
reflectance spectrum of Ibuprofen pellets, 1200-1280 nm filter represent the spectral region of 
least NIR absorbance while 1450-1470 and 1537-1663 nm filters cover slightly higher NIR 
absorbance region of Ibuprofen pellets. However, NIR absorbance of other components (table 
4.1) of the blend, also plays a significant role in the NIR CI (area scan) pixel contrast 
differentiating among different ingredients. Other components of the powder blends show 
similar absorption peak near 1150-1250 nm while NIR absorbance goes on increasing beyond 
1350 nm until 1600 nm. Consequently, NIR CI (area scan) using 1200-1280 nm bandpass 
filter does not show any pixel contrast for Ibuprofen since neither Ibuprofen nor other blend 
ingredients significantly absorb in that range, as well as the difference in their NIR absorbance 
is not greatly different.  
 However, NIR CI (area scan) with 1537-1663 nm filter showed Ibuprofen as 
comparatively brighter pixels which were later confirmed by adding an additional quantity of 
Ibuprofen pellets in the blend. NIR image pixels corresponding to the location of the other 
components appear darker (i.e. lower pixel intensity than Ibuprofen) in these images, which 
indicate that other ingredients of the composition absorb more than Ibuprofen in 1537-1663 
nm range. Thus the wide gap between their NIR absorbance helps to achieve better pixel 
contrast for NIR (area scan) using 1537-1663 nm filter. NIR CI (area scan) with 1632-1671 
nm filter show low contrast in pixel intensities since Ibuprofen pellets starts absorbing beyond 
1650 nm thus reducing the difference in the NIR absorbance of Ibuprofen pellets and other 
components of the powder blend.  
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5.3.2 Data Acquisition 
 Sample presentation to the camera was properly controlled using flat insert (Figure 3.3) 
to ensure image-to-image comparability. Sample-to-camera distance, optics, illumination and 
sample surface settings were kept constant. In addition, all NIR images were corrected for NIR 
source intensity variation over time using a white reference. For this purpose, a white 
reference was placed next to the flat insert. A ratio between the mean intensity of all the pixels 
representing this white reference in the respective image and the first image was used to 
correct the respective image for variation in the NIR light intensity. This ratio was multiplied 
to all pixel intensities in the NIR chemical image being corrected. 
  
Figure 5.2: NIR CI (area scan) showing different pixel intensities as a function of different 
Ibuprofen concentration  
Figure 5.2 shows a clear difference in the pixel intensities of NIR CI (area scan) taken during 
the compression of different powder blends with varying Ibuprofen concentration. As the 
concentration of Ibuprofen pellets increases in the blend, density of brighter pixels in the NIR 
CI (area scan) increases. Thus, at 2% w/w Ibuprofen concentration NIR CI (area scan) exhibit 
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lowest mean pixel value, which goes on increasing with increasing Ibuprofen concentration in 
the blend and reaches to highest for 18 % w/w Ibuprofen blend. 
 The trend in the mean pixel intensities indicate that selected NIR filter appropriately 
differentiates the NIR image pixel intensities as a function of Ibuprofen concentration. NIR 
image pixels distribution according to their intensity can allow comparison between NIR 
images taken for different Ibuprofen concentration blends. Thus, NIR CI (area scan) can be 
used for the purpose of Ibuprofen powder blend monitoring. 
5.3.3 Data treatment and analysis 
 NIR CI (area scan) data was analyzed following a similar method of analysis as 
explained in section 3.4.3 of chapter 3. Initially, histogram analysis was performed following 
which quantitative analysis was performed using PLS models. Scaling to unit variance and 
mean centering was used in the data pre-treatment. 
5.4 Results and discussion 
5.4.1 Comparison of NIR CI (area scan) and NIRS PLS models 
 The NIR CI (area scan)-based PLS calibration model for the feed frame was built with 
NIR CI (area scan) data collected during stable concentration phase of different blends. Stable 
concentration region for each powder blend was selected based on corresponding NIRS 
spectra (1100-1255nm spectral range) that showed stable PC1 score values (Figure 4.5) in 
each blend. PLS model with 4 latent variables showed R
2
adj value of 0.96. RMSEC and 
RMSECV values were 1.33 and 1.49 % w/w Ibuprofen, respectively. Calibration model 
parameters were found inferior to the NIRS data (R
2
adj value of 0.995. RMSEC and RMSECV 
values were 0.46 and 0.47% w/w Ibuprofen with 2 latent variables). Concentrations for all the 
blends inside feed frame were predicted on the basis of this calibration model. 
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Figure 5.3: NIR CI (area scan) predicted Ibuprofen concentrations inside the feed frame, the 
expected and NIRS predicted concentrations 
 NIR CI (area scan) PLS-predicted Ibuprofen concentrations versus time plot (Figure 5.3) 
show that NIR CI clearly depicted the concentration step changes inside the feed frame. Root 
mean square error (RMSE) value between NIR CI (area scan) predicted concentration and 
expected concentration was found 2.98 while a RMSE value between NIRS predicted 
concentration and expected concentration is 2.34, which indicate NIR CI (area scan) PLS 
model based concentration predictions are not as close to expected concentration as NIRS. The 
RMSE between NIR CI (area scan) and NIRS predictions was found as 2.12, which also 
shows that there is a similar level of difference in NIR CI (area scan) and NIRS predicted 
concentrations. 
 NIR CI (area scan) predicted concentrations show higher scatter around expected 
concentrations upon visual observation of Figure 5.3. The scatter of predicted concentrations 
was also higher than NIRS predicted concentrations for all the powder blends. The mean and 
standard deviation of predicted concentration during the steady state of compression were 
compared with NIRS-based predictions for statistical comparisons. 
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Table 8: Mean and standard deviation of NIR CI (area scan) and NIRS model predicted 
concentrations 
Expected 
concentration 
(% w/w) 
NIR CI (area scan) 
Mean concentration 
(% w/w) 
NIR CI (area 
scan) standard 
deviation 
(% w/w) 
NIRS Mean 
concentration 
(% w/w) 
NIRS standard 
deviation 
(% w/w) 
0 0.76 0.92 -0.13 0.20 
2 2.46 0.93 2.35 0.26 
8 7.73 1.39 7.65 0.49 
15.8 12.96 1.88 15.42 0.79 
18 18.61 1.86 18.26 0.82 
 As shown in table 5.1, NIR CI (area scan)-based mean concentration predictions for 8 
and 15.8 % Ibuprofen blends was slightly lower than expected concentrations while predicted 
mean concentrations for 0, 2, and 18 % Ibuprofen blends were slightly above the expected 
concentrations. NIRS PLS model predicted concentrations for 0, 8, and 15.8 % Ibuprofen were 
slightly lower than expected concentrations while predicted concentrations in the case of 2 and 
18 % Ibuprofen were slightly higher than the expected concentrations. In all cases NIR CI 
(area scan)-based concentration predictions showed higher standard deviation than NIRS-
based concentration predictions, indicating higher sample to sample variation in NIR CI (area 
scan).  
 Variance calculated for the steady states in the PLS model predicted concentrations 
(Figure 5.4) increased with increasing blend concentration in both the NIRS and NIR CI (area 
scan)-based concentration monitoring. However, variance values in NIR CI (area scan) 
predicted concentrations at all blend concentrations were higher than NIRS, indicating that 
signal-to-noise ratio in case of NIR CI (area scan) is slightly lower than NIRS. 
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Figure 5.4: Variance in NIRS and NIR CI (area scan) predicted Ibuprofen concentrations 
inside the feed frame 
5.4.2 Comparison of NIR CI (area scan) predicted concentrations with tablet 
assay  
 Powder concentration predictions using the PAT tools need to be verified against routine 
chemical analysis methods to avoid misleading conclusions on the product/process quality just 
based on chemometric model performances. Thus, NIR CI (area scan)-predicted 
concentrations inside the feed frame and the Ibuprofen UV assay results of tablet sub-samples 
collected at corresponding times were compared (Figure 5.5). Gross changes in powder blend 
concentrations inside the feed frame are clearly captured by NIR CI (area scan) predicted 
concentrations; however, NIR CI (area scan) predicted sample-to-sample concentrations 
among the respective blends vary considerably in comparison to UV assays of the tablet 
samples. As discussed in chapter 4, UV assay of certain tablets in the 15.8 and 18 % blend 
were scattered from rest of the tablets, however, scatters in the corresponding NIR CI (area 
scan) predicted concentrations were seen even higher. This indicates the presence of 
variation/noise in the gathered NIR CI (area scan) data in addition to the original level of 
concentration variations seen in the blend compositions owing to UV spectroscopic assays. 
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Figure 5.5: NIR CI (area scan) predicted Ibuprofen concentrations inside the feed frame and 
tablets’ UV assay results vs time 
The sample-to-sample concentration variation seen in case of NIR CI (area scan) is due to 
larger surface sampling by NIR CI (area scan) making it sensitive to surface distribution of the 
Ibuprofen as well as low signal-to-noise ratio over wavelength bandwidths allowed by the 
spectral filter. 
5.5 Conclusion 
Collectively, this work indicates that NIR CI (area scan) can be useful to trace gross 
changes in powder concentrations inside the feed frame however for quantitative 
concentration predictions for the purpose of strict quality control; there is a need for increasing 
the signal-to-noise ratio in NIR CI measurements. The poor signal quality in NIR CI (area 
scan) is due to variables such as wide wavelength range of spectral filter causing reduced 
specificity for active of interest, low intensity NIR emissions in the interested wavelength 
range causing lower NIR penetration, and low pixel resolution due to smaller sensor size 
representing larger sample area. Use of spectrograph (line scan) can help alleviate some of 
these limitations in NIR CI measurements. 
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CHAPTER 6 Simultaneous multiple components 
concentration monitoring inside the tablet press using 
NIRS and NIR CI (line scan) 
Title in French:  
Suivi simultané de la concentration de plusieurs composants par NIRS et NIR CI dans une 
presse à comprimés. 
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Summary 
Content: 
Chapter 5 demonstrated successful concentration predictions inside the feed frame using NIR 
CI (area scan image format using a wavelength bandwidth filter) but it also reported lower 
signal-to-noise ratio in the NIR CI (area scan) as compared to NIRS. NIR CI (line scan) using 
spectrograph can give spectral output similar to NIRS while giving spatial information as well. 
Thus, the present work evaluates NIR CI (line scan) to monitor 2 active ingredients in 
multicomponent pharmaceutical powder compositions. Calibration models prepared in off-line 
set up are evaluated for concentration prediction for in-line monitoring.   
 
Results:  
NIR CI (line scan) predicted the concentration of Ascorbic acid and Ibuprofen in close 
agreement with NIRS irrespective of the presence of multiple ingredients in the powder blend. 
Selection of wavelength ranges and spectral pre-treatments for respective actives are found as 
important parameters for performance of quantitative PLS models. Calibration model transfer 
from off-line testing to in-line monitoring was possible with removal of baseline variations in 
the spectral data. NIR CI (line scan) based concentration predictions in similar spatial location 
matched closely with NIRS. This shows that NIR CI (line scan) can be used to verify radial 
segregation by concentration prediction over the different spatial sections. 
Contributions to the thesis:  
This work presented the further advancement of NIR CI-based feed frame concentration 
monitoring in a much complex blend and simultaneously testing 2 active ingredients. NIR CI 
(line scan) not only gives similar spectral data as NIRS but also offers the opportunity to test 
radial segregation owing to larger spatial dimension covered by NIR CI with higher signal-to-
noise ratio than NIR CI (area scan) with single waveband filters. Along with off-line model 
performance, transfer to in-line monitoring is also demonstrated. This chapter showed NIR CI 
(line scan) as a robust alternative for feed frame monitoring. 
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Abstract 
 Concentration monitoring inside a tablet press during manufacturing is important not 
only to assess the quality of the powder blend is compressed but it can also help to intervene 
and control the process by notifying adverse quality phenomena such as segregation. Near-
infrared spectroscopy (NIRS)-based process analytical technology (PAT) has been successful 
for concentration monitoring in the press feed frame. However, it only tests small areas (e.g. 
15×4 mm) of the powder sample. On the contrary, near-infrared chemical imaging (NIR CI) 
can potentially improve process monitoring owing to its comparatively larger sample area (e.g. 
40×3 mm), thereby helping to detect local concentration changes as well as the presence of 
segregation. The present work reports simultaneous concentration monitoring of Ibuprofen 
and Ascorbic acid in a multi-component composition using both NIRS and NIR CI. Predictive 
models were built using Partial Least Square (PLS) analysis.  The transfer of these models 
from lab to production has been evaluated to simultaneously predict the concentration 
variation of multiple ingredients inside the feed frame.  
 NIR CI (line scan) PLS models successfully monitor the Ibuprofen and Ascorbic acid 
concentrations despite the presence of multiple excipient ingredients influencing their 
individual spectra. To create successful PLS calibration models and subsequent concentration 
predictions, selection of NIR spectral wavelength ranges and pre-treatments are found as a 
critical factor. Transfer of calibration models from off-line tests to in-line monitoring is also 
feasible owing removal of baseline variations by the suitable spectral pre-treatments. NIR CI 
(line scan) predicted concentrations in a spatially similar powder area as tested by NIRS 
matched closely with NIRS-based concentration predictions. This finding suggests that NIR 
CI (line scan) can be potentially useful to probe the radial segregation inside the feed frame by 
the way of spatial concentration testing. 
 
Keywords: NIRS; NIR CI (line scan); PAT; tablet; feed frame; segregation; model transfer
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Résumé français: 
Le suivi de la concentration dans une presse à comprimés durant la fabrication est important 
non seulement pour évaluer la qualité du mélange de poudre comprimé, mais aussi pour 
corriger et maîtriser le procédé en identifiant les attributs qualité défavorables tels que le 
démélange. La technologie d'analyse de procédé (PAT) basée sur la spectroscopie proche 
infrarouge (NIRS) est efficace pour le contrôle de la concentration dans la trémie 
d'alimentation de la presse. Cependant, elle ne teste que de petites zones d'échantillon de 
poudre (e.g. 15 x 4 mm). A l’inverse, l'imagerie chimique proche infrarouge (NIR CI) peut 
potentiellement améliorer le contrôle du procédé en raison de sa surface d'échantillon 
comparativement plus grande (e.g. 40 x 3 mm), aidant ainsi à détecter des changements de 
concentration locaux ainsi qu’un phénomène de démélange. Le travail actuel rapporte le 
contrôle simultané de la concentration de l'ibuprofène et de l'acide ascorbique dans une 
composition multi-composants en utilisant à la fois NIRS et NIR CI. Les modèles prédictifs 
sont construits en utilisant l'analyse des Moindres Carrés Partiels (PLS). Le transfert de ces 
modèles, du laboratoire à la production, sont évalués afin de prédire simultanément la 
variation de concentration de plusieurs ingrédients à l'intérieur de la trémie d'alimentation. 
 Les modèles NIR CI PLS contrôlent efficacement les concentrations d'ibuprofène et 
d'acide ascorbique malgré la présence de multiples excipients influençant leurs spectres 
individuels. Pour créer des bons modèles d'étalonnage PLS et des prédictions de concentration 
subséquentes, la sélection des plages de longueurs d'onde spectrales NIR et les prétraitements 
sont considérés comme des facteurs critiques. Le transfert de modèles d'étalonnage des essais 
hors ligne à la surveillance en ligne est également réalisable en raison de l'élimination des 
variations de la ligne de base par les prétraitements spectraux appropriés. Les concentrations 
prédites par la NIR CI dans une zone de poudre spatialement similaire, telle que testée par 
NIRS, correspondaient étroitement aux prévisions de concentration basées sur NIRS. Cette 
découverte suggère que la NIR CI peut être potentiellement utile pour sonder la ségrégation 
radiale à l'intérieur de la trémie d'alimentation par le biais de tests de concentration spatiale. 
  
Mots-clés: NIRS; NIR CI (balayage de ligne); PAT; comprimé; plateau d’alimentation; 
ségrégation; transfert de modèles 
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6.1 Introduction 
 Pharmaceutical manufacturing is transitioning from a quality by testing approach to one 
of quality by design with multiple changes in drug regulatory scenario as a result of ICH Q8 
(R2) [3], RTRT guidance [105], ICH Q9 [6], ICH Q10 [7], PAT guidance [2] and ICH Q11 
[125]. Real time release (RTR) of pharmaceuticals has become a reality in recent years due to 
regulatory advocacy for process understanding, monitoring, control and use of technological 
advances by pharmaceutical manufacturers for this purpose. The implementation of real time 
release testing (RTRt) is an ideal state of pharmaceutical manufacturing which benefits both 
manufacturers as well as patients. Higher quality assurance is achieved via monitoring all of 
the critical processes and material parameters and ensuring they are within the desired limits 
throughout all the manufacturing process as opposed to traditional approach of testing certain 
fraction of final products batch to ensure the overall quality. RTRt also results in higher 
process control due to a better process understanding, improved efficiency and inventory 
control. However, for a successful RTRt implementation, a diligent identification of all critical 
manufacturing operations, critical product attributes and corresponding PAT applications for 
their monitoring must first be asserted. 
6.1.1 RTRt in tablet manufacturing 
 In case of tablet manufacturing, a combination of in-process tablet weight, blend content 
uniformity measurement, drug substance purity and particle size could serve as a control 
strategy for drug content of a tablet if the relationship has been demonstrated. Monitoring of 
core tablet weight, blend uniformity, drug substance purity and particle size in this case are the 
RTR tests [105]. Tablet manufacturing involves different unit operations (mixing, milling, 
granulation, drying, compression, etc.)[126], which are critical for in-process and final product 
quality depending on the physicochemical properties of the tablet blend, manufacturing 
process i.e. based on wet or dry granulation. Among the different operations, tablet 
compression is one of the critical final operations irrespective of adopted manufacturing 
process i.e. dry granulation or wet granulation. During the tablet compression stage, blend 
concentration and its uniformity can only be tested at the hopper or in the feed frame. 
Monitoring blend concentration at the feed frame provides a better indication of final product 
properties considering the possibility of adverse quality phenomenon i.e. segregation while the 
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material is in continuous high speed movement. Segregation can occur due to influence of 
multiple factors e.g. differences in material particle size. [19], density differences [127], shape 
[128], moisture [129], speed of powder movement [53].  
6.1.2 NIRS in feed frame monitoring 
 NIRS PAT applications for concentration monitoring at the feed frame are rising in last 
few years due to its speed, flexibility, and the in-line manner implementation. NIR has been 
successfully implemented for concentration monitoring inside the feed frame in the range of 2-
30 % w/w [52][16]. Concentration monitoring can be performed by tracking changes in 
spectral intensity of single wavelength [61] or a range of wavelengths [15] by means of 
chemometric methods such as PCA and PLS. Most of the earlier works on monitoring feed 
frames using NIRS reports the monitoring of only single ingredient at a time. However, in 
practice, there is often more than one ingredient of interest in the tablet composition. NIRS 
spectra of most pharmaceutical ingredients are complex in nature [130] and show overlapping 
regions of NIR absorbance due to common functional groups. Thus, making accurate 
quantitative models for concentration monitoring, especially in the presence of multiple NIR 
active ingredients, could be challenging and needs to be studied.  
 Preparation of NIRS-based in-line quantitative concentration models has been reported 
in earlier work; however transferring quantitative models from one batch to another or from 
lab to production has not been successful. Different methods of NIRS calibration model 
transfer have been reported [131] [132] in the literature but most of them require extensive 
time and resource investment. In case of feed frame monitoring, additional factors such as 
continuous motion of the sample, density changes and baseline variations pose challenges in 
calibration transfer since they can contribute to variation in NIR spectral data [15]. In this 
study, the use of spectral pre-treatments to remove unwanted spectral variations while 
transferring the calibration method from batch to batch or lab to production needs was 
evaluated. 
6.1.3 NIR CI in feed frame monitoring 
Along with NIRS applications, NIR CI (area scan) using a wavelength band filter has 
also been reported for feed frame concentration monitoring owing to both  spectral and spatial 
information it provides which could detect adverse quality phenomenon like segregation 
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[133][134]. In case of multi-component mixtures, NIR imaging of the sample over multiple 
wavelength bands or considerable range of NIR spectrum is required. This could be achieved 
via multiple filters, but adjusting the NIR imaging parameters (especially to accommodate 
variations of NIR source intensity and filter transmitted light intensity) at different filters as 
well as material movement inside the feed frame poses challenges in successful data 
acquisition at the same time it leads to temporal delays between the wavelengths. In this 
regards, the amount of spectral information in a single image can be dramatically increased by 
combining it with a spectrograph rather than using multiple filters. Though we lose on spatial 
component for one spatial dimension (e.g. length) but we maintain information over the other 
spatial dimension (i.e. width) of the sample. For moving samples like inside feed frame, 
variation along width (signifying spatial concentration changes) is important than length since 
radial segregation is more prone under centrifugal force of the rotating paddles. A 
spectrograph offers spectral information over a range of discrete wavelengths instead of 
certain wavelength band as offered by single filter. As a result, NIR CI (line scan) gives 
spectral data similar to NIRS but covers a larger sample area. 
6.1.4 NIRS and NIRCI for concentration monitoring inside feed frame 
 The present work aims at evaluating simultaneous concentration monitoring of a 
multicomponent powder blend comprising Ibuprofen and Ascorbic acid inside a feed frame as 
well as to evaluate the possibility of the transfer of calibration model from lab to production 
and from one batch to another. The impact of selecting different wavelength ranges and 
different spectral pre-treatments on the qualitative (principal component analysis - PCA) and 
quantitative (partial least square - PLS regression) models has also been studied. More 
specifically, the effect of spectral pre-treatments on the NIRS baseline was evaluated to study 
the feasibility of calibration model transfer. Since spatial concentration variations inside the 
feed frame are the main indicator of segregation of the active ingredient, a model was built to 
predict the concentrations in different sections of a feed frame using NIR CI (line scan). 
Quantitative concentration predictions by NIRS-based PLS models inside the feed frame are 
compared with NIR CI (line scan)-based predictions. Finally, concentration change kinetics 
for Ibuprofen and Ascorbic acid are compared by both NIRS and NIR CI (line scan) methods 
to compare relative performance of NIR CI (line scan) and NIRS to detect concentration 
change inside the feed frame.  
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6.2 Materials and methods 
 Experimental work was carried out in 2 stages, off-line (away from tablet press, just 
using a table top feed frame set-up) and in-line (using feed frame on tablet press).  
6.2.1 Materials 
 Materials used in this study consisted of Ibuprofen coated pellets (Adare 
pharmaceuticals, Vandalia, Ohio, USA), Ascorbic acid granules (DSM, Jiangsu, China), 
mannitol (Roquette, Keokuk, IA, USA), microcrystalline cellulose (Avicel PH 101
r
, FMC 
biopolymer, Philadelphia, PA, USA), sodium starch glycolate (Roquette, Lestrem, France), 
colloidal silicon dioxide (Aerosil
r
 200 pharma, Evonik, Parsippany, NJ, USA) and magnesium 
stearate (Mallinckrodt, St. Louis, MO, USA). Particle size of Ibuprofen pellets (d80), mannitol 
(d85), microcrystalline cellulose (d90) and Ascorbic acid granules (d70) was 420-177 µm, 
500-104 µm, 77-156 µm and 150-850 µm respectively. In Ibuprofen pellets, 2% of total 
particles were larger than 420 µm, while in Ascorbic acid granules, 20 % of the particles size 
was above 850 µm. 
6.2.1.1 Formulation composition  
 Tablet blend composition in the present work consisted of 2 active ingredients at 
different concentrations namely Ibuprofen (available in pellet form coated with gelatin and 
cellulose acetate phthalate) and Ascorbic acid (available in granule form). Seven (7) blends 
with varying content of Ibuprofen and Ascorbic acid were prepared ensuring nonlinear change 
with respect to one another. All excipients other than magnesium stearate compensated the 
change in weight of Ibuprofen pellets and Ascorbic acid granules as shown in table 1. Bulk 
excipient (mannitol and microcrystalline cellulose) concentrations were varied in proportion to 
Ascorbic acid and Ibuprofen, while minor excipients (colloidal silicon dioxide, sodium starch 
glycolate and magnesium stearate) were maintained at the same concentration for all blends. 
Batch size was set to 12.0 kg, due to equipment capacities, desired tablet compression rate and 
the time necessary for concentration stabilization inside the feed frame. During the blend 
preparations all ingredients except magnesium stearate were added in the V blender (Patterson 
Kelly, USA) and rotated for 15 min at 26 rpm. Following this, magnesium stearate was added 
and mixing continued for 2 more minutes. At the end of mixing, all blends were transferred in 
a double lined polythene bag and used for tablet compression. 
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Table 6.1: Formulation composition with different levels of Ibuprofen and Ascorbic acid (all 
concentration values are in % w/w) 
Blend composition A B C D E F G H I 
Ibuprofen pellets 8.0 8.0 8.0 12.0 5.0 12.0 10.0 6.5 10.0 
Ascorbic acid granules 0.0 5.0 15.0 0.0 0.0 10.0 7.5 2.5 5.0 
Mannitol 75.4 71.0 62.3 71.9 78.0 63.1 67.1 74.5 69.3 
Microcrystalline cellulose 10.8 10.2 8.9 10.3 11.2 9.1 9.6 10.7 9.9 
Colloidal silicon dioxide 2.4 2.4 2.4 2.4 2.4 2.4 2.4 2.4 2.4 
Sodium starch glycolate 2.4 2.4 2.4 2.4 2.4 2.4 2.4 2.4 2.4 
Magnesium stearate 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 
 
 As shown in table 6.1. Ibuprofen pellet content was varied in the range of 0-12 % which 
in reality corresponded to 0-10.2 % w/w Ibuprofen, considering pellet assay value (85 % w/w 
Ibuprofen). For Ascorbic acid, concentration varied from 0-15 % which corresponded to 0-
13.5%, considering Ascorbic acid granules assay (90% w/w of Ascorbic acid). However, 
blends are referred herein according to total % w/w Ibuprofen pellet and Ascorbic acid 
granules content. Random blend order with respect to both active ingredient concentrations 
was adopted during tablet compression to minimize concentration change correlation of the 
two active ingredients. Blend compositions A-J described in Table 1 also presents the order in 
which blends were processed. Smallest step change in Ibuprofen and ascorbic acid 
concentrations occurred between blend F-G and H-I/F-G while highest step change occurred 
between D-E/E-F and C-D respectively. Such a sequence allowed to study the NIRS response 
to varying concentrations inside the feed frame as well as to clearly outline the 5 steady states 
in order to help quantify step-change dynamics. During the off-line testing, blends A-F were 
used in the preparation of PLS calibration models while blends G-I were used in validation of 
these models. Blends G-I were prepared by mixing 300 gm of blend from each of C and D, B 
and E, A and F respectively. 
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6.2.2 Equipment and Methods 
6.2.2.1 Feed frame monitoring (In-line) 
This study used a Manesty Novapress 37-station rotary tablet press with a feed frame. Details 
of feed frame design are reported in earlier publication [123].  
  
Figure 6.1 : NIRS and NIR CI (line scan) location on the feed frame  
 The NIR probe was placed above the second wheel just before the point where powder 
exits the feed frame and enters the die cavities for compression. The NIR Camera and its 
attached spectrograph were positioned just before and as close as possible to the NIR probe. 
The NIR probe tip was positioned using a micrometer screw ensuring its contact with the 
powder while preventing contact with the paddle wheel. In order to study the impact of the 
position of the NIR probe with respect to the paddle distance, off-line testing was performed 
with a probe to paddle distance of 8 mm while in-line testing was performed with a probe to 
paddle distance of 2 mm. For the NIR CI (line scan), the feed frame to spectrograph distance 
was adjusted to maximize the desired feed frame area in the captured images. Data acquisition 
was triggered by a sensor attached to the feed frame shaft. Two NIR spectra and NIR CI (line 
scan) were recorded at each rotation of the paddle wheel. NIRS probe and NIR CI (line scan) 
parameters with respective acquisition settings are listed in table 6.2. 
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Table 6.2: NIR spectral acquisition parameters 
PAT tool 
Spectral 
range (nm) 
Resolution 
(nm) 
Integration 
time per 
spectra (ms) 
Number of 
spectra 
averaged 
Total 
integration 
time (ms) 
Viavi NIR 
probe 
915-1701 6 5 50 250 
NIR Camera + 
Spectrograph 
900-1700 3 3 1 3 
 
 600 gm of the powder sample was taken from each respective blend and used for off-line 
test while remaining blend was used in the in-line test. During the off-line test, each blend was 
added sequentially in a closed feed frame rotated at 20 rpm and NIRS as well as NIR CI (line 
scan) signals were collected at a rate of two per revolution of paddle wheel. After collecting 
NIR spectral data for 10 min, care was taken to completely remove the respective blend before 
adding the next one inside the feed frame. 
 During the in-line tests, tablet compression was performed at a rate of 18360 tablets per 
hour (17 stations at 18 rpm). Feed frame paddle wheel rpm was adjusted at 18 rpm to obtain 
consistent tablet weight. NIRS spectra and NIR CI (line scan) were recorded at a rate of one 
per revolution of feed frame paddle wheel. Throughout this publication, this in-line test is 
referred to as first in-line tests.  
 Data from earlier in-line tests were used for the calibration model transfer from one 
batch to another. In this case, tablets were compressed at a rate of 23,460 per hour. Feed frame 
paddle wheel rpm was adjusted at 13 rpm to obtain consistent tablet weight. NIR probe was 
located 8 mm away from the paddle wheel. 1 NIR signal was collected at each revolution of 
the paddle wheel. Other details of the composition and set up can be found in earlier 
publication. Throughout this publication, this in-line test is referred to as second in-line test.  
6.2.2.2 NIRS data acquisition and pre-treatment 
 Before NIRS data acquisition, the intensity of the NIR probes (Viavi) was calibrated 
between 0 and 100% reflectance. For the 0% set-up, a NIR spectrum was acquired in absence 
of infrared light while for the 100% set-up, NIR spectrum was recorded while the intensity of 
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the NIR beam was set at 100% reflectance. Every raw spectrum acquired during the trials was 
corrected between 0% and 100% reflectance standards (equation 6.1): 
                𝐶 =
𝑅−𝐷
𝐵−𝐷
       (6.1)           
where C is the corrected spectra, R is the raw spectra, D is the 0% reflectance (dark) standard 
and B is the 100% reflectance (bright) standard. 
 Collected NIR spectra inside the feed frame contained Ibuprofen and Ascorbic acid 
concentration information; but were tainted by other variables detrimental to the building of 
PLS models, such as variations in material movement at different paddle speeds, powder to 
probe distance and difference in particle sizes. In order to remove the unwanted spectral 
features, spectral pre-treatments such as standard normal variate (SNV- for scatter correction), 
Savitzky-Golay first derivative (SG-D1), Savitzky-Golay second derivative (SG-D2- for 
resolving peak overlap, eliminating linear baseline drift between samples), multiple scatter 
correction (MSC- for minimizing baseline offsets and multiplicative effect), centering and 
scaling to unit variance (CS) as well as subtracting a polynomial fit to reduce any baseline 
variation were evaluated for their suitability in qualitative and quantitative analysis 
(calibration as well as prediction). 
6.2.2.3 NIR CI (line scan) data acquisition and pre-treatment 
 An observation window (Figure 6.2a) was made across the width of the feed frame 
which allowed having NIR CI (line scan) covering the entire powder region (40×3 mm) inside 
the feed frame. NIR CI (line scan) output was obtained in the form of 256×320 matrix (Figure 
6.2b) in which X-axis represented spatial dimension while Y-axis represented spectral 
information, with a resolution of 143 micron per pixel. The intensity of all of the NIR CIs was 
corrected with a white and dark standard which were recorded just before the start of sample 
data acquisition each time to standardize pixel intensities. The intensity of each NIR CIs was 
averaged over the spatial axis to get an output spectrum (Figure 6.3c). Thus powder area of 
40×3 mm was represented by a single spectra as against of NIRS which represent powder area 
of 15×4 mm.  Spectral axis of the NIR CI (line scan) was calibrated using the spectrum 
obtained from images of known spectral standards. 
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Figure 6.2: a) Location of the observation window on the feed frame, b) NIR CI (line scan) 
output image and c) NIR spectra obtained by averaging all of the image pixels.  
 NIR CI (line scan) data was affected with certain unwanted variable such as variation in 
NIR light intensity, powder density changes under circulation inside feed frame which were 
likely to create a bias in the predictability of the calibration models from off-line to in-line 
samples, thus various spectral pre-treatments as mentioned in section 6.2.2.2 were used to 
remove the spectral artifacts. 
6.2.2.4 NIRS Wavelength selection 
 Excipients or other ingredients with strong NIR absorbance (e.g. water/moisture) at the 
same range or in the vicinity of the interested NIR range can either mask or change the shape 
of active ingredient NIR absorbance spectra. Earlier studies using a single filter NIR CI 
(global) for Ascorbic acid (chapter 3) and NIRS of Ibuprofen (chapter 5) gave an indication 
for wavelength selection in the present work. However in these cases, powder blends had only 
one ingredient of interest, with little possibility of spectral overlap or interactions. For the 
purpose of NIR wavelength selection, characteristic spectral bands of Ibuprofen and Ascorbic 
acid were determined via the Savitzky-Golay second derivative spectral plot (Figure 6.3). 
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Figure 6.3: Savitzky-Golay second derivative spectra of Ibuprofen and Ascorbic acid 
 Both Ascorbic acid as well as Ibuprofen show characteristic peak shapes in NIR spectral 
region between 1000-1700 nm, but show higher or lower NIR absorbance in certain regions, 
e.g. 1020 to 1200 nm (Ibuprofen) and 1350 to 1550 nm (Ascorbic acid) making it possible to 
differentiate respective concentrations using these ranges. In the composite blends however, 
other ingredients dilute these spectral differences which can have an influence on the 
evaluation of the concentration of the active ingredient in the tablet blend. 
 Figure 6.4(a) shows key individual ingredients’ NIR spectra while figure 6.4(b) shows 
NIRS spectra and 6.4(c) shows NIR CI (line scan) spectra of all the blends used in the study. 
Comparison of individual and composite blend NIR spectra reveals that Mannitol dominates 
the NIR spectra. This is to be expected as it is present in the highest concentration of all 
ingredients of the blends (≈ 70 wt %).  PCA was used to select the spectral wavelengths and 
pre-treatments to be included in the quantitative analysis, focusing on the spectral range of 
each active’s peculiar peaks as well as the spectral the range in their vicinity. A suitable NIR 
range and pre-treatment was determined based on the criteria that changes in principal 
components score values exhibit the changes in concentration of the respective active in the 
blends.  
 Wavelength ranges 1020-1305, 1020-1212 and 1100-1250 nm were evaluated for 
Ibuprofen while 1373-1701, 1354-1552 and 1472-1602 nm were evaluated for Ibuprofen. 
Wavelength ranges and respective pre-treatments which showed desired concentration trends 
in PCA scores were selected further for quantitative analysis using PLS. Calibration model 
parameters such as the root mean square error of calibration (RMSEC), root mean square error 
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of cross validation (RMSECV) and root mean square error of prediction (RMSEP) for 
predicted concentrations were used to evaluate the suitability of the wavelengths selection for 
the quantitative models. 
 
 
Figure 6.4: a) NIRS spectra of key ingredients of the tablet composition and b) NIRS spectra 
c) NIR CI (line scan) spectra of all blends in off-line trial 
6.2.2.5 PLS calibration and validation models 
 For off-line test, PLS calibration models (based on NIRS as well as NIR CI (line scan)) 
for Ascorbic acid and Ibuprofen were prepared using blend samples A-G and validated using 
blend samples H-J prepared only for the purpose of validation in off-line test. These validated 
calibration models were used for predicting the concentration of Ibuprofen and Ascorbic acid 
in the respective data (NIRS and NIR CI (line scan)) of the in-line test. The intention here was 
  
 
130
to show the feasibility of PLS calibration transfer from lab to production (i.e. off-line to in-
line). 
6.2.2.6 Comparison of NIRS and NIR CI (line scan) predictions inside feed frame  
 As mentioned earlier, NIR CI (line scan) gives an image covering the entire powder 
surface in horizontal direction (40 mm) of the feed frame, while covers only 3 mm in powder 
flow direction. While NIR probe observation window size is 15×4 mm. NIR probe is placed in 
the middle of feed frame horizontal cross section. Thus, the powder area tested by NIRS is 
comparable with middle section of NIR CI (line scan) when divided in 3 equal parts. Thus, 
PLS model predicted concentrations of ascorbic acid and ibuprofen at the middle sections NIR 
CI (line scan) are compared to concentrations predicted by NIRS as well as the expected 
concentrations using the root mean square error (RMSE). 
6.2.2.7 Sample volume inside feed frame 
 The NIR sample volume is an important parameter to study the level of scrutiny in in-
line process monitoring since the effective sample volume in blend uniformity analysis should 
be comparable to a unit dose [22]. The sample volume was estimated using the NIRS sample 
area/spot size of NIRS probe, integration time, material bulk density and NIR penetration 
using equation 6.2. 
𝑆𝑎𝑚𝑝𝑙𝑒 𝑉𝑜𝑙𝑢𝑚𝑒 = 𝐴 × 𝐵 × 𝐶     (6.2) 
where A is the NIRS sample area, B is the NIR penetration depth, and C is the sample bulk 
density. 
 Inside the feed frame, the NIRS sample area and total integration time was 15 × 5 mm 
and 5 ms respectively. Each NIR spectra was averaged over 50 spectra, thus total integration 
time is 250 ms.  The sample area was calculated considering the material movement within 
this time based on the feed frame rpm. The NIR penetration depth was considered as 1.5 mm, 
according to earlier studies [123]. In the case of NIR CI (line scan), the sample area covered 
by each image was 40 × 3 mm, while NIR penetration depth was considered as 0.75 mm based 
on earlier studies [123]. 
 Sample volume tested by NIRS was found to be 67.5 mg while NIR CI tested 47.25 mg. 
Sample volumes in case of NIR CI (line scan) is slightly lower than NIRS, mostly due to 
higher NIR penetration depth in NIRS compared to NIRS. However, larger length of sample 
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helps in efficient concentration monitoring owing to complete powder sample coverage in the 
horizontal direction. 
6.3 Results and discussion 
6.3.1 Off-line NIRS PLS calibration models 
 NIRS PLS model parameters using 1020-1305 nm wavelength range, SNV, SG-D1, 
centering and scaling in spectral pre-treatments gave the best PLS model for Ibuprofen, i.e. 
lowest RMSEC, RMSECV and RMSEP values as 0.33, 0.33 and 0.41 % w/w Ibuprofen 
respectively. An adjusted R
2
 (R
2
adj) value of 0.98 (with 3 latent variables) also showed a good 
model fit to the calibration data. 
 In the case of Ascorbic acid, suitable wavelength range was found to be 1373-1701nm 
with SNV, SG-D1, centering and scaling in spectral pre-treatments. PLS model parameters 
like RMSEC, RMSECV and RMSEP showed values of 0.54, 0.54 and 0.80 % w/w Ascorbic 
acid respectively while R
2
adj was 0.98 (with 3 latent variables). These PLS model parameters 
indicated good model fit and model performance for Ascorbic acid calibration and validation 
samples respectively.  
 PLS models for both the actives show similar level of fit to calibration data based on 
R
2
adj using 3 latent variables. PLS model parameters like RMSEC, RMSECV and RMSEP are 
slightly higher for Ascorbic acid than Ibuprofen indicating slightly higher sample to sample 
variation in case of Ascorbic acid. These variations could be attributed to wide particle size 
distribution of ascorbic acid (more details on PSD are given in section 6.2.1). However, 
considering the concentration levels of the Ascorbic acid in the current formulations these 
values are well acceptable.  
 Figure 6.5a and 6.5b show that the PLS model predicted concentrations are closely 
distributed around the expected concentration for both the active ingredients. The optimal 
wavelength range showing good model fit and concentration prediction for Ibuprofen (i.e. 
1020-1305 nm), is comparatively broader than the earlier wavelength range (1100-1250 nm-
chapter 4) useful to precisely quantify the different Ibuprofen concentrations where it was 
single active of interest. Thus, it appears that in the presence of multiple ingredients, a broader 
spectral range selection outperforms the use of a few characteristic peaks of individual active 
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when building a quantitative model. This is attributed to masking influence of other 
components on the NIR peak of active. 
 
 
Figure 6.5: NIRS PLS predicted a) Ibuprofen and b) Ascorbic acid concentrations in 
calibration and validation samples 
6.3.2 Off-line NIR CI (line scan) PLS calibration models 
 NIR CI (line scan) PLS model for Ibuprofen using 1018-1213 nm wavelength range and 
SG-D1, SNV followed by scaling to unit variance and centering in pre-treatment exhibited 
good PLS model parameters i.e. RMSEC, RMSECV and RMSEP of 0.59, 0.59 and 1.05 
respectively. R
2
adj value using 3 latent variables was 0.94 which is slightly lower than the 
NIRS PLS model. The RMSEC, RMSECV and RMSEP values are also slightly higher than 
the NIRS PLS model. This indicates that NIR CI (line scan) PLS model is slightly less precise 
in comparison to NIRS. 
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 In case of Ascorbic acid, wavelength range between 1372-1701 nm with SNV, SG-D2 
followed by mean center (MC) gave good model parameters i.e. RMSEC, RMSECV and 
RMSEP as 1.01, 1.02 and 1.05 respectively. R
2
adj using 3 latent variables, was 0.96 which is 
slightly lower than the NIRS PLS model.  
 For Ascorbic acid, the same wavelength range (1372-1701 nm) as in NIRS was found 
suitable for NIR CI (line scan) while in case of Ibuprofen, slightly lower wavelengths 
exhibited better PLS model parameters. Visual comparison of PLS calibration and validation 
concentration plots of NIR CI (line scan) (Figure 6.6a, 6.6b) with NIRS (Figure 6.5a, 6.5b) 
reveals that Ibuprofen concentrations show similar spread around the expected concentration 
while Ascorbic acid concentrations show comparatively higher spread around the expected 
concentration. 
 
Figure 6.6: NIR CI (line scan) PLS predicted a) Ibuprofen and b) Ascorbic acid 
concentrations in calibration and validation samples 
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6.3.3 Comparison of NIRS and NIR CI (line scan) for concentration prediction 
RMSE in NIRS PLS concentration predictions 
RMSE values calculated between NIRS predicted and expected concentrations showed that 
NIRS PLS model for Ibuprofen has RMSE value of 0.25 while for Ascorbic acid RMSE value 
was 0.64 indicating that Ibuprofen concentrations were predicted close to expected 
concentration than the Ascorbic acid. The difference in RMSE values is attributed to wider 
particle size distribution of Ascorbic acid in the blend as compared to Ibuprofen which leads 
to slightly higher spectrum to spectrum variance. However these values are less than 1.0 % 
w/w which is deemed acceptable in the present case. 
RMSE in NIR CI (line scan) PLS concentration predictions 
 RMSE values between expected concentrations and NIR CI (line scan) predicted 
Ibuprofen and Ascorbic acid concentrations were found as 0.78 and 1.03 respectively. These 
values are slightly higher than NIRS PLS models but acceptable owing to the concentration 
levels of respective actives in the present formulations. RMSE values between NIRS PLS 
predicted concentrations and NIR CI (line scan) predicted Ibuprofen and Ascorbic acid 
concentrations were found as 0.72 and 1.21 respectively. Comparatively the RMSE values 
shown by NIR CI (area scan) at similar concentration levels of Ibuprofen were in the range of 
2-3 (section 4.2); this shows that signal-to-noise ratio is better in case of NIR CI (line scan) 
than NIR CI (area scan). 
Variance comparison 
 Variation in the NIRS and NIR CI (line scan) predicted concentrations were assessed to 
compare signal-to-noise ratio in the collected spectral data assuming all the blends were 
uniform and only interference in model prediction is signal-to-noise ratio in collected data. As 
seen from figure 6.7 and 6.8, NIR CI (line scan) predicted concentrations show higher 
variance than NIRS predicted concentrations for both the actives. Variance in Ibuprofen 
concentration prediction at similar concentration levels using NIR CI (area scan) was more 
than 3 (Figure 5.4) while the variance with NIR CI (line scan) PLS models, it is less than 0.45 
(% w/w)
2
 of Ibuprofen. This indicates that NIR CI (line scan) gives more precise sample 
information than NIR CI (area scan). 
 NIR CI (line scan) PLS predicted Ascorbic acid concentrations show higher variance 
than Ibuprofen, indicating that sample-to-sample variance in case of Ascorbic acid is higher. 
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As mentioned earlier, it is attributed to image to image variation in the surface distribution of 
Ascorbic acid due to wide particle size distribution, when a particularly larger granule of 
Ascorbic acid is on the surface the predicted concentration is comparatively higher than the 
average blend concentration. Other factors that contribute to higher sample-to-sample 
variation are the sample surface area tested by NIR CI (line scan) is larger than NIRS and 
lower NIR penetration depth value in NIR CI; which is found as 0.75 mm (chapter 3) with 
NIR illumination source used in this work. Collectively these factors make NIR CI sensitive to 
surface distribution of active particles when particle size variation in the sample is higher. In 
the present samples Ascorbic acid has wider particle size distribution than Ibuprofen (section 
6.2.1). 
 Variance in NIR CI (line scan) predicted Ibuprofen concentration was not drastically 
higher than NIRS since it has more uniform particle size as compared to Ascorbic acid. 
However, variance in NIR CI (line scan) predictions is still slightly higher than NIRS which 
points to comparatively smaller signal-to-noise ratio in NIR CI (line scan) than NIRS. 
Comparative study of variance values helps to signify importance of particle size, tested 
sample area and NIR penetration depth in the sample for NIR PLS model performance. 
 Irrespective of small differences as discussed above for NIRS and NIR CI (line scan) 
predicted concentrations, the off-line PLS calibration models proved that both these actives 
(Ascorbic acid and Ibuprofen) can be simultaneously quantified without interference from the 
other. 
 
Figure 6.7: Variance in predicted Ibuprofen concentrations comparing NIR CI (line scan) and 
NIRS PLS models 
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 Figure 6.8: Variance in predicted Ascorbic acid concentrations comparing NIR CI (line 
scan) and NIRS PLS models 
6.3.4 Calibration model transfer off-line (lab) to in-line (production) 
 Following the successful concentration predictions in the off-line testing, the best 
performing calibration models (both NIRS and NIR CI (line scan)) were used to predict 
Ibuprofen and Ascorbic acid in the in-line tests.   
 The blends used to make off-line calibration models were taken from the same bulk 
blends which were used in the in-line test, thus respective off-line PLS models were expected 
to predict exactly the same concentrations during the in-line test. However, it was found that 
the predicted in-line concentration was slightly off the expected concentrations. The trend in 
the concentration variations was predicted well but the absolute values of the concentrations 
were shifted either to lower or higher values. The shift in NIRS predicted concentrations were 
comparatively smaller than the concentrations predicted by NIR CI (line scan). 
 Off-line PLS models do not give the desired predictions as expected from blend 
concentrations, probably due to additional variations in the NIR spectral data as a result of 
different experimental conditions such as paddle wheel rpm, probe to paddle distance, etc. 
Careful examination of the NIRS and NIR CI (line scan) spectra showed differences in 
spectral baseline between off-line and in-line test samples. The baseline shift between the off-
line and in-line NIRS tests is attributed to the differences in the paddle to powder distance as 
well as in feed frame paddle wheel rpm. For the off-line test, NIR probe was 8 mm away from 
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paddle wheel while for the in-line test it was 2 mm away from the paddle. The feed frame rpm 
for the off-line and the in-line test was 24 and 17 respectively.  
 Presence of baseline variation in the NIR CI (line scan) data indicates that in addition to 
the feed frame variables (e.g. paddle speed), other parameters such as NIR light intensity and 
sample illumination are also important variables in the successful transfer of NIR CI (line 
scan)-based PLS calibration model.  In order to remove the baseline shifts, spectral pre-
treatments were applied and assessed based on the difference between the expected and 
predicted concentrations. The removal of the baseline shift, or detrending, was performed 
through a subtraction of a linear or polynomial fit of the baseline from the Ibuprofen and 
Ascorbic acid NIR and NIR CI (line scan) spectra in addition to other spectral pre- treatments.  
 Off-line NIRS PLS model with 3 latent variables for Ibuprofen using 1020-1305 nm 
wavelength range, SG-D1, detrend (offset), SNV, centering and scaling in spectral pre-
treatment showed R
2
adj value of 0.98 while RMSEC and RMSECV of 0.36 and 0.36 
respectively.  NIRS PLS model with 3 latent variables for Ascorbic acid using 1373-1701 
nm wavelength range, SG-D1, detrend (6
th
 order), SNV, centering and scaling in spectral pre-
treatment showed R
2
adj value of 0.99 while RMSEC and RMSECV of 0.56 and 0.56 
respectively. This indicates that there is no significant impact of additional baseline removal 
on the earlier off-line PLS models (section 6.3.2) except that the new models are now capable 
to predict in-line concentrations without any shift in values. 
 In case of NIR CI (line scan), PLS model with 3 latent variables for Ibuprofen using 
1018-1213 nm wavelength range, SG-D2, SNV, detrend (6
th
 order), centering and scaling in 
spectral pre-treatment showed R
2
adj value of 0.93 while RMSEC and RMSECV of 0.68 and 
0.68 respectively. Off-line PLS model with 3 latent variables for Ascorbic acid using 1372-
1701 nm wavelength range, SNV, SG-D2, detrend (5
th
 order), centering and scaling in spectral 
pre-treatment showed R
2
adj value of 0.96 while RMSEC and RMSECV of 1.13 and 1.14 
respectively. Again these parameters show that off-line NIR CI (line scan) PLS calibration 
models are not much impacted by additional spectral pre-treatments. 
6.3.5 Comparison of NIRS and NIR CI (line scan) predictions inside feed frame 
 Owing to the complete spatial coverage of feed frame powders by NIR CI (line scan), it 
is possible to predict active concentrations over different sections of the feed frame; especially 
to compare similar powder region tested by both NIRS and NIR CI (line scan). Off-line NIR 
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CI (line scan) PLS models were used to predict the Ibuprofen and Ascorbic acid 
concentrations at middle section NIR CI (line scan) that resembled NIRS tested region inside 
the feed frame. The plot of the NIRS and NIR CI (line scan in the middle section) PLS model 
predicted concentrations of Ibuprofen (Fig 9a) and Ascorbic acid (Fig 9b) together with 
expected concentrations helped to visualize active concentration in respective section as well 
as the comparative accuracy of NIRS and NIR CI (line scan). 
 
 
Figure 6.9: a) Plot of NIR CI (line scan) (in the middle section) and NIRS predicted 
concentrations for Ibuprofen b) Plot of NIR CI (line scan) (in middle sections) and NIRS 
predicted concentrations for Ascorbic acid 
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 NIR CI (line scan) PLS model predicted concentrations of Ibuprofen and Ascorbic acid 
are compared between the methods as well as with the expected concentrations and the NIRS 
predicted concentrations to evaluate the closeness of the predicted concentrations with the 
expected concentrations as well as with the NIRS predicted concentrations. 
Table 10 RMSE values for comparison between different image sections, NIRS predicted and 
expected concentrations inside the feed frame. 
Table 6.3: RMSE for Ibuprofen concentration prediction (% w/w) 
RMSE comparison between 
Expected concentration 
(% w/w) 
NIRS PLS predicted 
concentration (%w/w) 
NIR CI (line scan) middle section 1.35 0.52 
NIRS 1.20 0 
Table 6.4: RMSE for Ascorbic acid concentration prediction (% w/w) 
RMSE comparison between 
Expected concentration 
(% w/w) 
NIRS PLS predicted 
concentration (%w/w) 
NIR CI (line scan) middle section 1.49 0.99 
NIRS 1.24 0 
 As seen from the Figure 6.10a-b as well as RMSE values (table 6.4 and 6.4), Ibuprofen 
concentrations in middle section of the NIR CI (line scan) are close to NIRS predicted 
concentrations while both NIRS and NIR CI (line scan) predicted Ibuprofen concentrations are 
equally close to expected concentrations.  
 Comparatively, Ascorbic acid RMSE values are slightly higher than Ibuprofen 
concentrations but the middle section of the NIR CI (line scan) is still close to NIRS predicted 
concentrations and both NIRS and NIR CI (line scan) predicted Ascorbic acid concentrations 
are equally close to expected concentrations. This shows the comparability of NIR CI (line 
scan) and NIRS models for the feed frame monitoring. 
6.4 Conclusion 
 Present work successfully shows that NIR CI (line scan) is capable for concentration 
monitoring in comparison to NIRS for more than one component in a complex pharmaceutical 
  
 
140
composition. Off-line calibration models can be used to predict in-line concentrations using 
suitable spectral pre-treatments to remove baseline variations from the collected NIRS and 
NIR CI (line scan) data which are caused by experimental factors such as probe to powder 
distance, paddle wheel speed leading to density change, NIR light intensity variation as well as 
NIR illumination of powder samples. In addition to concentration prediction NIR CI (line 
scan) offers spectral data similar to NIRS covering entire powder sample along the horizontal 
direction. Considering the circular powder movement inside the feed frame, radial segregation 
of the powder is more prone to happen and may likely remain undetected by the NIRS which 
samples the powder just over a small area. NIR CI (line scan) data can be divided into several 
sections across the width of feed frame to probe the segregation. 
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CHAPTER 7 CONCLUSION 
Pharmaceutical manufacturing is undergoing a phenomenal change in order to meet the 
regulatory expectations in terms of process understanding, monitoring, and control. 
Consequently, different PAT tools are being introduced in order to monitor the various 
manufacturing processes with the intent to increase process understanding and implementing 
process controls. In case of tablet manufacturing, feed frame monitoring during tablet 
compression has been much less studied than blending, granulation, milling, and drying which 
have been extensively studied and monitored. Although in the recent years NIRS PAT based 
feed frame monitoring has been initiated, to be a robust PAT tool, it needs further exploration 
owing to certain variables (e.g. location NIR of probe, paddle wheel speed, probe to powder 
distance, etc.) impacting NIRS performance for concentration predictions as reported in earlier 
studies. In addition there is a need for evaluating other potentially useful tools that may allow 
overcoming limitations of NIRS (e.g. smaller sample test area, lack of spatial information). 
 The present work concentrated on the introduction of NIR CI (area scan and line scan) 
as alternate PAT tool for feed frame monitoring while using NIRS as a reference method since 
it is already reported for this purpose. NIRS is studied to gain more understanding on its 
implementation for the feed frame monitoring a well subsequent tablet monitoring. Initial 
work aimed at evaluating the feasibility of NIR CI (area scan) using discrete wavelength band 
filters in a simple blend (comprising 3 components) as well as optimizing the sample 
presentation inside the feed frame. These off-line studies showed the usefulness of NIR CI 
(area scan) for concentration prediction in comparison to NIRS as well as to verify segregation 
potential of the powder blend inside the feed frame. Tested sample volume was seen 4 times 
than the NIRS although NIR probe in the present study is specially designed for feed frame 
monitoring with larger sample window (15×4 mm). 
Following the successful feasibility of NIR CI (area scan), later studies concentrated on its 
evaluation to monitor in-line a pharmaceutically relevant complex blend comprising 1 active 
ingredient and 5 non-active ingredients. NIRS was used as reference inside feed frame and 
later to test compressed tablets in an in-line manner. Stratified tablet samples were also tested 
with off-line NIRS as well as UV assay to verify concentrations predicted inside the feed 
frame. Kinetics of concentration change inside feed frame and compressed tablets were 
compared to understand the implication of NIRS position as well as feed frame design in 
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concurrent concentration kinetics of feed frame and tablets. Results show that NIR CI (area 
scan) captures successfully all the concentration changes inside the feed frame but owing to 
multiple ingredients inside the blend the signal-to-noise ratio is slightly lower than NIRS. Due 
to the design of feed frame and NIR probe position, there was a delay in the onset of 
concentration change in the tablets from the moment it is first seen in feed frame. This 
information is very useful in continuous manufacturing where one can take preventive action 
well in advance to avoid mixing of uniform tablets with non-uniform tablets. 
Later work aimed to further evaluate NIR CI (line scan) using spectrograph giving 
spectral information similar to NIRS while enhancing the spatial coverage of the tested sample 
in a multicomponent monitoring in a complex pharmaceutical blend. Results show that NIR CI 
(line scan) can successfully predict the concentration of 2 components simultaneously in 
comparison to NIRS as well as signal-to-noise ratio is higher as compared to NIR CI (area 
scan). With suitable pre-treatment, off-line calibration models can be transferred to in-line 
monitoring offering saving on the resources in the development of the calibration models. 
Middle section of NIR CI (line scan) shows very close results to NIRS; in addition, owing to 
larger sample coverage it offers an opportunity to test radial concentration profiles inside the 
feed frame to probe radial segregation if present inside the feed frame. 
Overall, this Ph.D. project work successfully evaluates the feasibility of NIR CI for feed 
frame monitoring. In much simpler blends NIR CI (area scan) using single wavelength filter 
could be useful while for complex blends NIR CI (line scan) with spectrograph could be an 
alternate. In addition to increased sample size, NIR CI offers more potential to test adverse 
quality phenomenon such as segregation inside the feed frame. Methodologies and results 
obtained in this work could be definitely useful in the ongoing efforts of the pharmaceutical 
industry to understand, monitor and control the pharmaceutical manufacturing processes and 
to ensure quality by design in the manufactured products. 
Conclusion en Français 
 La fabrication pharmaceutique est en pleine mutation pour répondre aux attentes 
réglementaires en termes de compréhension, de suivi et de contrôle des procédés. Par 
conséquent, différents outils PAT sont introduits afin de surveiller les différents procédés de 
fabrication dans le but d'accroître la compréhension des procédés et de mettre en œuvre des 
contrôles de procédé. Dans le cas de la fabrication de comprimés, les études sur la trémie 
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d’alimentation sont beaucoup moins nombreuses que pour la granulation, le broyage et le 
séchage. Au cours des dernières années, le des études ont débuté sur le contrôle de la trémie 
d'alimentation par la NIRS PAT. Mais pour être un outil PAT robuste, elle doit être explorée 
davantage en fonction de certaines variables (par exemple position de la sonde NIR, vitesse de 
la roue, distance de la sonde au lit de poudre etc.) impactant les performances NIR pour les 
prédictions de concentration telles que rapportées dans des études antérieures. De plus, il y a le 
besoin d’étudier d'autres outils qui pourraient permettre de dépasser les limites de la NIRS (p. 
ex. zone d’analyse plus petite, manque d'informations spatiales). 
 Les travaux actuels se sont concentrés sur l'introduction de la NIR CI en tant qu'outil 
PAT alternatif pour le contrôle de la trémie d'alimentation tout en utilisant la NIRS comme 
méthode de référence puisqu'elle est déjà connue pour cette fin. La NIRS est étudiée pour 
mieux comprendre sa mise en œuvre dans latrémie d'alimentation suivi d'une surveillance 
ultérieure des comprimés. Les premiers travaux visaient à évaluer la faisabilité de la NIR CI 
en utilisant des filtres à bande de longueur d'onde discrète dans un mélange simple 
(comprenant 3 composants) ainsi qu'à optimiser la présentation de l'échantillon dans la trémie 
d'alimentation. Ces études hors ligne ont montré l'utilité de la NIR CI pour la prédiction de 
concentration par rapport à la NIRS, ainsi que pour vérifier le potentiel de ségrégation du 
mélange de poudres dans la trémie d'alimentation. Le volume d'échantillon testé se trouve être 
4 fois plus grand que celui de la NIRS, bien que la sonde NIR dans la présente étude soit 
spécialement conçue pour le contrôle de la trémie d'alimentation avec une fenêtre d'échantillon 
plus grande (15 x 4 mm). 
 Suite à la faisabilité réussie de la NIR CI en format filtre unique, les études suivantes se 
sont concentrées sur son évaluation pour surveiller en ligne un mélange pharmaceutique 
complexe et approprié, comprenant 1 ingrédient actif et 5 ingrédients non-actifs. La NIRS a 
été utilisée comme analyse de référence à l'intérieur de la trémie d'alimentation et plus tard 
pour tester les comprimés en ligne. Des échantillons de comprimés stratifiés sont également 
testés avec la NIRS hors ligne ainsi qu’en UV pour vérifier les concentrations prédites à 
l'intérieur de la trémie d'alimentation. La cinétique du changement de concentration à 
l'intérieur de la trémie d'alimentation et des comprimés a été comparée pour comprendre 
l'implication de la position de la NIRS ainsi que la conception de la trémie d'alimentation dans 
la cinétique de la concentration des comprimés. Les résultats montrent que la IR CI capture 
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avec succès tous les changements de concentration à l'intérieur de la trémie d'alimentation, 
mais en raison de plusieurs ingrédients à l'intérieur du mélange, le rapport signal / bruit est 
légèrement inférieur à celui de la NIRS. En raison de la conception de la trémie d'alimentation 
et de la position de la sonde NIR, il y a eu un retard dans le changement de concentration dans 
les comprimés à partir du moment où il a été vu pour la première fois dans le cadre 
d'alimentation. Cette information est très utile dans la fabrication en continu où l'on peut 
prendre des mesures préventives bien à l'avance pour éviter le mélange de comprimés 
uniformes avec des comprimés non uniformes. 
 Les travaux ultérieurs visaient à évaluer davantage la NIR CI en utilisant un 
spectrographe donnant des informations spectrales similaires à celles de la NIRS tout en 
améliorant la couverture spatiale de l'échantillon testé dans une surveillance multicomposant 
dans un mélange pharmaceutique complexe. Les résultats montrent que la NIR CI peut prédire 
avec succès la concentration de 2 composants simultanément ce qui n’est pas le cas de la 
spectroscopie NIRS, et que le rapport signal sur bruit est plus élevé que la NIR CI à filtre 
unique. Avec un pré-traitement approprié, les modèles d'étalonnage hors ligne peuvent être 
transférés à la surveillance en ligne, ce qui permet d'économiser sur les ressources dans le 
développement des modèles d'étalonnage. La section centrale de la NIR CI montre des 
résultats très proches de la NIRS; En outre, grâce à une plus grande couverture des 
échantillons, il est possible de tester les profils de concentration radiale à l'intérieur de la 
trémie d'alimentation afin de sonder la ségrégation radiale si elle est présente à l'intérieur de 
celle-ci. 
 Dans l'ensemble, ce travail de thèse a permis d'évaluer avec succès la faisabilité de la 
NIR CI pour la surveillance de l'alimentation. Dans des mélanges beaucoup plus simples, la 
NIR CI en format de filtre unique pourrait être utile tandis que pour les mélanges complexes, 
la NIR CI avec spectrographe pourrait être une alternative. En plus de l'augmentation de la 
taille de l'échantillon, la NIR CI offre plus de potentiel pour tester les phénomènes de qualité 
défavorable tels que la ségrégation à l’intérieur de la trémie d’alimentation. Les méthodologies 
et les résultats obtenus dans ce travail pourraient être certainement utiles dans les efforts 
continus de l'industrie pharmaceutique pour comprendre, contrôler et maîtriser les procédés de 
fabrication pharmaceutiques et pour assurer la qualité par la conception dans les produits 
manufacturs. 
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CHAPTER 8 FUTURE PLAN 
 Present work successfully demonstrates the feasibility of NIR CI in dynamic process 
environment during the pharmaceutical tablet manufacturing. Depending upon the expected 
level of scrutiny NIR CI can be implemented in area scan or line scan format. Considering 
present Ph.D. work as a proof of concept for NIR CI based in-line PAT applications, 
pharmaceutical industry can adopt the experimental and analytical methodologies presented in 
this work for monitoring the other manufacturing operations. Future work can be divided in 2 
areas: first for further consolidating NIR CI application in the feed frame monitoring and 
second for evaluating NIR CI for its potential use in other dynamic process monitoring 
applications. 
 Consolidation of NIR CI based feed frame PAT should concentrate on further 
ameliorating experimental set up for longer duration process monitoring during the 
commercial production batches considering factors such as cooling of NIR camera, fixing the 
NIR light, wireless data transfer, sample area variations, and PAT method validation for 
regulatory filing. 
 Further evaluation of NIR CI for pharmaceutical process monitoring can involve the 
other processes during tablet manufacturing (e.g. monitoring of the granulation, compressed 
tablets, etc.) or monitoring the manufacturing processes of other dosage forms such as liquids, 
semisolids. 
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ANNEXES 
A.1 NIRS technology 
The MicroNIR spectrometer from VIAVI is a particular example of such small and handy 
spectrophotometers which have a versatile application potential. Weighing less than 60 g and 
measuring less than 50 mm in diameter, it is more practical to cost-effectively implement as an 
on-line and at-line tool for process development, process transfer, and manufacturing process 
monitoring and control. 
  
Figure A.8.1: MicroNIR in SS housing Figure A.8.2: Working principle of the linear 
variable filter (LVF) 
 The MicroNIR uses a linear variable filter (LVF) component mounted over a diode array 
detector that separates incoming light into individual wavelengths. The working principle of 
the LVF is provided in Figure 3. The spectrometer integrates the light source and readout 
electronics inside a small construction. It can be mounted directly on the window of a blender, 
a fluid bed dryer, or any other process without the need for costly fiber optic probes. It can 
also operate in a wireless configuration, allowing use on rotating blenders for end-point 
monitoring [135].  
 LVF is mounted directly over a linear detector array with multiple pixel elements. Light 
illuminates the LVF & the wavelength transmitted through the filter is dependent on its linear 
position along the filter. Each pixel element of the linear array will detect a specific 
wavelength [136].  
  
 
148
 
Figure A.8.3: Schematic representations of LVF principle 
LVF in MicroNIR is used as the dispersive element versus traditional diffraction based 
spectrometers. The LVF is a dielectric thin-film Fabry-Perot bandpass filter deposited using 
energetic processes, well-known to produce stable and reliable optical components. The LVF 
filter coating used in the MicroNIR is intentionally wedged in one direction. Since the center 
wavelength of the bandpass filter is a function of the coating thickness, the peak transmitted 
wavelength varies continuously along the direction of the wedge [137].  
Table A.9: Properties of Micro NIR spectrophotometer 
Weight  60 grams 
Dimensions  45mm diameter x 42mm height 
Spectral Range Micro NIR 1700:  950 -1650nm 
Number of pixels 128 pixels, 125 points standardized grid 
Optical Resolution  <1.25 % of center wavelength, i.e. at 1000nm wavelength, 
resolution is <12.5nm 
Geometric Resolution  6.25nm per pixel 
Wavelength Accuracy  < 3 nm, as compared to NIST SRM-2036 
Wavelength Repeatability  < 1 nm, as compared to NIST SRM-2036 
Power Requirement  USB powered, <500mA at 5V 
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A.2 SPECTROGRAPH – NIR CI 
 Spectrometers or spectrophotometers are usually able to measure optical spectrum from 
a surface area as one point. This is done either with one detector scanning the spectrum in 
narrow wavelength bands or with an array detector, in which case all the spectral components 
are acquired at once. If one desires to measure the spectrum at several spatial locations of a 
surface, the target under examination or the measuring instrument has to be mechanically 
scanned. Technically it is not possible to simultaneously measure spectral information across a 
2 -dimensional surface matrix, because this would lead to a four-dimensional information 
space (X, Y -coordinates, wavelength, and intensity). This is obviously impossible to realize 
with standard two-dimensional detectors which can register only position and intensity of 
radiation at a time. This leads to the idea of measuring the spatial information across a line 
only (X-axis with a specified length and small but finite width) and the spectral information 
(wavelength and intensity) for each point (pixel) in this line (Fig. A.2.1.). 
 A 3-dimensional information space results that can be measured with an area (matrix) 
detector array connected to a dispersive, stationary spectrograph module. One dimension of 
the detector now constitutes a spatial line image and the other dimension measures the 
spectrum for each line pixel. This is the operating principle of the imaging spectrograph. A 
NIR camera equipped with an imaging spectrometer instrument is capable of simultaneously 
measuring the optical spectrum components and the spatial location of the powder surface. In 
present work spectrograph designed for 900 - 1700nm wavelength range is used to transform a 
NIR camera into a line-scan spectral imaging device. 
 NIR CI was measured in 256 × 320 pixel format where 256 pixels represented spectral 
axis while 320 pixels represented spatial axis. NIR CI taken inside feed frame represented 20 
mm × 36 mm actual feed frame powder area. 20 mm along the powder movement direction 
while 36 mm along the width of feed frame. All image pixels were averaged in spatial 
dimension since powder was in continuous motion and we are interested in radial segregation 
rather than segregation in the direction of the powder movement. The resulting output for each 
NIR CI was a NIR spectrum over 900-1700 nm (Fig. A.2.1.).  
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Figure A.8.4: Schematic representations of NIR CI scanning and output 
 
Figure A.2.2 and A.2.3 shows side and front view of the spectrograph used in this work. 
 
 
Figure A.8.5: Spectrograph side view Figure A.8.6: Spectrograph front view 
(slit is enlarged for visibility) 
 
 
Entrance 
slit 
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A.3 NIRS SPECTAL PRE-TREATMENTS 
 All of the NIRS measurements performed inside the feed frame and the tablets are 
performed in-line manner causing certain variations in the spectra due to sample presentation 
(section 1.3.2). These variations were mostly due to physical parameters such as density 
change, particle size variation, particle shape (inside the feed frame) while hardness variation 
(in case of tablets) as well as probable variation in NIR source intensity over time. The 
contribution of these factors to the recorded NIR spectra is purely non-essential for the present 
purpose of data analysis since concentration monitoring is our main target. Consequently, 
these artifacts were removed from the NIR spectral data using different mathematical pre-
treatments to enhance spectral features [138] as described below. 
a) Standard normal variate (SNV) 
 Standard normal variate (SNV) is a widely known method to reduce spectral distortions 
due to NIR light scattering. SNV centers and scales each spectrum individually, so each has a 
mean equal to 0 and standard deviation equal to 1. SNV removes slope variation from each 
wavelength on an individual basis [139] thus all samples have an equal impact on the model. 
The standard deviation of all of the pooled variables is calculated for a given sample and entire 
sample is normalized using this standard deviation. At the same time, individual spectrum 
mean value is subtracted from each individual value of the spectrum as shown below. 
?̅? =
∑ 𝑥𝑖,𝑗
𝑛
𝑗=1
𝑛
        (A.3.1) 
 
                            𝑤𝑖 = √
∑ (𝑥𝑖.𝑗−?̅?)
2𝑛
𝑗=1
(𝑛−1)
+ 𝛿−1      (A.3.2) 
 
𝑛 is the number of variables,  𝑥𝑖,𝑗 is value of the  j
th
 variable in the i
th
 sample, 𝛿 is user 
definable offset which is meant to avoid over normalization of sample having close to zero 
standard deviation. Default value of the 𝛿 is zero [33] .   
b) Savitzky-Golay smoothing and derivatives 
 Smoothing is a low-pass filter used for removing high-frequency noise from the 
samples. In case of NIR spectra, this operation is done separately on each row of the data 
  
 
152
matrix and acts on adjacent variables. Smoothing assumes that variables which are near to 
each other in the data matrix (i.e., adjacent columns) are related to each other and contain 
similar information which can be averaged together to reduce noise without a significant loss 
of the signal of interest. Savitzky-Golay smoothing fits polynomials of different orders over 
the selected range of variables, which is called as filter size. 
 Derivatives de-emphasize lower frequencies and emphasize higher frequencies thus they 
tend to accentuate noise (high-frequency signal). For this reason, the Savitzky-Golay 
smoothing is used simultaneously as derivative is taken which helps in improving the utility of 
derivatized data. In case of the first derivative, each variable in a sample is subtracted from its 
immediate neighboring variable. This subtraction removes the signal which is the same 
between the two variables and leaves only the part of the signal which is different. When 
performed on an entire sample, a first derivative effectively removes any offset from the 
sample and de-emphasizes lower-frequency signals. A second derivative is calculated by 
repeating the sampling process, which further accentuates higher-frequency features [33]. 
c) Detrend 
 Detrend is useful when constant, linear or curved offset present in the spectral data. 
Detrend fits a polynomial of a given order to the entire sample and removes/subtracts this 
polynomial from the sample data. Considering the fact that detrend fits the polynomial to all 
points of the spectra including baseline as well as signal, it only works well when largest 
contributor to sample spectra is the background interference. On the contrary, if the significant 
contribution to the spectra is from the sample itself then detrend tends to remove useful 
information from the spectra, which obviously not desirable. 
d) Multiple scatter correction (MSC) 
 MSC helps to remove scaling and offset effects from the spectral data. MSC corrects the 
spectra by regressing measured spectrum against a reference spectrum and then correcting 
measured spectrum using slope and intercept of regression fit. The reference spectrum is 
generally the mean spectrum. It defines 𝑋 as column vector corresponding to the raw spectrum 
(i.e. spectrum to be corrected), r as vector corresponding to reference spectrum. These vectors 
are often mean centered using the mean of the respective spectrum as 
  𝑋𝑐 = 𝑥𝑖 − ?̅?        (A.3.3) 
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𝑋𝑐 is mean centered raw spectrum, ?̅? is mean of raw spectra and 𝑥𝑖  is value of the i
th
 
wavelength in sample spectrum. 
𝑟𝑐 = 𝑟𝑖.𝑗 − ?̅?        (A.3.4) 
𝑟𝑐 is mean centered reference spectrum, ?̅? is mean of reference spectrum and 𝑟𝑖 is value of the 
i
th
 wavelength in reference the spectrum. 
The multiplicative factor (b) is found as:   
𝑟𝑐 = 𝑏𝑋𝑐         (A.3.5) 
              𝑏 = (𝑟𝑐
𝑇𝑟𝑐)
−1𝑟𝑐
𝑇𝑋𝑐        (A.3.6) 
The corrected spectrum ?̂? is given by; 
       ?̂? = 𝑋𝑐 𝑏⁄  +  ?̅?        (A.3.7) 
e) Centering and scaling to unit variance 
 Centering and scaling to unit variance also called as ‘autoscale’ is a column-wise pre-
treatment which makes the spectral data ready for multivariate model analysis. The 
mathematical treatment involves subtracting column mean and then dividing each column 
(variable) by the standard deviation of the column, consequently each column in the resulting 
data matrix has mean of zero and standard deviation of one 
  155 
REFERENCES 
[1] R.A. Nash, A.A. Wachter, eds., Pharmaceutical process validation, 2003rd ed., Marcel 
Dekker, Inc., 2003. 
[2] U.F. Department of Health and Human Service, Guidance for Industry PAT- A 
Framework for Innovative Pharmaceutical Development, Manufacuring, and Quality 
Assurance, 2004. 
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Gui
dances/ucm070305.pdf. 
[3] ICH Expert Working Group, Pharmaceutical Development Q8, ICH Harmon. Tripart. 
Guidel. 8 (2009) 1–28. 
[4] G.A. Van Norman, Drugs, Devices, and the FDA: Part 1: An Overview of Approval 
Processes for Drugs, JACC Basic to Transl. Sci. 1 (2016) 170–179. 
doi:10.1016/j.jacbts.2016.03.002. 
[5] FDA, Pharmaceutical CGMPs for the 21s Century - A risk-based approach, Food Drug 
Adm. (2004) 32. 
http://www.fda.gov/Drugs/DevelopmentApprovalProcess/Manufacturing/Questionsand
AnswersonCurrentGoodManufacturingPracticescGMPforDrugs/UCM071836. 
[6] ICH Expert Working Group, Quality Risk Management Q9, ICH Harmon. Tripart. 
Guidel. (2005) 1–23. doi:10.1007/s11095-007-9511-1. 
[7] ICH Expert Working Group, ICH pharmaceutical quality system Q10, ICH Harmon. 
Tripart. Guidel. (2008) 1–21. doi:EMEA/CHMP/ICH/214732/2007. 
[8] N. Abatzoglou, Pharmaceutical Industry _ University’ R&D collaboration on Process 
Analytical Technologies - European Pharmaceutical Review, Eur. Pharm. Rev. (2010) 
1–9. https://www.europeanpharmaceuticalreview.com/article/1915/pharmaceutical-
industryuniversity-rd-collaboration-on-process-analytical-technologies/. 
[9] P. DURÃO, Monitoring of multicomponent pharmaceutical powders in a compression 
process: development of a robust real time monitoring tools, thése de doctorat 
Université de Sherbrooke, 2017. 
  
 
156
[10] United states pharmacopoeial commision, USP Uniformity of Dosage Forms, 2016. 
http://www.usppf.com/pf/pub/index.html. 
[11] L.M. Kandpal, J. Tewari, N. Gopinathan, J. Stolee, R. Strong, P. Boulas, B.K. Cho, 
Quality assessment of pharmaceutical tablet samples using Fourier transform near 
infrared spectroscopy and multivariate analysis, Infrared Phys. Technol. 85 (2017) 300–
306. doi:10.1016/j.infrared.2017.07.016. 
[12] R.K. May, K. Su, L. Han, S. Zhong, J.A. Elliott, L.F. Gladden, M. Evans, Y. Shen, J.A. 
Zeitler, Hardness and density distributions of pharmaceutical tablets measured by 
terahertz pulsed imaging, J. Pharm. Sci. 102 (2013) 2179–2186. doi:10.1002/jps.23560. 
[13] M.C. Sarraguça, A. V. Cruz, S.O. Soares, H.R. Amaral, P.C. Costa, J.A. Lopes, 
Determination of flow properties of pharmaceutical powders by near infrared 
spectroscopy, J. Pharm. Biomed. Anal. 52 (2010) 484–492. 
doi:10.1016/j.jpba.2010.01.038. 
[14] C. Bodson, W. Dewé, P. Hubert, L. Delattre, Comparison of FT-NIR transmission and 
UV-vis spectrophotometry to follow the mixing kinetics and to assay low-dose tablets 
containing riboflavin, J. Pharm. Biomed. Anal. 41 (2006) 783–790. 
doi:10.1016/j.jpba.2006.01.022. 
[15] D. Mateo-Ortiz, Y. Colon, R.J. Romanach, R. Mendez, Analysis of powder phenomena 
inside a Fette 3090 feed frame using in-line NIR spectroscopy, J. Pharm. Biomed. Anal. 
100 (2014) 40–49. doi:10.1016/j.jpba.2014.07.014. 
[16] H.W. Ward, D.O. Blackwood, M. Polizzi, H. Clarke, Monitoring blend potency in a 
tablet press feed frame using near infrared spectroscopy, J. Pharm. Biomed. Anal. 80 
(2013) 18–23. doi:10.1016/j.jpba.2013.02.008. 
[17] M.D. Tousey, Tablet press operation, 2004. https://tabletscapsules.com/wp-
content/uploads/pdf/tc_20040901_34.pdf. 
[18] R. Mendez, F. Muzzio, C. Velazquez, Study of the effects of feed frames on powder 
blend properties during the filling of tablet press dies, Powder Technol. 200 (2010) 
105–116. doi:10.1016/j.powtec.2010.02.010. 
[19] D. Mateo-Ortiz, F.J. Muzzio, R. Méndez, Particle size segregation promoted by powder 
  
 
157 
157 
flow in confined space: The die filling process case, Powder Technol. 262 (2014) 215–
222. doi:10.1016/j.powtec.2014.04.023. 
[20] C. Ravn, Near-infrared chemical imaging in formulation development of solid dosage 
forms, University of Copenhagen, Denmark, 2009. 
http://forskningsbasen.deff.dk/Share.external?sp=S12d674e0-a095-11df-928f-
000ea68e967b&sp=Sku. 
[21] J.E. Burger, Hyperspectral NIR Image Analysis: data exploration, correction and 
regression, Swedish University of Agricultural Sciences, 2006. 
[22] E.N. Lewis, J. Schoppelrei, E. Lee, Near-infrared Chemical Imaging and the PAT 
Initiative NIR-CI adds a completely new dimension to conventional NIR spectroscopy 
., Spectroscopy. 19 (2004) 26–35. 
[23] S. Matero, J. Pajander, A.M. Soikkeli, S.P. Reinikainen, M. Lahtela-Kakkonen, O. 
Korhonen, J. Ketolainen, A. Poso, Predicting the drug concentration in starch acetate 
matrix tablets from ATR-FTIR spectra using multi-way methods, Anal. Chim. Acta. 
595 (2007) 190–197. doi:10.1016/j.aca.2007.02.008. 
[24] Y. Roggo, P. Chalus, L. Maurer, C. Lema-Martinez, A. Edmond, N. Jent, A review of 
near infrared spectroscopy and chemometrics in pharmaceutical technologies, J. Pharm. 
Biomed. Anal. 44 (2007) 683–700. doi:10.1016/j.jpba.2007.03.023. 
[25] FDA, Application of the near-infrared spectroscopy in the pharmaceutical technology, 
J. Pharm. Biomed. Anal. 66 (2012) 1–10. doi:10.1016/j.jpba.2012.03.009. 
[26] K.A. Bakeev, ed., Process analytical technology book, 2005th ed., Blackwell 
publishing, 2005. 
[27] Metrohm, NIR Spectroscopy : A guide to near-infrared spectroscopic analysis of 
industrial manufacturing processes, Monograph. (2013) 1–46. doi:8.108.5026EN – 
2013-02. 
[28] A. Inc., Product Monograph Apo-Ibuprofen 200 mg, 2014. 
https://pdf.hres.ca/dpd_pm/00024656.PDF. 
[29] M. Institutional, Product monograph: Ascorbic acid injection, 2016. 
  
 
158
https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=d05200cb. 
[30] L. Alvarenga, D. Ferreira, D. Altekruse, J.C. Menezes, D. Lochmann, Tablet 
identification using near-infrared spectroscopy (NIRS) for pharmaceutical quality 
control, J. Pharm. Biomed. Anal. 48 (2008) 62–69. doi:10.1016/j.jpba.2008.05.007. 
[31] E.M. Hetrick, Z. Shi, L.E. Barnes, A.W. Garrett, R.G. Rupard, T.T. Kramer, T.M. 
Cooper, D.P. Myers, B.C. Castle, Development of Near Infrared Spectroscopy-based 
Process Monitoring Methodology for Pharmaceutical Continuous Manufacturing Using 
an Offline Calibration Approach, Anal. Chem. 89 (2017) 9175–9183. 
doi:10.1021/acs.analchem.7b01907. 
[32] C. for D.E. and R. US FDA, Development and Submission of Near Infrared Analytical 
Procedures Guidance for Industry, 2015. 
https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Gu
idances/UCM440247.pdf. 
[33] B.M. Wise, N.B. Gallagher, R. Bro, J.M. Shaver, W. Windig, R.S. Koch, PLS_Toolbox 
Version 4.0 for use with MATLAB 
TM
, 4.0, 2006. 
http://mitr.p.lodz.pl/raman/jsurmacki/pliki/zajecia/LMDiT/cw4i5/LMDiT_PLS_Manual
_4.pdf. 
[34] D. Ely, S. Chamarthy, M.T. Carvajal, An investigation into low dose blend uniformity 
and segregation determination using NIR spectroscopy, Colloids Surfaces A 
Physicochem. Eng. Asp. 288 (2006) 71–76. doi:10.1016/j.colsurfa.2006.04.032. 
[35] H. Wu, M. Tawakkul, M. White, M.A. Khan, Quality-by-Design (QbD): An integrated 
multivariate approach for the component quantification in powder blends, Int. J. Pharm. 
372 (2009) 39–48. doi:10.1016/j.ijpharm.2009.01.002. 
[36] P.-P. Lapointe-Garant, J.-S. Simard, N. Abatzoglou, Real-time NIR Monitoring of a 
Pharmaceutical Blending Process through Multivariate Analysis-derived Models, 1st 
WSEAS Int. Conf. Multivar. Anal. Its Appl. Sci. Eng. (2008) 109–118. 
[37] C. V. Liew, A.D. Karande, P.W.S. Heng, In-line quantification of drug and excipients 
in cohesive powder blends by near infrared spectroscopy, Int. J. Pharm. 386 (2010) 
138–148. doi:10.1016/j.ijpharm.2009.11.011. 
  
 
159 
159 
[38] Z. Wu, O. Tao, X. Dai, M. Du, X. Shi, Y. Qiao, Monitoring of a pharmaceutical 
blending process using near infrared chemical imaging, Vib. Spectrosc. 63 (2012) 371–
379. doi:10.1016/j.vibspec.2012.09.001. 
[39] W. Li, A. Woldu, R. Kelly, J. McCool, R. Bruce, H. Rasmussen, J. Cunningham, D. 
Winstead, Measurement of drug agglomerates in powder blending simulation samples 
by near infrared chemical imaging, Int. J. Pharm. 350 (2008) 369–373. 
doi:10.1016/j.ijpharm.2007.08.055. 
[40] M. Fonteyne, J. Vercruysse, D.C. Díaz, D. Gildemyn, C. Vervaet, J.P. Remon, T. De 
Beer, Real-time assessment of critical quality attributes of a continuous granulation 
process, Pharm. Dev. Technol. 13 (2011) 1–13. doi:10.3109/10837450.2011.627869. 
[41] D. Bär, H. Debus, S. Brzenczek, W. Fischer, P. Imming, Determining particle size and 
water content by near-infrared spectroscopy in the granulation of naproxen sodium, J. 
Pharm. Biomed. Anal. 151 (2018) 209–218. doi:10.1016/j.jpba.2018.01.005. 
[42] A. Miwa, K. Makado, A method for predicting the amount of water required for wet 
granulation using NIR, Int. J. Pharm. 376 (2009) 41–45. 
doi:10.1016/j.ijpharm.2009.04.013. 
[43] M. Blanco, M. Bautista, J.M. Gonza, On-Line Monitoring of A Granulation Process By 
NIR Spectroscopy, J. Pharm. Sci. 99 (2010) 336–345. doi:10.1002/jps.21818. 
[44] M. Fonteyne, J. Arruabarrena, J. De Beer, M. Hellings, T. Van Den Kerkhof, A. 
Burggraeve, C. Vervaet, J. Paul, T. De Beer, NIR spectroscopic method for the in-line 
moisture assessment during drying in a six-segmented fluid bed dryer of a continuous 
tablet production line: Validation of quantifying abilities and uncertainty assessment, J. 
Pharm. Biomed. Anal. 100 (2014) 21–27. doi:10.1016/j.jpba.2014.07.012. 
[45] M. Fonteyne, D. Gildemyn, E. Peeters, S.T.F.C. Mortier, J. Vercruysse, K. V. Gernaey, 
C. Vervaet, J.P. Remon, I. Nopens, T. De Beer, Moisture and drug solid-state 
monitoring during a continuous drying process using empirical and mass balance 
models, Eur. J. Pharm. Biopharm. 87 (2014) 616–628. doi:10.1016/j.ejpb.2014.02.015. 
[46] A. Peinado, J. Hammond, A. Scott, Development, validation and transfer of a Near 
Infrared method to determine in-line the end point of a fluidised drying process for 
  
 
160
commercial production batches of an approved oral solid dose pharmaceutical product, 
J. Pharm. Biomed. Anal. 54 (2011) 13–20. doi:10.1016/j.jpba.2010.07.036. 
[47] M. Khorasani, J.M. Amigo, P. Bertelsen, C.C. Sun, J. Rantanen, Process optimization 
of dry granulation based tableting line : Extracting physical material characteristics 
from granules , ribbons and tablets using near-IR ( NIR ) spectroscopic measurement, 
Powder Technol. 300 (2016) 120–125. doi:10.1016/j.powtec.2016.03.004. 
[48] M. Khorasani, J.M. Amigo, C.C. Sun, P. Bertelsen, J. Rantanen, Near-infrared chemical 
imaging (NIR-CI) as a process monitoring solution for a production line of roll 
compaction and tableting, Eur. J. Pharm. Biopharm. 93 (2015) 293–302. 
doi:10.1016/j.ejpb.2015.04.008. 
[49] R. Mendez, F.J. Muzzio, C. Velazquez, Powder Hydrophobicity and Flow Properties: 
Effect of Feed Frame Design and Operating Parameters, AIChE J. 58 (2012) 697–106. 
doi:10.1002/aic. 
[50] W.R. Ketterhagen, Simulation of powder flow in a lab-scale tablet press feed frame: 
Effects of design and operating parameters on measures of tablet quality, Powder 
Technol. 275 (2015) 361–374. doi:10.1016/j.powtec.2015.01.073. 
[51] X. Xie, V.M. Puri, Uniformity of powder die filling using a feed shoe: A review, Part. 
Sci. Technol. 24 (2006) 411–426. doi:10.1080/02726350600934663. 
[52] P.R. Wahl, G. Fruhmann, S. Sacher, G. Straka, S. Sowinski, J.G. Khinast, PAT for 
tableting: Inline monitoring of API and excipients via NIR spectroscopy, Eur. J. Pharm. 
Biopharm. 87 (2014) 271–278. doi:10.1016/j.ejpb.2014.03.021. 
[53] Y. Guo, C.Y. Wu, C. Thornton, The effects of air and particle density difference on 
segregation of powder mixtures during die filling, Chem. Eng. Sci. 66 (2011) 661–673. 
doi:10.1016/j.ces.2010.11.017. 
[54] R. Mendez, F.J. Muzzio, C. Velazquez, Powder Hydrophobicity and Flow Properties: 
Effect of Feed Frame Design and Operating Parameters, Am. Inst. Chem. Eng. 58 
(20012) 697–706. doi:10.1002/aic.12639. 
[55] J.J. Moes, M.M. Ruijken, E. Gout, H.W. Frijlink, M.I. Ugwoke, Application of process 
analytical technology in tablet process development using NIR spectroscopy: Blend 
  
 
161 
161 
uniformity, content uniformity and coating thickness measurements, Int. J. Pharm. 357 
(2008) 108–118. doi:10.1016/j.ijpharm.2008.01.062. 
[56] M. Blanco, M. Alcalá, Content uniformity and tablet hardness testing of intact 
pharmaceutical tablets by near infrared spectroscopy: A contribution to process 
analytical technologies, Anal. Chim. Acta. 557 (2006) 353–359. 
doi:10.1016/j.aca.2005.09.070. 
[57] C. Benedetti, N. Abatzoglou, J.S. Simard, L. McDermott, G. L??onard, L. Cartilier, 
Cohesive, multicomponent, dense powder flow characterization by NIR, Int. J. Pharm. 
336 (2007) 292–301. doi:10.1016/j.ijpharm.2006.12.014. 
[58] W. Li, L. Bagnol, M. Berman, R.A. Chiarella, M. Gerber, Applications of NIR in early 
stage formulation development. Part II. Content uniformity evaluation of low dose 
tablets by principal component analysis, Int. J. Pharm. 380 (2009) 49–54. 
doi:10.1016/j.ijpharm.2009.06.032. 
[59] K. Jarvinen, W. Hoehe, M. Jarvinen, S. Poutiainen, J. Mikko, S. Borchert, In-line 
monitoring of the drug content of powder mixtures and tablets by near-infrared 
spectroscopy during the continuous direct compression tableting process, Eur. J. Pharm. 
Sci. 48 (2013) 680–688. doi:10.1016/j.ejps.2012.12.032. 
[60] Y. Liu, D. Blackwood, Sample Presentation in Rotary Tablet Press Feed Frame 
Monitoring by Near Infrared Spectroscopy, Am. Pharm. Rev. (2012) 1–9. 
[61] Slobodan, D. Blackwood, A. Liu, H.W. Ward, H. Clarke, Detailed analysis of the 
online near-infrared spectra of pharmaceutical blend in a rotary tablet press feed frame, 
J. Pharm. Biomed. Anal. 103 (2015) 73–79. doi:10.1016/j.jpba.2014.11.008. 
[62] D. of Health, C. Hong Kong SAR, Pharmaceutical product recall guideline, Hong Kong 
SAR,China, 2015. 
[63] A.S. El-Hagrasy, H.R. Morris, F. D’Amico, R.A. Lodder, J.K. Drennen, Near-infrared 
spectroscopy and imaging for the monitoring of powder blend homogeneity, J. Pharm. 
Sci. 90 (2001) 1298–1307. doi:10.1002/jps.1082. 
[64] R.C. Lyon, D.S. Lester, E.N. Lewis, E. Lee, L.X. Yu, E.H. Jefferson, A.S. Hussain, 
Near-infrared spectral imaging for quality assurance of pharmaceutical products: 
  
 
162
analysis of tablets to assess powder blend homogeneity., AAPS PharmSciTech. 3 
(2002) E17. doi:10.1007/BF02830615. 
[65] H. Ma, C. Andeson, Characetrization of pharmaceutical powder blends by NIR CI, J. 
Pharm. Sci. 99 (2008) 3305–3320. doi:10.1002/jps. 
[66] J.M. Amigo, J. Cruz, M. Bautista, S. Maspoch, J. Coello, M. Blanco, Study of 
pharmaceutical samples by NIR chemical-image and multivariate analysis, TrAC - 
Trends Anal. Chem. 27 (2008) 696–713. doi:10.1016/j.trac.2008.05.010. 
[67] J.G. Osorio, G. Stuessy, G.J. Kemeny, F.J. Muzzio, Characterization of pharmaceutical 
powder blends using in situ near-infrared chemical imaging, Chem. Eng. Sci. 108 
(2014) 244–257. doi:10.1016/j.ces.2013.12.027. 
[68] K. Murayama, D. Ishikawa, T. Genkawa, H. Sugino, M. Komiyama, Y. Ozaki, Image 
monitoring of pharmaceutical blending processes and the determination of an end point 
by using a portable near-infrared imaging device based on a polychromator-type near-
infrared spectrometer with a high-speed and high-resolution photo diode array d, 
Molecules. 20 (2015) 4007–4019. doi:10.3390/molecules20034007. 
[69] Y. Roggo, N. Jent, A. Edmond, P. Chalus, M. Ulmschneider, Characterizing process 
effects on pharmaceutical solid forms using near-infrared spectroscopy and infrared 
imaging, Eur. J. Pharm. Biopharm. 61 (2005) 100–110. doi:10.1016/j.ejpb.2005.04.005. 
[70] C. Gendrin, Y. Roggo, C. Collet, Content uniformity of pharmaceutical solid dosage 
forms by near infrared hyperspectral imaging: A feasibility study, Talanta. 73 (2007) 
733–741. doi:10.1016/j.talanta.2007.04.054. 
[71] C. Ravn, E. Skibsted, R. Bro, Near-infrared chemical imaging (NIR-CI) on 
pharmaceutical solid dosage forms-Comparing common calibration approaches, J. 
Pharm. Biomed. Anal. 48 (2008) 554–561. doi:10.1016/j.jpba.2008.07.019. 
[72] J.M. Amigo, C. Ravn, N.B. Gallagher, R. Bro, A comparison of a common approach to 
partial least squares-discriminant analysis and classical least squares in hyperspectral 
imaging, Int. J. Pharm. 373 (2009) 179–182. doi:10.1016/j.ijpharm.2009.02.014. 
[73] Z. Wu, O. Tao, W. Cheng, L. Yu, X. Shi, Y. Qiao, Visualizing excipient composition 
and homogeneity of Compound Liquorice Tablets by near-infrared chemical imaging, 
  
 
163 
163 
Spectrochim. Acta - Part A Mol. Biomol. Spectrosc. 86 (2012) 631–636. 
doi:10.1016/j.saa.2011.10.030. 
[74] J.M. Amigo, C. Ravn, Direct quantification and distribution assessment of major and 
minor components in pharmaceutical tablets by NIR-chemical imaging, Eur. J. Pharm. 
Sci. 37 (2009) 76–82. doi:10.1016/j.ejps.2009.01.001. 
[75] J.M. Prats-Montalbán, J.I. Jerez-Rozo, R.J. Romañach, A. Ferrer, MIA and NIR 
Chemical Imaging for pharmaceutical product characterization, Chemom. Intell. Lab. 
Syst. 117 (2012) 240–249. doi:10.1016/j.chemolab.2012.04.002. 
[76] S.A. Schönbichler, L.K.H. Bittner, A.K.H. Weiss, U.J. Griesser, J.D. Pallua, C.W. 
Huck, Comparison of NIR chemical imaging with conventional NIR, Raman and ATR-
IR spectroscopy for quantification of furosemide crystal polymorphs in ternary powder 
mixtures, Eur. J. Pharm. Biopharm. 84 (2013) 616–625. 
doi:10.1016/j.ejpb.2013.01.006. 
[77] D. Brouckaert, L. De Meyer, B. Vanbillemont, P.J. Van Bockstal, J. Lammens, S. 
Mortier, J. Corver, C. Vervaet, I. Nopens, T. De Beer, Potential of Near-Infrared 
Chemical Imaging as Process Analytical Technology Tool for Continuous Freeze-
Drying, Anal. Chem. 90 (2018) 4354–4362. doi:10.1021/acs.analchem.7b03647. 
[78] N. Souihi, D. Nilsson, M. Josefson, J. Trygg, Near-infrared chemical imaging (NIR-CI) 
on roll compacted ribbons and tablets - Multivariate mapping of physical and chemical 
properties, Int. J. Pharm. 483 (2015) 200–211. doi:10.1016/j.ijpharm.2015.02.006. 
[79] I. Singh, P. Juneja, B. Kaur, P. Kumar, Pharmaceutical Applications of Chemometric 
Techniques, ISRN Anal. Chem. 2013 (2013) 1–13. doi:10.1155/2013/795178. 
[80] R. Ergon, Informative PLS score-loading plots for process understanding and 
monitoring, J. Process Control. 14 (2004) 889–897. doi:10.1016/j.jprocont.2004.02.004. 
[81] O. Scheibelhofer, N. Balak, P.R. Wahl, D.M. Koller, B.J. Glasser, J.G. Khinast, 
Monitoring blending of pharmaceutical powders with multipoint NIR spectroscopy., 
AAPS PharmSciTech. 14 (2013) 234–44. doi:10.1208/s12249-012-9910-4. 
[82] S.S. Sekulic, H.W. Ward, D.R. Brannegan, E.D. Stanley, C.L. Evans, S.T. Sciavolino, 
P.A. Hailey, P.K. Aldridge, On-line monitoring of powder blend homogeneity by near-
  
 
164
infrared spectroscopy, Anal. Chem. 68 (1996) 509–513. doi:10.1021/ac950964m. 
[83] Y. Lin, W. Li, J. Xu, P. Boulas, Development of a NIR-based blend uniformity method 
for a drug product containing multiple structurally similar actives by using the quality 
by design principles, Int. J. Pharm. 488 (2015) 120–126. 
doi:10.1016/j.ijpharm.2015.04.025. 
[84] L. Martínez, A. Peinado, L. Liesum, G. Betz, Use of near-infrared spectroscopy to 
quantify drug content on a continuous blending process: Influence of mass flow and 
rotation speed variations, Eur. J. Pharm. Biopharm. 84 (2013) 606–615. 
doi:10.1016/j.ejpb.2013.01.016. 
[85] Y. Sulub, M. Konigsberger, J. Cheney, Blend uniformity end-point determination using 
near-infrared spectroscopy and multivariate calibration, J. Pharm. Biomed. Anal. 55 
(2011) 429–434. doi:10.1016/j.jpba.2011.02.017. 
[86] P. Luukkonen, M. Fransson, I.N. Björn, J. Hautala, B. Lagerholm, S. Folestad, Real-
time assessment of granule and tablet properties using in-line data from a high-shear 
granulation process, J. Pharm. Sci. 97 (2008) 950–959. doi:10.1002/jps.20998. 
[87] F. Shikata, S. Kimura, Y. Hattori, M. Otsuka, Real-time monitoring of granule 
properties during high shear wet granulation by near-infrared spectroscopy with a 
chemometrics approach, RSC Adv. 7 (2017) 38307–38317. doi:10.1039/C7RA05252A. 
[88] R.A. Mattes, Rudolf Schroeder, V. Dhopeshwar, R. Kowal, W. Randolph, Monitoring 
Granulation Drying Using Near-Infrared Spectroscopy, Pharm. Technol. Eur. (2005) 
41–45. 
[89] L. Chablani, M.K. Taylor, A. Mehrotra, P. Rameas, W.C. Stagner, Inline Real-Time 
Near-Infrared Granule Moisture Measurements of a Continuous Granulation–Drying–
Milling Process, AAPS PharmSciTech. 12 (2011) 1050–1055. doi:10.1208/s12249-011-
9669-z. 
[90] K. Awa, T. Okumura, H. Shinzawa, M. Otsuka, Y. Ozaki, Self-modeling curve 
resolution (SMCR) analysis of near-infrared (NIR) imaging data of pharmaceutical 
tablets, Anal. Chim. Acta. 619 (2008) 81–86. doi:10.1016/j.aca.2008.02.033. 
[91] I. Tomuţă, R. Iovanov, E. Bodoki, S.E. Leucuţa, Quantification of Meloxicam and 
  
 
165 
165 
excipients in intact tablets by near Infrared spectrometry and chemometry., Farmacia. 
58 (2010) 559–571. 
[92] H. Tanabe, K. Otsuka, M. Otsuka, 18-Theoretical analysis of tablet hardness prediction 
using chemoinformetric near-infrared spectroscopy., Anal. Sci. 23 (2007) 857–62. 
doi:10.2116/analsci.23.857. 
[93] C. V. Möltgen, T. Puchert, J.C. Menezes, D. Lochmann, G. Reich, A novel in-line NIR 
spectroscopy application for the monitoring of tablet film coating in an industrial scale 
process, Talanta. 92 (2012) 26–37. doi:10.1016/j.talanta.2011.12.034. 
[94] K. Korasa, G. Hudovornik, F. Vrečer, Applicability of near-infrared spectroscopy in the 
monitoring of film coating and curing process of the prolonged release coated pellets, 
Eur. J. Pharm. Sci. 93 (2016) 484–492. doi:10.1016/j.ejps.2016.08.038. 
[95] B. Igne, H. Arai, J.K. Drennen, C.A. Anderson, Effect of sampling frequency for real-
time tablet coating monitoring using near infrared spectroscopy, Appl. Spectrosc. 70 
(2016) 1476–1488. doi:10.1177/0003702816662622. 
[96] B. Bakri, M. Weimer, G. Hauck, G. Reich, Assessment of powder blend uniformity: 
Comparison of real-time NIR blend monitoring with stratified sampling in combination 
with HPLC and at-line NIR Chemical Imaging, Eur. J. Pharm. Biopharm. 97 (2015) 78–
89. doi:10.1016/j.ejpb.2015.10.002. 
[97] M. Blanco, R. Cueva-Mestanza, J. Cruz, Critical evaluation of methods for end-point 
determination in pharmaceutical blending processes, Anal. Methods. 4 (2012) 2694. 
doi:10.1039/c2ay25379h. 
[98] J. Vercruysse, M. Toiviainen, M. Fonteyne, N. Helkimo, J. Ketolainen, M. Juuti, U. 
Delaet, I. Van Assche, J.P. Remon, C. Vervaet, T. De Beer, Visualization and 
understanding of the granulation liquid mixing and distribution during continuous twin 
screw granulation using NIR chemical imaging, Eur. J. Pharm. Biopharm. 86 (2014) 
383–392. doi:10.1016/j.ejpb.2013.10.012. 
[99] A. Kumar, M. Alakarjula, V. Vanhoorne, M. Toiviainen, F. De Leersnyder, J. 
Vercruysse, M. Juuti, J. Ketolainen, C. Vervaet, J.P. Remon, K. V. Gernaey, T. De 
Beer, I. Nopens, Linking granulation performance with residence time and granulation 
  
 
166
liquid distributions in twin-screw granulation: An experimental investigation, Eur. J. 
Pharm. Sci. 90 (2016) 25–37. doi:10.1016/j.ejps.2015.12.021. 
[100] P.R. Wahl, I. Pucher, O. Scheibelhofer, M. Kerschhaggl, S. Sacher, J.G. Khinast, 
Continuous monitoring of API content, API distribution and crushing strength after 
tableting via near-infrared chemical imaging, Int. J. Pharm. 518 (2017) 130–137. 
doi:10.1016/j.ijpharm.2016.12.003. 
[101] M. Xu, L. Zhou, Q. Zhang, Z. Wu, X. Shi, Y. Qiao, Near-infrared chemical imaging for 
quantitative analysis of chlorpheniramine maleate and distribution homogeneity 
assessment in pharmaceutical formulations, J. Innov. Opt. Health Sci. 09 (2015) 
1650002. doi:10.1142/S1793545816500024. 
[102] J. Cruz, M. Blanco, Content uniformity studies in tablets by NIR-CI, J. Pharm. Biomed. 
Anal. 56 (2011) 408–412. doi:10.1016/j.jpba.2011.04.018. 
[103] R.L. Carneiro, R.J. Poppi, A Quantitative Method using Near Infrared Imaging 
Spectroscopy for Determination of Surface Composition of Tablet Dosage Forms: an 
Example of Spirolactone Tablets, J. Braz. Chem. Soc. 23 (2012) 1570–1576. 
[104] M.B. Lopes, J.-C. Wolff, J.M. Bioucas-Dias, M.A.T. Figueiredo, Quantification of 
Components in Non-Homogenous Pharmaceutical Tablets Using near Infrared 
Reflectance Imaging, J. Near Infrared Spectrosc. 18 (2010) 333–340. 
doi:10.1255/jnirs.897. 
[105] Committee for medicinal products for human use (CHMP), Real Time Release Testing 
(formerly Guideline on Parametric Release), 2012. 
[106] L.L. and J.S. H.Libberman, ed., Pharmaceutical dosage forms-tablets (volume 3), 
second edi, Marcel Dekker, Inc., 1990. 
[107] M. Popo, S. Romero-torres, C. Conde, R.J. Romañach, Blend Uniformity Analysis 
Using Stream Sampling and Near Infra- red Spectroscopy, AAPS PharmSciTech. 3 
(2002) 1–11. 
[108] N. Heigl, D.M. Koller, B.J. Glasser, F.J. Muzzio, J.G. Khinast, Quantitative on-line vs . 
off-line NIR analysis of fluidized bed drying with consideration of the spectral 
background, Eur. J. Pharm. Biopharm. 85 (2013) 1064–1074. 
  
 
167 
167 
doi:10.1016/j.ejpb.2013.09.012. 
[109] F.M. Pawar Pallavi, Yifan Wang, Solshid Keyvan, Gerardo Callegari, Alberto Cuitino, 
Enabling real time release testing by NIR prediction of dissolution of tablets made by 
continuous direct compression, Int. J. Pharm. 512 (2016) 96–107. 
http://dx.doi.org/10.1016/j.ijpharm.2016.08.033. 
[110] O. Berntsson, T. Burger, S. Folestad, L. Danielsson, J. Kuhn, J. Fricke, Effective 
Sample Size in Diffuse Reflectance Near-IR Spectrometry, Anal. Chem. 71 (1999) 
617–623. doi:10.1021/ac980652u. 
[111] K. Yekpe, N. Abatzoglou, B. Bataille, R. Gosselin, T. Sharkawi, J. Simard, A. 
Cournoyer, Predicting the dissolution behavior of pharmaceutical tablets with NIR 
chemical imaging, Int. J. Pharm. 486 (2015) 242–251. 
doi:10.1016/j.ijpharm.2015.03.060. 
[112] T. Puchert, D. Lochmann, J.C. Menezes, G. Reich, Near-infrared chemical imaging 
(NIR-CI) for counterfeit drug identification-A four-stage concept with a novel approach 
of data processing (Linear Image Signature), J. Pharm. Biomed. Anal. 51 (2010) 138–
145. doi:10.1016/j.jpba.2009.08.022. 
[113] J. Dubois, J.-C. Wolff, J.K. Warrack, J. Schoppelrei, E.N. Lewis, NIR Chemical 
Imaging for Counterfeit Pharmaceutical Products Analysis. (Cover story), 
Spectroscopy. 22 (2007) 40–50. 
http://search.ebscohost.com/login.aspx?direct=true&db=aph&AN=24004872&site=eho
st-live. 
[114] R. Gosselin, P. Durão, N. Abatzoglou, J. Guay, R. Gosselin, P. Durão, N. Abatzoglou, 
J. Guay, N. Abatzoglou, J. Guay, Monitoring the concentration of flowing 
pharmaceutical powders in a tableting feed frame Monitoring the concentration of 
flowing pharmaceutical powders in a tableting feed frame, Pharm. Dev. Technol. 7450 
(2016). doi:10.3109/10837450.2015.1102278. 
[115] K. Langhauser, On Solid Ground : Pharma ’ s Most Mature Dosage Form Endures, 
Pharmceutical Manuf. (2016) 1–8. 
http://www.pharmamanufacturing.com/articles/2016/on-solid-ground-pharmas-most-
  
 
168
mature-dosage-form-endures/?show=all. 
[116] K. Hall, T. Stewart, J. Chang, M. Kelly Freeman, Characteristics of FDA drug recalls: 
A 30-month analysis, Am. J. Heal. Pharm. 73 (2016) 235–240. 
doi:10.2146/ajhp150277. 
[117] W. Li, J. Cunningham, H. Rasmussen, D. Winstead, A qualitative method for 
monitoring of nucleation and granule growth in fluid bed wet granulation by reflectance 
near-infrared spectroscopy, J. Pharm. Sci. 96 (2007) 3470–3477. 
doi:10.1002/jps.20974. 
[118] P. Durão, C. Fauteux-Lefebvre, J.M. Guay, N. Abatzoglou, R. Gosselin, Using multiple 
Process Analytical Technology probes to monitor multivitamin blends in a tableting 
feed frame, Talanta. 164 (2017) 7–15. doi:10.1016/j.talanta.2016.11.013. 
[119] A.D. Karande, P.W.S. Heng, C.V. Liew, In-line quantification of micronized drug and 
excipients in tablets by near infrared (NIR) spectroscopy: Real time monitoring of 
tabletting process, Int. J. Pharm. 396 (2010) 63–74. doi:10.1016/j.ijpharm.2010.06.011. 
[120] C.P. Meza, M.A. Santos, R.J. Romañach, Quantitation of drug content in a low dosage 
formulation by transmission near infrared spectroscopy, AAPS PharmSciTech. 7 (2006) 
E206–E214. doi:10.1208/pt070129. 
[121] A. Palou, J. Cruz, M. Blanco, J. Tomàs, J. De Los Ríos, M. Alcalà, Determination of 
drug, excipients and coating distribution in pharmaceutical tablets using NIR-CI, J. 
Pharm. Anal. 2 (2012) 90–97. doi:10.1016/j.jpha.2011.11.003. 
[122] S. Talwar, R. Roopwani, C.A. Anderson, I.S. Buckner, J.K. Drennen, Determination of 
Spatially Resolved Tablet Density and Hardness Using Near-Infrared Chemical 
Imaging (NIR-CI), Appl. Spectrosc. 71 (2017) 1906–1914. 
doi:10.1177/0003702817693856. 
[123] H. Dalvi, C. Fauteux-Lefebvre, J.-M. Guay, N. Abatzoglou, R. Gosselin, Concentration 
monitoring with near infrared chemical imaging in a tableting press, J. Spectr. Imaging. 
7 (2018) 1–18. doi:10.1255/jsi.2018.a5. 
[124] D.R. Ely, M.T. Carvajal, Determination of the scale of segregation of low dose tablets 
using hyperspectral imaging, Int. J. Pharm. 414 (2011) 157–160. 
  
 
169 
169 
doi:10.1016/j.ijpharm.2011.05.027. 
[125] ICH expert working group, ICH Q11 - Development and Manufacture of drug 
substabces, ICH Harmon. Tripart. Guidel. (2012) 30. doi:10.5639/gabij.2012.0103.025. 
[126] M.E.Aulton, Pharmaceutics: The science of dosage form design, Second edi, 2001. 
doi:10.1016/0168-3659(89)90050-3. 
[127] F. Riser, B. Hirschberg, J. Werther, Factors Affecting Solids Segregation, AIChE J. 4 
(1998) 25–34. 
[128] R. Hogg, Mixing and segregation in powders: Evaluation, mechanisms and processes, 
KONA Powder Part. J. 27 (2009) 3–17. doi:10.14356/kona.2009005. 
[129] A.K. Jha, H. Yi, V.M. Puri, Percolation Segregation and Flowability Measurement of 
Urea under Different Relative Humidity Conditions, Kona-Powder Part. 26 (2008) 167–
177. doi:10.14356/kona.2008015. 
[130] C. Pasquini, Near infrared spectroscopy: Fundamentals, practical aspects and analytical 
applications, J. Braz. Chem. Soc. 14 (2003) 198–219. doi:10.1590/S0103-
50532003000200006. 
[131] A. Folch-Fortuny, R. Vitale, O.E. de Noord, A. Ferrer, Calibration transfer between 
NIR spectrometers: New proposals and a comparative study, J. Chemom. 31 (2017) 1–
11. doi:10.1002/cem.2874. 
[132] J. Workman, H. Mark, Calibration Transfer Chemometrics , Part I : Review of the 
Subject Calibration Transfer Chemometrics, Spectroscopy. 32 (2017) 1–8. 
http://www.spectroscopyonline.com/calibration-transfer-chemometrics-part-i-review-
subject. 
[133] D.R. Ely, Dry powder segregation and flowability: experimental and numerical studies, 
PhD thesis Purdue University, 2010. 
[134] T. Koide, T. Nagato, Y. Kanou, K. Matsui, S. Natsuyama, T. Kawanishi, Y. Hiyama, 
Detection of component segregation in granules manufactured by high shear 
granulation with over-granulation conditions using near-infrared chemical imaging, Int. 
J. Pharm. 441 (2013) 135–145. doi:10.1016/j.ijpharm.2012.12.005. 
  
 
170
[135] A. Note, Fit-for-Purpose MicroNIR 
TM
 Spectrometer Facilitates Quality-by-Design ( 
QbD ) Adoption, Appl. Note. (2013) 81–84. 
[136] C. Pederson, P.A. Engineer, Real-time tablet API analysis : a comparison of a palm-size 
NIR spectrometer to HPLC method, Present. IFPAC. (2014). 
[137] C.G. Pederson, D.M. Friedrich, C. Hsiung, M. von Gunten, N.A. O’Brien, H.-J. 
Ramaker, E. van Sprang, M. Dreischor, Pocket-size near-infrared spectrometer for 
narcotic materials identification, 9101 (2014) 91010O. doi:10.1117/12.2050019. 
[138] EMA, Guideline on the use of Near Infrared Spectroscopy ( NIRS ) by the 
pharmaceutical industry and the data requirements for new submissions and variations, 
Eur. Med. Agency. 44 (2014) 1–28. 
http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/06
/WC500167967.pdf. 
[139] R.J. Barnes, M.S. Dhanoa, S.J. Lister, Standard normal variate transformation and de-
trending of near-infrared diffuse reflectance spectra, Appl. Spectrosc. 43 (1989) 772–
777. doi:10.1366/0003702894202201. 
 
